ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
7,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
8,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
9,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
9,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
10,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
11,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
12,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
14,2,Reversible airways obstruction,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
15,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
15,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
15,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
16,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
16,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
16,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
16,4,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
17,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
17,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
18,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
19,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
20,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
20,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
21,1,Headache,Headaches NEC,Headaches,Nerv,N
21,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
21,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
22,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
23,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
23,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
26,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
27,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
27,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
28,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
30,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
31,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
32,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
33,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
34,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
35,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
36,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
36,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
36,3,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
36,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
36,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
37,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
37,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
37,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
37,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
38,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
39,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
39,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
40,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
42,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
43,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
43,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
44,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
44,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
44,3,Headache,Headaches NEC,Headaches,Nerv,N
44,4,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
44,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
44,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,7,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
44,8,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
44,9,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
46,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
46,2,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
46,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
48,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
49,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
50,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
53,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
54,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
55,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
56,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
57,1,Headache,Headaches NEC,Headaches,Nerv,N
57,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
57,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
59,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
59,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
59,3,Headache,Headaches NEC,Headaches,Nerv,N
59,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
59,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
59,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
59,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
60,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
61,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
61,3,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
62,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
62,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
63,1,Migraine,Migraine headaches,Headaches,Nerv,N
64,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
64,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
65,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
68,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
69,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
70,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
72,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
73,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
74,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
75,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
75,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
75,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
75,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
76,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
77,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
78,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,1,Dislocation of vertebra,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
79,2,Headache,Headaches NEC,Headaches,Nerv,N
79,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
80,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
80,2,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
81,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
82,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
82,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
82,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
82,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
83,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
84,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
84,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
84,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
85,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
86,1,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
87,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
88,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
89,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
89,2,Headache,Headaches NEC,Headaches,Nerv,N
90,1,Pneumonia mycoplasmal,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
91,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
92,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
92,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
93,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
94,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
95,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
95,2,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
96,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
97,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
98,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
98,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
98,4,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
98,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
98,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
100,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
100,4,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
100,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
101,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
102,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
102,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
102,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
102,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
102,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
103,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
104,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
104,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
104,3,Device dislocation,Device issues NEC,Device issues,Prod,N
105,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
106,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,2,Headache,Headaches NEC,Headaches,Nerv,N
106,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
106,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
106,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
107,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
108,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
109,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
111,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
112,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
113,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
114,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
115,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
116,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
116,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
117,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
118,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
118,2,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
118,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
118,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
119,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
120,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
121,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
122,1,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
122,2,Wound sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
123,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
124,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
125,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
126,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
127,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
128,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
128,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
128,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
128,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
129,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
129,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
130,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
130,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
131,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
131,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
132,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
132,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
133,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
134,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
134,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
134,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
135,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
135,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
135,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
135,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
135,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
135,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
136,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
137,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
138,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
138,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
138,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
138,4,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
138,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
138,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
138,7,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
138,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
140,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
141,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
141,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
142,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,Y
142,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
142,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
142,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
142,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
143,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
143,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,3,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
143,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
145,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
146,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
146,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
146,3,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
147,1,Vulval ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
148,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
148,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
148,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
149,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
149,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
150,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
151,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
151,2,Headache,Headaches NEC,Headaches,Nerv,N
152,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
153,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
153,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
154,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
154,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
155,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
156,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
156,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
157,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
158,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
159,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
160,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
161,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
162,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
162,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
162,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
162,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
163,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
164,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
165,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
165,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
165,3,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
165,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
165,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
165,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
165,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
165,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
165,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,10,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
165,11,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
165,12,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
165,13,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
166,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
167,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
167,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
167,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
168,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
168,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
169,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
169,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
170,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
171,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
172,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
172,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
173,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
175,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
176,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
177,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
179,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
180,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
180,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
180,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
181,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
181,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
182,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
182,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
183,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
184,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
184,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
184,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
184,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
184,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
184,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
184,7,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
184,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
185,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
185,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
186,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
186,3,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
187,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
188,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
188,2,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
188,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
188,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
189,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
190,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
191,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
191,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
192,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
193,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
194,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
195,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
196,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
196,2,Inferior vena caval occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
197,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
197,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
198,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
198,2,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
200,1,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
201,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
201,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
201,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
201,6,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
202,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
202,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
203,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
204,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
204,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
205,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
206,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
206,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
207,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
208,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
208,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
209,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
209,2,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
210,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
211,2,Mumps,Mumps viral infections,Viral infectious disorders,Infec,N
212,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
212,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
214,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
214,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
216,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
217,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
218,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
219,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
220,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
220,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
221,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
222,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
223,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
223,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
224,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
225,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
226,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
226,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
226,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
227,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
228,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
228,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
228,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
229,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
229,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
230,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
230,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
231,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
232,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
232,2,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
232,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
232,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
232,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
232,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
233,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
233,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
233,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
234,1,Penile oedema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
234,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
235,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
235,2,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
236,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
236,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
237,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
238,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
238,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
238,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
239,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
239,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
240,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
241,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
242,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
243,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
244,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
245,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
246,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
246,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
246,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
246,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
247,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
248,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
248,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
248,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
249,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
250,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
250,2,Headache,Headaches NEC,Headaches,Nerv,N
250,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
250,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
250,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
251,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
251,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
251,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
252,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
253,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
254,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
254,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
255,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
256,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
257,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
258,1,Biopsy lymph gland abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
258,2,Carcinoma in situ,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
258,3,Gallbladder polyp,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
258,4,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
259,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
259,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
260,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
261,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
261,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
261,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
262,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
263,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
263,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
264,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
265,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
265,2,Headache,Headaches NEC,Headaches,Nerv,N
265,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
266,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
267,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
267,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
267,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
268,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
268,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
268,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
270,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
270,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
272,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
272,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
273,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
273,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
274,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
275,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
276,1,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
277,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
277,2,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
278,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
278,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
279,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
279,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
280,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
281,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
281,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
281,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
281,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
281,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
282,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
283,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
283,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
284,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
284,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
285,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
286,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
287,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
288,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
289,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
290,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
291,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
292,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
292,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
292,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
293,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
294,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
294,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
294,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
294,5,Rheumatoid lung,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
295,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
296,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
297,1,Headache,Headaches NEC,Headaches,Nerv,N
297,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
297,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
299,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
300,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
300,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
301,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
302,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
303,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
304,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
305,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
305,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
305,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
306,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
307,1,Bursitis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
308,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
308,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
309,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
309,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
309,3,Mitral valve calcification,Mitral valvular disorders,Cardiac valve disorders,Card,N
310,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
310,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
311,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
311,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
311,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
311,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
312,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
313,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
315,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
316,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
316,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
317,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
317,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
317,3,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
318,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
318,2,Headache,Headaches NEC,Headaches,Nerv,N
318,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
318,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
319,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
319,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
320,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
320,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
320,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
320,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
320,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
321,1,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
322,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
322,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
322,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
322,4,Mean cell volume abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
322,5,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
322,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
323,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
324,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
325,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
325,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
325,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
326,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
326,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
326,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
326,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
326,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
327,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
327,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
328,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
328,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
329,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
329,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
332,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
333,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
333,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
333,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
334,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
335,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
336,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
336,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
337,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
337,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
337,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
338,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
338,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
338,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
339,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
339,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
339,3,Granuloma,Inflammations,General system disorders NEC,Genrl,N
339,4,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
340,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
340,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
340,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
341,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
341,2,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
341,4,Pleurisy viral,Viral infections NEC,Viral infectious disorders,Infec,N
342,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
343,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
344,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
344,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
345,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
346,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
347,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
347,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
348,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
348,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
349,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
349,2,Nasal inflammation,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
349,3,Nasal septum perforation,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
349,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
350,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
351,1,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
352,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
352,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
352,3,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
352,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
353,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
354,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
354,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
354,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
355,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
355,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
356,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
357,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
358,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
359,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
359,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
359,3,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
359,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
359,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
360,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
360,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
361,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
362,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
363,1,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
363,2,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
364,1,Amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
364,2,Fascial infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
364,3,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
365,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
366,1,Rheumatoid lung,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
367,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
368,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
370,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
371,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
371,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
371,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
371,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
371,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,Y
371,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
372,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
372,2,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
373,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
374,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
374,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
374,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
375,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
375,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
375,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
376,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
376,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
377,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
378,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
378,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
379,1,Lipoma of breast,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
380,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
381,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
381,2,Post streptococcal glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
381,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
382,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
383,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
383,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
383,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
383,4,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
383,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
384,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
385,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
386,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
386,2,Headache,Headaches NEC,Headaches,Nerv,N
386,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
387,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
388,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
388,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
389,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
389,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
389,3,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
390,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
390,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
390,3,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
390,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
391,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
391,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
392,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
392,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,3,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
393,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
394,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
394,2,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
394,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
395,1,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
395,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
396,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
396,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
396,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
397,2,Headache,Headaches NEC,Headaches,Nerv,N
397,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
397,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
397,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
399,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
399,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
399,3,Rectal neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
400,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
401,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
402,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
403,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
404,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
405,1,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
406,1,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
406,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
406,3,Vulvovaginitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
407,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
407,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,3,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
407,4,Syringomyelia,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
408,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
409,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
410,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
411,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
412,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
412,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
412,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
413,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
413,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
414,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
416,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
417,3,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
418,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
418,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
419,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
419,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
419,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
420,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
420,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
420,3,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
421,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
421,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
422,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
423,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
423,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
423,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
423,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
423,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
424,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
425,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
426,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
427,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
427,2,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
427,3,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
428,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
429,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
430,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
431,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
432,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
432,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
433,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
433,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
434,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
434,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
434,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
434,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
435,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
436,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
437,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
437,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
438,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
438,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
440,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
440,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
441,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
441,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
442,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
443,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
443,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
443,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
444,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
445,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
446,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
447,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
447,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
448,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
449,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
450,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
450,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
451,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
452,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
452,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
453,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
454,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
455,1,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
456,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
456,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
456,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
457,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
457,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
458,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
459,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
460,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
460,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
461,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
462,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
462,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
462,3,Intervertebral disc compression,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
462,4,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
462,5,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
463,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
463,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
464,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
465,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
465,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
466,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
467,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
467,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
468,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
468,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
468,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
469,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
469,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
469,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
469,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
470,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
471,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
471,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
471,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
471,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
471,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
472,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
473,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
474,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
475,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
476,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
477,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
477,2,Headache,Headaches NEC,Headaches,Nerv,N
477,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
477,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
477,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
478,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
478,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
478,3,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
479,1,Synovial cyst,Synovial disorders,Synovial and bursal disorders,Musc,N
480,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
480,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
481,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
482,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
483,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
483,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
483,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
483,4,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
483,5,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,Y
484,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
485,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
486,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
487,1,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
488,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
488,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
489,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
489,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
489,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
490,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
491,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
492,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
493,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
493,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
493,3,Headache,Headaches NEC,Headaches,Nerv,N
493,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
493,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
493,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
496,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
496,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
498,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
499,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
499,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
500,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
501,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
502,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
503,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
504,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
505,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
505,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
506,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
506,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
506,3,Cor pulmonale,Right ventricular failures,Heart failures,Card,N
507,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
507,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
507,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
507,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
508,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
509,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
511,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
511,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
512,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
512,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
512,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
513,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
513,2,Sacral pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
514,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
514,2,Headache,Headaches NEC,Headaches,Nerv,N
514,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
515,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
516,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
516,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
516,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
516,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
516,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
516,6,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
516,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
517,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
518,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
518,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
518,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
518,4,Peripheral artery aneurysm,Peripheral aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
519,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
520,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
520,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
521,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
521,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
521,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
522,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
523,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
523,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
523,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
524,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
524,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
524,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
525,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
525,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
525,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
526,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
526,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
526,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
527,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
528,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
529,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
530,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
531,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
531,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
531,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
532,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
532,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
533,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
533,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
533,3,Headache,Headaches NEC,Headaches,Nerv,N
533,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
533,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
534,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
535,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
535,2,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
536,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
537,1,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
537,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
538,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
539,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
540,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
540,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
541,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
542,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
543,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
544,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
544,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
544,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
545,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
546,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
546,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
546,3,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
547,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
547,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
547,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
548,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
549,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
550,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
551,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
551,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
552,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
553,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
554,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
554,3,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
554,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
555,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
556,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
557,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
557,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
557,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
558,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
559,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
560,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
561,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
562,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
562,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
562,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
563,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
564,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
564,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
564,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
565,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
565,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
566,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
567,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
568,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
568,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
569,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
571,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
571,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
572,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
573,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
574,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
575,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
576,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
576,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
576,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
576,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
577,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
577,2,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
577,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
577,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
578,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
578,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
579,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
579,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
580,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
581,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
582,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
582,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
583,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
584,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
584,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
584,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
584,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
584,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
584,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
585,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
585,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
585,3,Headache,Headaches NEC,Headaches,Nerv,N
585,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
586,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
586,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
587,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
588,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
589,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
590,1,Carcinoma in situ of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
590,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
591,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,2,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
592,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
592,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
593,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
594,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
594,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
594,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
594,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
594,5,Rheumatoid lung,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
595,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
595,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
596,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
596,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
596,3,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
597,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
597,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
598,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
599,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
599,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
600,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
601,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
601,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
602,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
603,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
603,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
604,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
604,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
604,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
604,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
604,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
605,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
606,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
607,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
607,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
608,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
608,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
609,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
609,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
610,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
610,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
610,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
611,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
611,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
612,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
612,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
612,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
613,1,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
614,1,Tracheitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
615,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
616,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
617,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
617,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
618,1,Infected dermal cyst,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
619,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
619,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
620,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
621,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
621,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
621,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
622,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
622,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
623,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
624,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
624,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
625,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
626,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
626,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
626,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
627,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
627,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
627,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
627,4,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
628,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
629,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
630,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
630,2,Senile dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
631,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
632,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
633,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
633,2,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
634,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
634,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
635,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
636,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
636,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
636,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
636,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
637,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
638,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
638,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
639,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
640,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
640,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
640,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
641,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
642,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
643,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
643,2,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
644,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
644,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
645,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
645,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
646,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
646,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
647,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
648,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
648,2,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
649,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
650,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
650,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
650,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
651,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
651,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
651,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
652,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
653,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
653,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
654,2,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
654,3,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
655,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
655,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
656,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
657,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
658,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
659,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
660,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
661,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
661,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
661,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
662,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
662,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
663,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
663,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
664,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
665,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
666,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
666,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
666,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
667,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
667,2,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
667,3,Pulmonary granuloma,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
668,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
669,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
670,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
670,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
670,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
671,1,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
671,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
672,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
673,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
674,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
675,1,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
676,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
676,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
676,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
676,4,Enterovesical fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
676,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
676,6,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
676,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
676,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
677,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
677,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
678,1,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
679,1,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
680,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
681,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
682,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
683,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
683,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
683,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
684,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
685,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
686,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
687,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
688,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
688,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
689,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
690,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
691,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
691,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
691,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
692,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
693,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
694,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
694,2,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
694,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
695,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
696,1,Aspergilloma,Aspergillus infections,Fungal infectious disorders,Infec,N
696,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
696,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
697,1,Benign breast neoplasm,Breast and nipple neoplasms benign,Breast neoplasms benign (incl nipple),Neopl,N
698,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
698,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
699,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
699,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
700,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
700,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
700,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
700,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
700,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
701,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
702,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
703,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
704,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
704,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
705,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
705,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
705,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
705,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
705,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
706,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
707,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
708,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
708,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
709,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
710,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
710,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
710,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
711,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
711,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
712,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
712,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
713,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
714,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
714,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
714,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
715,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
716,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
716,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
716,3,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
717,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
717,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
717,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
718,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
719,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
719,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
720,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
720,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
721,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
721,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
721,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
722,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
722,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
722,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
723,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
723,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
723,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
723,4,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
724,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
724,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
724,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
726,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
727,1,Pneumonitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,Y
728,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
729,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
729,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
730,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
730,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
730,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
731,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
732,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
732,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
732,3,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
732,4,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
733,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
733,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
734,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
735,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
735,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
735,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
736,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
737,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
737,2,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
738,1,Haematology test abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
739,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
739,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
740,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
740,2,Meningitis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
741,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
741,2,Meningitis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
742,1,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
743,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
744,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
745,1,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
745,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
746,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
746,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
746,3,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
747,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
748,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
748,2,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
749,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
750,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
751,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
751,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
752,1,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
753,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
753,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
754,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
755,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
756,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
757,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
758,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
758,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
758,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
758,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
758,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
758,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
759,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
760,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
761,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
761,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
762,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
763,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
764,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
765,1,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
766,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
766,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
766,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
767,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
767,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
767,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
767,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
768,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
768,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
768,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
769,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
770,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
770,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
771,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
771,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
771,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
771,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
771,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
773,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
773,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
773,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
774,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
774,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
775,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
776,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
777,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
777,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
778,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
778,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
778,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
778,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
778,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
779,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
779,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
779,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
780,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
781,1,ACTH stimulation test abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
781,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
782,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
783,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
783,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
783,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
784,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
784,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
784,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
785,1,Headache,Headaches NEC,Headaches,Nerv,N
785,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
785,3,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
786,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
786,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
787,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
787,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
787,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
788,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
788,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
788,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
788,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
789,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
790,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
791,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
791,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
792,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
793,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
793,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
793,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
795,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
796,1,Headache,Headaches NEC,Headaches,Nerv,N
796,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
796,3,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
797,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
797,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
797,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
797,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
797,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
797,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
799,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
799,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
800,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
800,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
800,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
801,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
802,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
803,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
804,1,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
805,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
806,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
807,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
807,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
807,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
807,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
807,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
808,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
809,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
810,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
810,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
810,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
810,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
811,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
811,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
812,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
812,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
812,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
812,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
812,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
812,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
812,7,Weaning failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
813,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
813,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
814,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
815,1,Abdominal symptom,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
815,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
815,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
815,4,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
816,1,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
817,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
818,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
818,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
818,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
819,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
820,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
821,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
821,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
821,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
822,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
823,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
824,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
824,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
824,3,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
824,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
824,5,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
825,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
825,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
825,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
825,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
826,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
826,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
826,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
827,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
828,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
828,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
829,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
829,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
829,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
829,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
829,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
829,6,Weaning failure,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
830,1,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
831,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
831,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
832,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
832,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
833,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
834,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
834,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
834,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
835,1,Chest wall abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
836,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
837,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
838,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
839,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
839,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
840,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
840,2,Headache,Headaches NEC,Headaches,Nerv,N
840,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
841,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
842,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
842,2,Bone cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
842,3,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
842,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
842,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
842,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
842,7,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
843,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
843,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
844,1,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
845,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
845,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
846,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
846,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
846,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
846,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
846,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
847,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
847,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
848,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
849,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
849,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
850,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
850,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
851,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
851,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
852,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
852,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
852,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
852,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
852,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
853,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
854,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
854,2,Oral lichenoid reaction,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
855,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
856,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
857,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
857,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
857,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
858,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
858,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
858,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
858,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
858,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
858,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
859,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
859,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
859,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
860,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
861,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
861,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
862,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
862,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
862,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
863,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
863,2,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
864,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
865,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
865,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
866,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
866,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
867,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
867,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
867,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
867,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
867,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
867,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
867,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
868,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
869,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
870,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
870,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
871,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
872,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
872,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
872,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
873,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
873,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,Y
874,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
874,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
874,3,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
874,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
875,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
875,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
875,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
875,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
876,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
877,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
877,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
877,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
878,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
878,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
879,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
880,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
880,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
880,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
881,1,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
881,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
882,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
882,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
883,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
884,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
884,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
884,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
884,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
884,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
884,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
884,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
884,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
884,9,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
884,10,Venous pressure jugular increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
885,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
886,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
886,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
887,1,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
887,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
888,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
889,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
890,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
890,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
890,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
891,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
891,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
891,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
891,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
891,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
891,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
891,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
891,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
891,9,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
891,10,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
891,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
891,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
891,13,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
891,14,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
891,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
891,16,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
891,17,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
891,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
891,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
891,20,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
891,21,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
891,22,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
891,23,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
891,24,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
891,25,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
891,26,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
892,3,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
893,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
893,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
893,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
893,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
893,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
893,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
894,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
895,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
895,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
896,1,Subacute endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
897,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
898,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
898,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
899,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
899,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
900,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
901,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
901,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
901,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
902,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
903,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
903,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
904,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
904,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
905,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
905,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
905,3,Nail bed bleeding,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
905,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
905,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
905,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
905,7,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
906,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
907,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
908,1,Carcinoid syndrome,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
908,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
909,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
909,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
909,3,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
910,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
911,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
912,1,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
912,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
913,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
913,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
913,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
913,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
914,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
914,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
915,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
916,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
917,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
918,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
918,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
918,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
919,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
919,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
920,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
920,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
921,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
921,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
922,1,Carcinoid tumour of the prostate,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
923,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
924,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
925,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
926,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
927,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
928,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
928,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
929,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
929,2,Headache,Headaches NEC,Headaches,Nerv,N
929,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
930,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
931,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
932,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
933,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
933,2,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
934,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
935,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
936,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
937,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
937,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
937,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
937,4,Varicose ulceration,Varicose veins NEC,Venous varices,Vasc,N
938,1,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
939,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
939,2,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
940,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
941,1,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
941,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
941,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
941,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
942,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
942,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
943,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
943,3,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
944,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
944,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
945,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
945,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
945,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
946,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
946,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
947,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
947,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
948,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
948,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
948,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
949,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
950,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
950,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
950,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
951,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
951,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
952,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
952,2,Dislocation of vertebra,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
952,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
952,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
952,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
953,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
953,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
954,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
954,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
954,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
954,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
954,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
954,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
955,1,Small intestine adenocarcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
956,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
957,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
957,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
957,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
958,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
959,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
959,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
960,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
960,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
961,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
962,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
962,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
962,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
962,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
962,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
962,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
962,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
962,8,Spinal cord abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
962,9,Spinal fusion surgery,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
963,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
963,2,Infected bite,Infections NEC,Infections - pathogen unspecified,Infec,N
964,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
964,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
964,3,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
964,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
965,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
965,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
965,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
966,1,Arteritis coronary,Coronary artery disorders NEC,Coronary artery disorders,Card,N
966,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
966,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
966,4,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
966,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
966,6,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
966,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
966,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
967,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
967,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
967,3,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
967,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
968,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
968,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
969,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
970,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
971,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
971,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
972,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
972,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
972,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
973,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
973,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
973,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
973,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
973,5,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
973,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
973,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
973,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
974,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
975,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
975,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
976,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
976,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
976,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
977,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
977,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
977,3,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
977,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
977,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
977,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
977,7,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
977,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
977,9,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,10,Subcorneal pustular dermatosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
977,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
978,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
979,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
980,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
981,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
982,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
982,2,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,Y
983,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
983,2,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
984,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
984,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
984,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
984,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
985,1,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
986,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
986,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
986,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
986,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
986,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
987,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
987,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
987,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
987,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
987,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
987,6,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
988,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
989,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
989,2,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
989,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
990,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
991,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
991,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
991,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
991,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
991,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
992,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
992,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
992,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
992,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
992,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
993,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
993,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
994,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
994,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
995,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
995,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
995,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
996,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
996,2,Headache,Headaches NEC,Headaches,Nerv,N
996,3,Migraine,Migraine headaches,Headaches,Nerv,N
996,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
997,1,Headache,Headaches NEC,Headaches,Nerv,N
998,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
999,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
999,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
999,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1000,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1001,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1001,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1002,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1002,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1003,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1003,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1004,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1004,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1004,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1004,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1005,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1005,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1005,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1006,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1007,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1008,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1008,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1009,1,Bone swelling,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1009,2,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1010,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1010,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1011,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1011,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1012,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1013,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1014,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1014,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1015,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1016,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1017,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1017,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1017,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1018,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1019,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1020,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1020,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1021,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1021,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,3,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1021,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1022,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1023,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1023,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1023,3,Hepatitis A antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1024,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1024,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1024,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1025,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1025,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1026,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1026,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1027,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1027,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1027,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1028,1,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1028,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1029,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1029,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1029,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1029,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1030,1,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1031,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1031,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1032,1,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1032,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1032,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1033,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1033,2,Chest wall mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1033,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1033,4,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1034,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1035,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1035,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1036,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1036,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1037,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1037,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1038,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1038,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1039,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1040,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1041,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1041,2,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1041,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1042,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1043,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1043,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1043,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1044,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1045,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1045,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1045,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1045,4,Subcorneal pustular dermatosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1046,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1046,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1046,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1046,4,Headache,Headaches NEC,Headaches,Nerv,N
1046,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1046,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1046,7,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1046,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1047,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1048,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1049,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1049,2,Headache,Headaches NEC,Headaches,Nerv,N
1049,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1049,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1050,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1050,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1051,1,Pneumonia mycoplasmal,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
1052,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1052,2,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
1052,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1053,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1053,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1053,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1053,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1053,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1053,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1054,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1055,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1056,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1056,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1056,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1057,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1058,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1059,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1060,1,Bleeding varicose vein,Varicose veins NEC,Venous varices,Vasc,N
1061,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1061,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1062,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1062,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1063,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1064,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1064,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1065,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1066,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1067,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1067,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1067,3,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1068,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1068,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1068,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1069,1,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1070,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1071,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1072,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1072,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1072,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1072,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1072,5,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1073,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1073,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1073,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1074,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1074,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1075,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1075,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1076,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1076,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1077,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1077,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1077,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1077,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1077,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1077,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1078,1,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1079,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1079,2,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1079,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
1079,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1079,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1080,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1080,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1081,1,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1081,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1081,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1081,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1081,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1082,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1083,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1083,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1083,3,Multifocal motor neuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
1083,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1083,5,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1084,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1084,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1084,3,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1084,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1085,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1085,2,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1086,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1087,1,Pneumonia moraxella,Moraxella infections,Bacterial infectious disorders,Infec,N
1088,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1088,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1088,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1088,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1088,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1088,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1089,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1090,1,Microscopic polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1091,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1091,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1092,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1092,2,Effusion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1092,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1093,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1093,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1094,1,Dermal sinus,Skin and subcutaneous malformations and anomalies NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1094,2,Device dislocation,Device issues NEC,Device issues,Prod,N
1094,3,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1095,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1095,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1095,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1095,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1095,5,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1096,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
1096,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1097,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1098,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1098,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1098,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1098,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1098,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1099,1,Rheumatoid lung,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1099,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1099,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1099,4,Ventricular failure,Heart failures NEC,Heart failures,Card,Y
1100,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1101,1,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
1101,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1102,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
1102,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1103,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1103,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1104,1,Hypertrophic osteoarthropathy,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1104,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1104,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1104,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1104,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1104,6,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1105,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1106,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1106,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1107,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1107,2,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1108,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
1108,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1109,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1109,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1110,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1111,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1112,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1112,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1113,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1113,2,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1113,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1114,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1115,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1115,2,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1116,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1117,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1117,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1117,3,Rheumatoid vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1117,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1118,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1119,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
1119,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1119,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1120,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1120,2,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1121,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1121,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1121,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1122,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1123,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1124,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1124,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
1124,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1124,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1124,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1125,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1126,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1126,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1127,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1127,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
1127,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1127,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1127,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1128,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1128,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1129,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1130,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1130,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1131,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1131,2,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1131,3,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1132,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1132,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1132,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1133,1,Febrile infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1133,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1133,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1134,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1134,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1135,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1136,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1136,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1137,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1137,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1138,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1139,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1139,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1140,1,Nodular vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1141,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1142,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1142,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1143,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1144,1,Pneumonia necrotising,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1145,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1145,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1147,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1147,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1147,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1148,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1149,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1150,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1150,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1150,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1150,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1150,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1150,6,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1151,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1151,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1151,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1151,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1151,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1152,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1153,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1153,2,Staphylococcal osteomyelitis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1153,3,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1154,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1154,2,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1155,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1156,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1157,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1157,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1158,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1159,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1160,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1160,2,Vitritis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1161,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1161,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1161,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1161,4,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1162,1,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1162,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1163,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1164,1,Headache,Headaches NEC,Headaches,Nerv,N
1164,2,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1165,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1165,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1165,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1166,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1166,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1167,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1167,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1168,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1168,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1169,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1170,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1171,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1172,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1173,1,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1174,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1175,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1176,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1177,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1178,1,Malignant neoplasm of eyelid,Ocular neoplasms malignant (excl melanomas),Ocular neoplasms,Neopl,N
1179,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1179,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1179,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1180,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1180,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1181,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1181,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1182,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1183,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1184,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1185,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1186,1,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1187,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1187,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1188,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1188,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1189,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1190,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1191,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1192,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1192,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1192,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1193,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1193,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1193,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1193,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1193,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1193,6,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1194,1,Pelvic neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1195,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1196,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1196,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1196,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1197,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1197,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1198,1,Clostridial infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1198,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1198,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1199,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1199,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1200,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1200,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1200,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1201,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1202,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1202,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1202,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1202,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1202,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1202,6,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1202,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1202,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1202,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1203,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1204,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1205,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1205,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1206,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1207,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1207,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1208,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1209,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1210,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1210,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1210,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1211,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1211,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1212,1,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1213,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1213,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1214,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1215,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1215,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1216,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1217,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1217,2,Infectious pleural effusion,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1217,3,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1217,4,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1217,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1217,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1218,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1219,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1220,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1220,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1220,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1221,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1221,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1222,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1222,2,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1222,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1222,4,Pelvic neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1222,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1222,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1223,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1223,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1223,3,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1223,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1223,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1223,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1224,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1224,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1225,1,Headache,Headaches NEC,Headaches,Nerv,N
1225,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1225,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1225,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1225,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1225,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1225,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1226,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1227,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1227,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1228,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1229,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1230,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1230,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1230,3,Gastrointestinal dysplasia,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1231,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1231,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1232,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1232,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1232,3,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1233,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1234,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1234,2,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1235,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1236,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1237,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1237,2,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1238,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1238,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1238,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1238,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1238,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1238,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1239,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1240,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1240,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
1240,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1240,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1241,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1242,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
1243,1,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
1243,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1243,3,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1244,1,Haematology test abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1244,2,Haemochromatosis,Iron excess,Iron and trace metal metabolism disorders,Metab,N
1244,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1245,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
1245,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1246,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1247,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1248,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1248,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1248,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1249,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1250,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1250,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1250,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1250,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1250,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1251,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1251,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1251,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1251,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1251,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1251,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1251,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1252,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1252,2,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1253,1,Tinea versicolour,Tinea infections,Fungal infectious disorders,Infec,N
1254,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1254,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1255,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1256,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1256,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1256,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1256,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1257,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1258,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1258,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1258,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1259,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1259,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1259,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1260,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1261,1,Campylobacter infection,Campylobacter infections,Bacterial infectious disorders,Infec,N
1261,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1262,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1262,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1263,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1263,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1264,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1264,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1265,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1265,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1265,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1266,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1268,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1269,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1269,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1270,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1271,1,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1271,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1272,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1273,1,Inflammatory carcinoma of the breast,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1274,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1275,1,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1275,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1275,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1276,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1276,2,Catheter site pain,Implant and catheter site reactions,Administration site reactions,Genrl,N
1276,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1276,4,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1277,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1277,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1277,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1277,4,Lung neoplasm,Respiratory tract and pleural neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1277,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1277,6,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1278,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1279,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1279,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1279,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1280,1,Septic rash,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1281,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1282,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1282,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1282,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1282,4,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1282,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1282,6,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1282,7,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1282,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1282,9,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1282,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1282,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1283,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1283,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1284,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1284,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1284,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1284,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1284,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1284,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1284,8,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1284,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1285,2,Hydrosalpinx,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1285,3,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
1285,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1286,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1287,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1287,2,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1287,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1287,4,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1288,1,Headache,Headaches NEC,Headaches,Nerv,N
1288,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1288,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1288,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1288,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1289,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1289,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1290,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1290,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1290,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1290,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1290,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1290,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1291,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1291,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1291,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1291,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1291,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1292,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1293,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1294,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1295,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1296,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1296,2,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1296,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1297,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1297,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1297,3,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1297,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1297,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1297,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1297,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1297,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1297,9,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1298,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1298,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1299,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1300,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1301,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1302,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1302,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1303,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1304,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1304,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1304,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1305,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1305,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1305,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1305,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1306,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1306,2,Perichondritis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1307,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1307,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1307,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1307,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1307,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1307,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1307,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1308,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1309,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1310,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1311,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1311,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1312,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
1312,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1313,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1314,1,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1315,1,Headache,Headaches NEC,Headaches,Nerv,N
1315,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1316,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1317,1,Extranodal marginal zone B-cell lymphoma (MALT type),Extranodal marginal zone B-cell lymphomas (low grade B-cell),Lymphomas non-Hodgkin's B-cell,Neopl,Y
1317,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1317,3,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1318,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1319,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1319,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1320,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1321,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1322,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1323,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1324,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1325,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1326,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1327,1,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1328,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1328,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1328,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1328,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1329,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1330,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1331,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1331,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1332,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1332,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1333,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1334,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1335,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1336,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1337,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1338,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1338,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1339,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1339,2,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1340,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1341,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1342,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1342,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1343,1,CD8 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1343,2,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1344,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1345,1,Migraine,Migraine headaches,Headaches,Nerv,N
1346,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1346,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1347,1,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1347,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1347,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1347,4,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1347,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1350,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1350,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1350,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1350,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1351,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1351,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1351,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1351,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1352,1,Nasal sinus cancer,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1353,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1353,2,Type IIa hyperlipidaemia,Inborn errors of lipid metabolism,Metabolic and nutritional disorders congenital,Cong,N
1354,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1354,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1354,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1354,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1354,5,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1355,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1355,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1355,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1356,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1356,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1356,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1357,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1358,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1358,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1358,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1358,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1358,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1358,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1359,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1359,2,Nasal neoplasm,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1359,3,Nasal sinus cancer,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1359,4,Ocular neoplasm,Ocular neoplasms malignancy unspecified,Ocular neoplasms,Neopl,N
1360,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1360,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1360,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1360,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1361,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1362,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1363,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1363,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1363,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1364,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1364,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1365,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1366,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1367,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1368,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1368,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1368,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1368,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1368,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1369,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1369,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1369,3,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1369,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1370,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1370,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1371,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1372,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1372,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1372,3,Umbilical haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1373,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1373,2,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1373,3,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1373,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1374,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1374,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1374,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1374,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1374,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1374,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1374,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1374,8,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1374,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1375,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1376,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1376,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1377,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1377,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1377,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1377,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1378,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1378,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1378,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1378,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1379,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1379,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1379,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1380,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1380,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1380,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1381,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1381,2,Bone operation,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
1381,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1382,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1382,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
1383,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1384,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1385,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1385,2,Ovarian epithelial cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1386,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1386,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1387,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1387,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1387,3,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
1388,1,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1388,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1388,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1389,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1389,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1390,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1390,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1390,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1390,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1390,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1391,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1392,1,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
1392,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1392,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1392,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1393,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1394,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1394,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1394,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1395,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1395,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1395,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1395,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1395,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1396,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1396,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1396,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1397,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1397,2,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1397,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1397,4,Pylorus dilatation,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1397,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1397,6,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1397,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1398,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1399,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
1399,2,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1399,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1400,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
1401,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1401,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1401,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1401,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1401,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1401,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1402,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1402,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1402,3,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1403,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1403,2,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1404,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1404,2,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1404,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1405,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1406,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1407,1,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1407,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
1408,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1408,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1409,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1410,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1410,2,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1410,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1410,4,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1410,5,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
1410,6,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1411,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1411,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1412,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1413,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1413,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1414,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1415,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1415,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1416,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1416,2,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1416,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1416,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1416,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1417,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1417,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1418,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1418,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1418,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1419,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1419,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1420,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1420,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1420,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1420,4,Gastrointestinal hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1420,5,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1420,6,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1420,7,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1420,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1420,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1421,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1421,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1422,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1423,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1423,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1424,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1425,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1425,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1425,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1425,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1425,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1426,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1426,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1426,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
1427,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1427,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1428,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1428,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1428,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1428,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1429,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1429,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1429,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1429,4,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1429,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1430,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1431,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1432,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1432,2,Headache,Headaches NEC,Headaches,Nerv,N
1432,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1432,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1432,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1433,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1433,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1433,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1433,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1434,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1435,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1436,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1437,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1437,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1437,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1437,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1437,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1437,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1437,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1438,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1438,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1439,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1440,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1440,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1441,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1442,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1442,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1442,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1443,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1443,2,Wound infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1444,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1444,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1445,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1446,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1446,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1446,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1446,4,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1446,5,Listeria sepsis,Listeria infections,Bacterial infectious disorders,Infec,N
1446,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1447,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1447,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1447,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1447,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1447,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1447,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1448,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1448,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1449,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1449,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1450,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1450,2,Intervertebral disc space narrowing,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1450,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1451,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1451,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1451,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1451,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1451,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1451,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1452,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1453,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1454,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1454,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1454,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1454,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1454,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1455,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1456,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1457,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1457,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1457,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1457,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1457,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1457,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1457,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1458,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1458,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1458,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1458,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1458,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1458,6,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1458,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1458,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1458,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1458,10,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1458,11,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1459,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1459,2,Adhesion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1459,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1460,1,Salivary gland cancer,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1461,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1461,2,Arthrodesis,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1461,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1461,4,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1461,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1461,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1461,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1461,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1461,9,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1461,10,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1462,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1462,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1462,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1462,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1463,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1463,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1464,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1464,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1464,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1465,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1466,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1467,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1468,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1469,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1469,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1469,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1470,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1470,2,Headache,Headaches NEC,Headaches,Nerv,N
1470,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1470,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1471,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1472,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1473,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1473,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1473,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1473,4,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1474,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1474,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1474,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1475,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1475,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1475,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1475,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1476,1,Multi-organ disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1476,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1476,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1476,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1476,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1477,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1477,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1477,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1478,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1479,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1480,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1480,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1480,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1480,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1480,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1480,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1481,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1482,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1482,2,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1482,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1483,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1483,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1483,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1483,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1483,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1483,6,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1483,7,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1483,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1483,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1483,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1484,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1485,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1485,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1485,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1485,4,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1485,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1485,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1486,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1487,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1487,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1487,3,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1487,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1487,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1487,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1488,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1488,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1488,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1488,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1489,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1489,2,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1489,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1489,4,Synovectomy,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1490,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1491,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1491,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1491,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1491,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1492,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1492,2,Vascular rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1493,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1493,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1493,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1494,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1494,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1495,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1495,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1495,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1495,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1495,5,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1496,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1496,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1496,3,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1497,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1497,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1497,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1498,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1498,2,Headache,Headaches NEC,Headaches,Nerv,N
1498,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1499,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1499,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1500,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1501,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1501,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1502,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1502,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1503,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1504,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1504,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1504,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1505,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1505,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1506,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1506,2,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1506,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1507,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1507,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1507,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1508,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1509,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1509,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1509,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1509,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1509,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1509,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1509,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1509,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1509,9,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1510,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1510,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1510,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1510,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1510,5,Colonic fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1510,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1510,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1510,8,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1510,9,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1510,10,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1510,11,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1510,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1510,13,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1510,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1511,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1512,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1512,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1513,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1514,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1514,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1515,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1516,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1516,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1517,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1518,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1518,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1519,1,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1519,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1519,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1520,1,Colorectal cancer stage IV,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1520,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
1521,1,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1522,1,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1523,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1523,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1524,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1524,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1525,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1525,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1526,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1526,2,Headache,Headaches NEC,Headaches,Nerv,N
1526,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1526,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1526,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1526,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1527,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1527,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1528,1,Antineutrophil cytoplasmic antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1528,2,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1528,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1528,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1529,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1530,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1530,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1531,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1531,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1531,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1531,4,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1532,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1532,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1532,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1532,4,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1532,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1532,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1533,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1534,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1534,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1535,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1536,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1537,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1537,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1538,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1539,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1540,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1541,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1541,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1541,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1541,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1541,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1542,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1542,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1542,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1543,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1544,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1544,2,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
1544,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1544,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1544,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1545,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1546,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1546,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1546,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1546,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1546,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1547,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1547,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1547,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1547,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1547,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1547,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1547,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1547,8,Headache,Headaches NEC,Headaches,Nerv,N
1547,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1547,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1547,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1547,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1547,13,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1548,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1549,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1549,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1549,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1550,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1550,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1551,1,Intestinal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1551,2,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1552,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1552,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1552,3,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1553,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1553,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1553,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1553,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1554,1,Blood pressure inadequately controlled,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1554,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1555,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1555,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1556,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1556,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1556,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1556,4,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
1556,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1557,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1557,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1557,4,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1557,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1557,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1557,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1557,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1557,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1558,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1559,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1559,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1560,1,Acne,Acnes,Skin appendage conditions,Skin,N
1560,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1560,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1560,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1560,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1560,6,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1560,7,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
1560,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1560,9,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1560,10,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1560,11,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1560,12,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1560,13,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1560,14,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1560,15,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1561,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1561,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1561,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1561,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1561,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1562,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1563,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1563,2,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
1563,3,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1563,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1563,5,Invasive breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1564,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1564,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1564,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1565,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1565,2,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1565,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1565,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1565,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1565,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1566,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1567,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1568,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1568,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1569,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1570,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1570,2,Serositis,Inflammations,General system disorders NEC,Genrl,N
1571,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1572,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1572,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1572,3,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1572,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1572,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1572,6,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1572,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1572,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1572,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1572,10,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1572,11,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1572,12,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1572,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1572,14,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1572,15,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1572,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1572,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1572,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1572,19,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1572,20,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1572,21,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1573,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1573,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1573,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1573,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1573,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1573,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1573,7,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1573,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1573,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1574,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1574,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1574,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1574,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1575,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1576,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1576,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1576,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1576,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1576,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1577,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1577,2,Malignant peritoneal neoplasm,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1577,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1578,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1578,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1578,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1579,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1580,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1581,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1582,1,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1583,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1583,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1584,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
1584,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1584,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1584,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1584,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1585,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1585,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1585,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1585,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1586,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1586,2,Genital infection male,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1586,3,Genital swelling,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1587,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1587,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1587,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1587,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1588,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1588,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1589,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1589,2,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1590,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1590,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1590,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1590,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1590,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1591,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1591,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1591,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1592,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1592,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1592,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1592,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1592,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1592,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1592,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1592,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1593,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1593,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1593,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1593,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1594,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1595,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1596,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1597,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1598,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1598,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1599,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1599,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1599,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1599,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1599,5,Myopathy,Myopathies,Muscle disorders,Musc,N
1599,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1600,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1601,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1601,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1601,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1601,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1601,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1601,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1602,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1603,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1603,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1603,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1603,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1603,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1603,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1603,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1603,8,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1604,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1604,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1605,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1605,2,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1605,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1606,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1606,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1607,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1608,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1608,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1608,3,Hepatitis B test negative,Virus identification and serology,Microbiology and serology investigations,Inv,N
1608,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1608,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1609,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1609,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1609,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1609,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1609,5,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
1609,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1609,7,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1609,8,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1609,9,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
1609,10,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1609,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1609,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1609,13,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1609,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1609,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1609,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1609,17,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1610,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1610,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1610,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1610,4,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1610,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1611,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1611,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1611,3,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1611,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1611,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1612,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1612,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1612,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1612,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1612,5,Headache,Headaches NEC,Headaches,Nerv,N
1612,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1612,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1612,8,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1612,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1612,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1612,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
1614,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1614,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1614,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1615,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,Y
1615,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1615,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1616,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1616,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1616,3,Diaphragm muscle weakness,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
1616,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1616,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1616,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1616,7,Myopathy,Myopathies,Muscle disorders,Musc,N
1616,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1617,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1617,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1617,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1617,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1618,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1618,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1619,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1619,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1619,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1619,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1619,5,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
1620,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1621,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1622,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1622,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1622,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1622,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1622,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1622,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1622,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1622,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1623,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1623,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1623,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1623,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1624,1,Listeria sepsis,Listeria infections,Bacterial infectious disorders,Infec,N
1625,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1626,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1627,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1627,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1627,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1628,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1628,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1629,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1630,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1631,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1631,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1632,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1632,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1633,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1634,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1634,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1634,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1635,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1635,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1635,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1635,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1635,5,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1636,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1637,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1638,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1639,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1640,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1641,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1641,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1641,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1641,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1642,1,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1642,2,CSF protein abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
1642,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1642,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1642,5,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1642,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1642,7,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1643,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1644,1,Headache,Headaches NEC,Headaches,Nerv,N
1644,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1645,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1645,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1645,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1645,4,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1646,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1646,2,Neck deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1646,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1646,4,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1647,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1647,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1647,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1648,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1649,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1649,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1650,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1650,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1650,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1650,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1650,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1651,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1651,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1651,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1651,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1651,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1652,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1652,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1652,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1653,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1653,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1654,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1654,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1654,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1655,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1656,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1657,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1657,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1657,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1658,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1659,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1660,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1660,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1661,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1662,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1662,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1662,3,Headache,Headaches NEC,Headaches,Nerv,N
1662,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1662,5,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1662,6,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1662,7,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1662,8,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1662,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1662,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1662,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1663,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1664,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1664,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1664,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1664,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1664,5,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1664,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1664,7,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1664,8,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1664,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1665,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1665,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1665,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1665,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1666,1,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1666,2,Vulval oedema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1667,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1667,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1667,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1667,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1667,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1668,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1668,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1668,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1668,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1668,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1668,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1669,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1670,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1670,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1670,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1670,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1670,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1670,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1670,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1670,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1671,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1672,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1673,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1674,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1674,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1674,3,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1675,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1675,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1676,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1677,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1677,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1678,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1679,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1680,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1680,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1681,1,Cervix carcinoma stage 0,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1681,2,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
1682,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1682,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1683,1,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
1684,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1684,2,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
1684,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1685,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1686,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1686,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1686,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1686,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1686,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1686,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1687,2,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1687,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1687,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1687,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1687,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1687,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1687,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1687,9,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1687,10,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1687,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1688,1,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1689,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1690,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1690,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1690,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1690,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1691,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1691,2,Headache,Headaches NEC,Headaches,Nerv,N
1691,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1691,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1692,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1692,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1692,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1693,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1693,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1693,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1693,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1694,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1694,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1694,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1695,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1695,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1695,3,Headache,Headaches NEC,Headaches,Nerv,N
1695,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1695,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1695,6,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1695,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1695,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1696,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1697,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1698,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1698,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1698,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1699,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1699,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1699,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1700,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1701,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1701,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1701,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1701,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1701,5,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
1701,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1701,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1701,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1701,9,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1701,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1702,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1703,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1703,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1703,3,Injection,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1703,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1703,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1704,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1704,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1704,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1704,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1705,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1706,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1707,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1707,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1707,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1707,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1707,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1707,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1708,1,Bladder cancer stage II,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1708,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1709,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1709,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1710,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1711,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1712,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1712,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1712,3,Diaphragm muscle weakness,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
1712,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1712,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1712,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1712,7,Myopathy,Myopathies,Muscle disorders,Musc,N
1712,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1713,1,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1714,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1715,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1715,2,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
1715,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1716,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1716,2,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1716,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1716,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1717,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1717,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1718,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1719,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1720,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1721,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1721,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1721,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1721,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1722,1,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1722,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1722,3,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1722,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1723,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1723,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1724,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1724,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1725,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1726,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1726,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1726,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1726,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1727,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1727,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1728,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1729,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1730,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1730,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1730,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1731,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
1732,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,Y
1733,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1734,1,Anal neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1734,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1734,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1735,1,Bursitis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1735,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1736,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1737,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1737,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1738,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1738,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1738,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
1738,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1739,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1740,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1741,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1741,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1742,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
1743,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1743,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1743,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1743,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1744,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1745,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1746,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
1746,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1746,3,Long QT syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1747,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1747,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1747,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1748,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1748,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1748,3,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1748,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1748,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1749,1,Nail psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1749,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1749,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1750,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1751,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1751,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1752,1,Adenoiditis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1752,2,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1753,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1753,2,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
1754,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
1754,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1754,3,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1755,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1755,2,Haemorrhagic cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,Y
1755,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1755,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1755,5,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1755,6,Synovial cyst,Synovial disorders,Synovial and bursal disorders,Musc,N
1755,7,Synovial disorder,Synovial disorders,Synovial and bursal disorders,Musc,N
1756,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1756,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1757,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1757,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1758,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1758,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1759,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1759,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1759,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1759,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1759,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1760,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1760,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1761,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1761,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1762,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1762,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1763,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1764,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1764,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1764,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1764,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1765,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1766,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
1766,2,Bronchial secretion retention,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1766,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1766,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1766,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1766,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1766,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1767,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1767,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1768,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1769,1,Headache,Headaches NEC,Headaches,Nerv,N
1769,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1770,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1771,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1771,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1771,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1772,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1772,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1772,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1772,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1772,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1772,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1772,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1773,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1773,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1773,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1774,1,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1774,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1774,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1775,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1775,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1775,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1775,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1775,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1775,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1775,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1775,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1776,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1776,2,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
1776,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
1776,4,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1776,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1777,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1778,1,Cellulitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1778,2,Dacryocystitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1778,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1779,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1780,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1780,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1780,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1780,4,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1780,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1780,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1781,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1781,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1781,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1782,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1782,2,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1782,3,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1783,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1784,1,Peritoneal tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1785,1,Bursitis infective staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1786,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1787,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1788,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1788,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1789,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1789,2,Urethral pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1790,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1791,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1792,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1793,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1794,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1794,2,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1794,3,Enterovesical fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1794,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1794,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1794,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1795,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1795,2,Meningitis tuberculous,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1795,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1796,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1797,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1797,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1798,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1799,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1799,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1799,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1800,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1801,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1802,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1802,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1802,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1802,4,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1803,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1803,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1804,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1804,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1804,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1804,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1804,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1805,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1805,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1805,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1805,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1805,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1805,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1806,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1807,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1808,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1809,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
1809,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1810,1,Ileostomy closure,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1811,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1812,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1812,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1813,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1814,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1814,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1814,3,Pleural disorder,Pleural conditions NEC,Pleural disorders,Resp,N
1815,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1815,2,Paternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1815,3,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1816,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1816,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1816,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1816,4,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1816,5,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1816,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1816,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1816,8,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1816,9,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1816,10,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1816,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1816,12,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1816,13,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1816,14,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1816,15,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1817,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1818,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1819,1,Actinic elastosis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1819,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1819,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1820,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1821,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1821,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1822,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1822,2,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,Y
1822,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1823,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1824,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1824,2,Headache,Headaches NEC,Headaches,Nerv,N
1824,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1824,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1824,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1825,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1825,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1825,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1825,4,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
1825,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1826,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1827,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1827,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1827,3,Headache,Headaches NEC,Headaches,Nerv,N
1827,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1827,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1827,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1828,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1828,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1828,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1828,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1828,5,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
1828,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1828,7,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1828,8,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
1828,9,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
1829,1,Epstein-Barr virus antibody positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1829,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1829,3,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1829,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1829,5,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1829,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1830,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1830,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1830,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1830,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1831,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1832,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1832,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1833,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1834,1,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1834,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1834,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1835,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1836,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1836,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1837,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1837,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1837,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1838,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1839,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1839,2,Joint arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1839,3,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1839,4,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1839,5,Positron emission tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1840,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1840,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1840,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1840,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1841,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1842,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1843,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1843,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1844,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1844,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1844,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1845,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1845,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1845,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1845,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1846,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1846,2,Headache,Headaches NEC,Headaches,Nerv,N
1846,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1847,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1847,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1848,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1848,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1849,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1849,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1849,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1850,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1850,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1850,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1850,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1850,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1850,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1850,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1851,1,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1851,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1851,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1852,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1852,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1853,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1853,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1853,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1854,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1855,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1855,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1856,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1857,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1857,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1858,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1859,1,Epiglottitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1859,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1859,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1860,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1860,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1861,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1861,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1862,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1862,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1863,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1864,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1864,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1865,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1866,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1867,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1868,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1869,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1869,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1870,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1871,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1872,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1872,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1872,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1872,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1872,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1872,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1872,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1872,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1872,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1872,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1873,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1874,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1875,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1875,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1876,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1877,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1877,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1877,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1877,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1877,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1877,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1877,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1877,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1877,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1877,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1877,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1877,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1878,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1878,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1879,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1879,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1880,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1881,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1881,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1881,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1881,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1881,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1881,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1882,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1882,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1883,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1884,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1884,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1885,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1886,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1887,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1887,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1888,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1888,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1889,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
1889,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1890,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1891,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1892,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1893,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1894,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
1894,2,Axillary mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1894,3,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1894,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1894,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1894,6,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1894,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1894,8,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1895,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1895,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1895,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1895,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1895,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1895,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1896,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1896,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1897,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1897,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1897,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1897,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1897,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1897,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1897,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1897,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1897,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1898,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1899,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1899,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1900,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1900,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1901,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1901,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1902,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1903,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1903,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1904,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1905,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1906,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1907,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1907,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1908,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1908,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1908,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1908,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1909,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1910,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1910,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1911,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1911,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1911,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1912,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1912,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1912,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1913,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1913,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1914,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1914,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1914,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1914,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1914,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1914,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1915,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1916,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1916,2,Necrobiosis lipoidica diabeticorum,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1917,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1918,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1918,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1919,1,Stoma site haemorrhage,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1920,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1921,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1922,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1923,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1924,1,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1924,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1924,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1925,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1926,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1926,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1926,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1926,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1926,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1926,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1927,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1927,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1927,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1928,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1928,2,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1929,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1929,2,Necrobiosis lipoidica diabeticorum,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1930,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1930,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1930,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1930,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1930,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1930,6,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1930,7,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1930,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1931,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1931,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1931,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1932,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1932,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
1932,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1932,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1932,5,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
1932,6,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1932,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1932,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1933,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1933,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1933,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1933,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1933,5,Headache,Headaches NEC,Headaches,Nerv,N
1933,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1933,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1933,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1934,1,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
1935,1,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1935,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1935,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1935,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1936,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1936,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1936,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1937,1,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
1937,2,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1938,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1939,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1940,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1940,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1940,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1940,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1940,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1940,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1940,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1940,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1941,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1941,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1941,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1942,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1942,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1943,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1943,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1944,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1944,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1945,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
1946,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1946,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1946,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1946,4,Headache,Headaches NEC,Headaches,Nerv,N
1946,5,Migraine,Migraine headaches,Headaches,Nerv,N
1946,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1946,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1946,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1947,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1947,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1947,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1947,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1947,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1947,6,Headache,Headaches NEC,Headaches,Nerv,N
1947,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1947,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1947,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1947,10,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1947,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1947,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1947,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1948,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1948,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1949,1,Migraine,Migraine headaches,Headaches,Nerv,N
1950,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1950,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1951,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1952,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1953,1,Meningitis tuberculous,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1954,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1954,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1954,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1955,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1955,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1955,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1956,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1957,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1957,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1957,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1958,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1958,2,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1958,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1959,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1959,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1959,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1960,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1960,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1961,1,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
1962,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1962,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1963,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1963,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1963,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1964,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1965,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1966,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1966,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1966,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1966,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1966,5,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1967,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1967,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1967,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1967,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1967,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1967,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1967,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1968,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1968,2,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1969,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1969,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1970,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1971,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1972,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1972,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1972,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1973,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1974,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1974,2,Headache,Headaches NEC,Headaches,Nerv,N
1975,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1976,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1976,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1977,1,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1977,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1978,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1979,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1979,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1979,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1980,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1981,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1982,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1982,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1982,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1983,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1983,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1983,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1984,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1985,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1985,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1985,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1985,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1986,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1986,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1986,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1986,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1986,5,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1986,6,Ileectomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1986,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1986,8,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1987,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1987,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1987,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1987,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1987,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1988,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1989,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1989,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1990,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1991,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1991,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1992,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1992,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1992,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1993,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1994,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1994,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1994,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1995,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1995,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1996,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1997,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1997,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1997,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1997,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1997,5,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1998,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1999,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2000,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2001,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2002,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2003,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2003,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2003,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2003,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2004,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2004,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2004,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2005,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2005,2,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
2005,3,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
2005,4,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
2005,5,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2005,6,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
2005,7,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
2005,8,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2005,9,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
2005,10,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2005,11,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2005,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2006,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2007,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2007,2,Headache,Headaches NEC,Headaches,Nerv,N
2007,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2007,4,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2008,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2009,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2010,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2010,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2011,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2012,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2013,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2013,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2014,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2015,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2015,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2016,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2017,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2017,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2017,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2018,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2018,2,Headache,Headaches NEC,Headaches,Nerv,N
2019,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2020,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2021,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2022,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2022,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2023,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2024,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2024,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2025,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2025,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2026,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2026,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2026,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2027,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2027,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2027,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2028,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2028,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2029,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2030,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2031,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2032,1,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2033,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2033,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2033,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2033,4,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2034,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2035,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2035,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2035,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2035,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2035,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2035,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2036,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2036,2,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2036,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2037,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
2037,2,Alopecia universalis,Alopecias,Skin appendage conditions,Skin,N
2038,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2038,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2039,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2040,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2040,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2040,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2041,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2041,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2041,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2041,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2042,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2043,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2043,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2044,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2044,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2044,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2044,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2044,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2044,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2044,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2045,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2045,2,Leukodystrophy,Lysosomal storage disorders,Metabolic and nutritional disorders congenital,Cong,N
2046,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2046,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2046,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2046,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2047,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2047,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2048,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2049,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2050,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
2051,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2051,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2052,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2053,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2053,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2054,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2055,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2055,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2055,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2055,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2055,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2055,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2056,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2056,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2056,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2056,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2056,5,Headache,Headaches NEC,Headaches,Nerv,N
2057,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2057,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2058,1,Thyroiditis acute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
2059,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2060,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2060,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2060,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2060,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2061,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2061,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2061,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2061,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2062,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2063,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2064,1,Squamous cell carcinoma of the vulva,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2065,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2065,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2065,3,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2066,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2066,2,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2067,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2067,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2068,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2069,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2070,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2071,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2071,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2072,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2073,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2073,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
2074,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2075,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2075,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2075,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2076,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2077,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2077,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2077,3,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
2078,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2078,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2078,3,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2079,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2079,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2079,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2079,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2079,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2080,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2080,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2080,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2080,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2080,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2080,6,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2081,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2081,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2081,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2081,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2081,5,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2081,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2081,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2081,8,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2082,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2083,1,Colon cancer stage IV,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
2084,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
2084,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2084,3,Heart valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
2085,1,Headache,Headaches NEC,Headaches,Nerv,N
2086,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2086,2,Headache,Headaches NEC,Headaches,Nerv,N
2087,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2087,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2087,3,Headache,Headaches NEC,Headaches,Nerv,N
2088,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2088,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2088,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
2089,1,Headache,Headaches NEC,Headaches,Nerv,N
2089,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2089,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2089,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2090,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2091,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2092,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2092,2,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2092,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2092,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2092,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2092,6,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2092,7,Headache,Headaches NEC,Headaches,Nerv,N
2092,8,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
2092,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2092,10,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2092,11,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2092,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2092,13,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2092,14,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2092,15,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2092,16,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2092,17,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2092,18,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2092,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2092,20,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2093,1,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2093,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2094,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2094,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2095,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2095,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2095,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2096,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2097,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2097,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2097,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2097,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2097,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2097,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2097,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2097,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2098,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2099,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2099,2,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2100,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2100,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2100,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2100,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2101,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2101,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2101,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2102,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2103,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2103,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2104,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2105,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2105,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2105,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2106,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2107,1,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
2107,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2107,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2108,1,Colorectal cancer stage IV,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
2108,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
2109,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2109,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2109,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2109,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2109,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2110,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2110,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2110,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2110,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2111,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2112,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2113,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2113,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2113,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2114,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2115,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2115,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2115,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2115,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
2116,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2117,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2117,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2118,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
2119,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2119,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2119,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2120,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2121,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2121,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2121,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2122,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2122,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2123,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2123,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2123,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
2123,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2123,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2124,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2125,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2125,2,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2125,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2126,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2127,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2127,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2127,3,QRS axis abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2128,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2129,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2130,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2131,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
2132,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2133,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2133,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2134,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2134,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2134,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2134,4,Headache,Headaches NEC,Headaches,Nerv,N
2134,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2134,6,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2135,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2136,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2137,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2138,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2138,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2139,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2139,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2141,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2142,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2142,2,Meibomianitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2143,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2143,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2143,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2144,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
2145,1,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2145,2,Sporotrichosis,Sporothrix infections,Fungal infectious disorders,Infec,N
2146,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2147,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2148,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2148,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2149,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2150,1,Headache,Headaches NEC,Headaches,Nerv,N
2150,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2150,3,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
2151,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
2151,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
2151,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2151,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2151,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2152,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2153,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2153,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2153,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2153,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2153,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2154,1,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
2155,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2155,2,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2155,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2155,4,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2155,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2156,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2156,2,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2156,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2156,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2156,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2157,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2158,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2158,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2158,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2158,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2159,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2159,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2159,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2159,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2159,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2159,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2159,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2159,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2160,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2160,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2161,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2161,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2161,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2162,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2163,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2163,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2164,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2164,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2164,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2164,4,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2164,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2165,1,Vulvovaginitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2166,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2167,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2168,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2169,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2169,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2169,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2169,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2169,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2169,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2170,1,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
2170,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2171,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2172,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2173,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2173,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2173,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2174,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2174,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2175,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2176,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2177,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2177,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2177,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2178,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2178,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2178,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2179,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
2179,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2180,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
2181,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2181,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2181,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2181,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2181,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2182,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2183,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2184,1,Acne,Acnes,Skin appendage conditions,Skin,N
2184,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2184,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2185,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
2185,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2186,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2186,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2186,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
2187,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2187,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2187,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2187,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2187,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2187,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2187,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2188,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2188,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2188,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2189,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2189,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2190,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2190,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2191,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
2192,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2192,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2192,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2192,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2192,5,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2193,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2194,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2194,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2194,3,Joint lock,Joint related disorders NEC,Joint disorders,Musc,N
2194,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2194,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2194,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2195,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2195,2,Dissociation,Dissociative states,Dissociative disorders,Psych,N
2195,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2195,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2195,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2195,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2196,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2197,1,Malignant melanoma stage I,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2198,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2198,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2199,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2200,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2200,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2200,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2200,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2200,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2200,6,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2200,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2200,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2201,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2202,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2202,2,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2203,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
2203,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2204,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2205,1,Cirrhosis alcoholic,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
2205,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2205,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,4,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2206,1,Headache,Headaches NEC,Headaches,Nerv,N
2206,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2207,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2208,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2208,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2208,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2208,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2208,5,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
2208,6,Varicose vein,Varicose veins NEC,Venous varices,Vasc,N
2209,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2209,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2210,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2211,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2211,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2212,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2212,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2212,3,Heart valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
2212,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2212,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2213,1,Carcinoid tumour pulmonary,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
2214,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2214,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2214,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2214,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2214,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2214,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2214,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2214,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2215,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2215,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2215,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2215,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2215,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2215,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2216,1,Headache,Headaches NEC,Headaches,Nerv,N
2216,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2216,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2216,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2217,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2217,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2217,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2217,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2217,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2217,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2217,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2217,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2217,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2217,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2217,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2217,12,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2218,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2219,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2219,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2220,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2221,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2222,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2222,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2223,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2223,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2223,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2223,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
2224,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2225,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2225,2,Ulcer haemorrhage,Ulcers NEC,Tissue disorders NEC,Genrl,N
2226,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2226,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2227,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2228,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
2229,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2230,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2231,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2232,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
2232,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2232,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2233,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2234,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2234,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2234,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2234,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2235,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2235,2,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2235,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2235,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2236,1,Abortion of ectopic pregnancy,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
2237,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2238,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2239,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2239,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2240,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2241,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2242,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2243,1,Rheumatoid vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2244,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2244,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2245,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2246,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2246,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2246,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2246,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2246,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2246,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2247,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2248,1,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2249,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2250,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2250,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
2251,1,Pregnancy of partner,Family and partner issues,Family issues,SocCi,N
2252,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2252,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2253,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2253,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2253,3,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2254,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2255,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
2256,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2257,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2257,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2258,1,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2258,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2259,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
2259,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2259,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2260,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2260,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2260,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2260,4,Headache,Headaches NEC,Headaches,Nerv,N
2260,5,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2260,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2260,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2260,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
2260,9,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2260,10,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2260,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2261,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2261,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2262,1,Bladder transitional cell carcinoma stage III,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2263,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2264,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2265,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2265,2,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2266,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2266,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2266,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2267,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2267,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2267,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
2267,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2268,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2268,2,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2269,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2269,2,Staphylococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2270,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2270,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2271,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2271,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2271,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2272,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2272,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2272,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2273,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2273,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2273,3,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2274,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2274,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2275,1,Headache,Headaches NEC,Headaches,Nerv,N
2275,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2275,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2275,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2275,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2276,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2277,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2278,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2278,2,Pancreatic steatosis,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
2279,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2279,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2279,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2279,4,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2279,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2279,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2279,7,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2279,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2279,9,White blood cell count,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2280,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2280,2,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2280,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2280,4,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2281,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2281,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2282,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2282,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2282,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
2282,4,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
2282,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2283,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2283,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2283,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2284,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2285,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2286,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2286,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2287,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
2287,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2287,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2288,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2288,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2288,3,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2289,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2290,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2290,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2290,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2290,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2290,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2290,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2290,7,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2290,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2290,9,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2290,10,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2290,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2290,12,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2291,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2291,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2291,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2291,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2292,1,Diffuse large B-cell lymphoma stage IV,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2292,2,X-ray abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2293,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2293,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2294,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2294,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2295,1,Rabies,Rabies viral infections,Viral infectious disorders,Infec,N
2296,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
2296,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2296,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2296,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2297,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2298,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2298,2,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
2299,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2299,2,Smear site unspecified abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2300,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2300,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2301,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2301,2,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
2302,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2303,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2303,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2303,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2303,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2303,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2303,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2304,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
2304,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2304,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2305,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
2306,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2306,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2306,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2307,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2308,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2308,2,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2308,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
2308,4,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
2309,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2310,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2311,1,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
2312,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2312,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2312,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2312,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2313,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2313,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2314,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2314,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2315,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2316,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2317,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2317,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2317,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2317,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2317,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2318,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
2318,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2318,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2318,4,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
2318,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2318,6,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
2319,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
2319,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2320,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2321,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2322,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2322,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2322,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2323,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2324,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2325,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2326,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2327,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2327,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2327,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2327,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2328,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2329,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2329,2,Bone marrow granuloma,Haematological disorders,Haematological disorders NEC,Blood,N
2329,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2329,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2329,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2329,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2329,7,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2330,1,Bronchogenic cyst,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
2330,2,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
2330,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2331,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2332,1,Mucoepidermoid carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2332,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2333,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2333,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2334,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2334,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2335,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2335,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2335,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2335,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2335,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2336,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2336,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2336,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
2337,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2337,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2337,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2337,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2338,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2338,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2339,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2339,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2340,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2340,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2341,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2342,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2342,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2343,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2344,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2344,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2345,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2345,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
2346,1,Mucoepidermoid carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2346,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2347,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2347,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2348,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2348,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2348,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2348,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2348,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2348,6,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2348,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2348,8,Joint injection,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2348,9,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2348,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2348,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2348,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2348,13,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2348,14,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2349,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2350,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2350,2,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2351,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2351,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2352,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2352,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2353,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
2354,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2354,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2354,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2355,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
2356,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2356,2,Uterine enlargement,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
2357,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
2358,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2358,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2359,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2359,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2360,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2360,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2361,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
2361,2,Headache,Headaches NEC,Headaches,Nerv,N
2361,3,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2361,4,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2361,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2362,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2363,1,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2364,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2364,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2365,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2365,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2365,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2365,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2366,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2366,2,Headache,Headaches NEC,Headaches,Nerv,N
2366,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2366,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2366,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2366,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2367,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2367,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
2367,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2367,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2368,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2368,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2368,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2369,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
2369,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2369,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2369,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2369,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2370,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2370,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2371,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2371,2,Staphylococcal impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2372,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2373,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2374,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2374,2,Staphylococcal impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2375,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2375,2,Staphylococcal impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2376,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2377,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2378,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2378,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2378,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2378,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2378,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2378,6,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2378,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2379,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2379,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2379,3,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2379,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2379,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2379,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2379,7,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2379,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2379,9,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2379,10,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2380,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2381,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
2381,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2381,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2381,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2381,5,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2381,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2381,7,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2381,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2381,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2382,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
2382,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2383,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2384,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2385,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2385,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2386,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2387,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2388,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2388,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2389,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2390,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2391,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2391,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2391,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2392,1,Ruptured cerebral aneurysm,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2392,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2393,1,Bone marrow granuloma,Haematological disorders,Haematological disorders NEC,Blood,N
2393,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2393,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2393,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2393,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2393,6,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2394,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2395,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2395,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2395,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2395,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2396,1,Granular cell tumour,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2396,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2397,1,Rabies,Rabies viral infections,Viral infectious disorders,Infec,N
2398,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2399,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2399,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2399,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2400,1,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
2401,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2401,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2402,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2402,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2403,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2403,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2404,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2404,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2404,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2405,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2406,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2407,1,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2407,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2408,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2409,1,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
2409,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2409,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2409,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2410,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2411,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2412,1,Antineutrophil cytoplasmic antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2412,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2413,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2414,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2414,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2414,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2415,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2416,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
2417,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2417,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2417,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2417,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2417,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2417,6,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2417,7,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2417,8,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2417,9,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2417,10,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
2417,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2418,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2419,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2419,2,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2419,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2420,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2420,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2420,3,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2420,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2420,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2421,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
2421,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2421,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2422,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2422,2,Pachymeningitis,Meningitis NEC,Central nervous system infections and inflammations,Nerv,N
2422,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2423,1,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
2423,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2423,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2424,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2425,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2426,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2426,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2426,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2426,4,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2426,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2427,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2427,2,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,Y
2427,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
2427,4,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2427,5,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
2428,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2428,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2429,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2430,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2431,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2431,2,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2432,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2433,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2433,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2433,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
2433,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2433,5,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
2434,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2435,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2435,2,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
2435,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2435,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2436,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2436,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2437,1,Large cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2438,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2439,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2439,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2439,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2439,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2439,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2439,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2439,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2439,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2440,1,Polycythaemia vera,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2441,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2441,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2442,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2442,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2443,1,Complication of delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
2444,1,Arthrodesis,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2444,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2444,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2444,4,Headache,Headaches NEC,Headaches,Nerv,N
2445,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2445,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2445,3,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2445,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2445,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2446,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2446,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2446,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2447,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2447,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2447,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2447,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2447,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2447,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2447,7,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2447,8,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2447,9,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2447,10,Headache,Headaches NEC,Headaches,Nerv,N
2447,11,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2447,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2447,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2447,14,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2447,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2447,16,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2447,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2447,18,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2447,19,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2447,20,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2447,21,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2447,22,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2447,23,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2448,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2449,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2449,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2450,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2451,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2451,2,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2452,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2452,2,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2453,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2454,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
2454,2,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2455,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2456,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2456,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2456,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2456,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2456,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2457,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2457,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2457,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2457,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2457,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2458,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2458,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2458,3,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
2458,4,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
2458,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2459,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2459,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2459,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2459,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2459,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2459,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2459,7,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2459,8,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2459,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2459,10,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2459,11,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2459,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2459,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2459,14,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2459,15,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2459,16,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2459,17,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2459,18,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2459,19,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2459,20,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2460,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2461,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2461,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2461,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,1,Large cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2463,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2463,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2463,3,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2464,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2465,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
2466,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2466,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2466,3,Headache,Headaches NEC,Headaches,Nerv,N
2466,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2466,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2466,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
2466,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2466,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2467,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2467,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2467,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2467,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2468,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
2469,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2469,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2469,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2470,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2470,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
2470,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2470,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2470,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2470,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2470,7,Myocardial fibrosis,Myocardial disorders NEC,Myocardial disorders,Card,N
2470,8,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2470,9,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2470,10,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
2470,11,Pericarditis adhesive,Noninfectious pericarditis,Pericardial disorders,Card,N
2470,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2470,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2470,14,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2470,15,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2470,16,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2471,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2471,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2471,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2472,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2472,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2472,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2472,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2472,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2472,6,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2472,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2473,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2473,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
2473,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2473,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2473,5,Parathyroid disorder,Parathyroid disorders NEC,Parathyroid gland disorders,Endo,N
2474,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2474,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2474,3,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
2474,4,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2474,5,Lip exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2474,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2474,7,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2474,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2475,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2476,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2477,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2477,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2478,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2479,1,Foetal cardiac disorder,Foetal complications NEC,Foetal complications,Preg,N
2479,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2479,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2479,4,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
2480,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2480,2,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2480,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2480,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2480,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2481,1,Episcleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2482,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2482,2,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2482,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2482,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2482,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2483,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2483,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2483,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2483,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2484,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2485,1,Necrotising fasciitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2486,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2486,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2487,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2488,1,Carpal tunnel decompression,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
2488,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2489,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2489,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2489,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2489,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2490,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2490,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2490,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
2490,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2491,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2492,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2492,2,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2492,3,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2492,4,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2492,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2492,6,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
2492,7,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
2493,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2494,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2494,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2495,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2495,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2495,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2495,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2495,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2495,6,Solar lentigo,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2497,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2497,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2498,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2499,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2499,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2499,3,Septic arthritis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2500,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2500,2,Penile squamous cell carcinoma,Penile neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2501,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2502,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2502,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2502,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2503,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2504,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2504,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2504,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2504,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2504,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2504,6,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2504,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2504,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2504,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2504,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2505,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2505,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2505,3,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2506,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2506,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2507,1,Necrotising fasciitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,Y
2508,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2508,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
2509,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2509,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
2509,3,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
2509,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2509,5,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
2509,6,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2509,7,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2509,8,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,Y
2509,9,Left atrial dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
2509,10,Mitral valve disease,Mitral valvular disorders,Cardiac valve disorders,Card,N
2509,11,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2509,12,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2509,13,Pancreatic atrophy,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
2509,14,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2509,15,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2509,16,Pulmonary arterial pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2509,17,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
2509,18,Right atrial dilatation,Myocardial disorders NEC,Myocardial disorders,Card,N
2509,19,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2510,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2511,1,Headache,Headaches NEC,Headaches,Nerv,N
2512,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2512,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2513,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
2513,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2514,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2515,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2515,2,Non-small cell lung cancer stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2516,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2517,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2517,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2518,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2518,2,Headache,Headaches NEC,Headaches,Nerv,N
2518,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2518,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2518,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2518,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2518,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2519,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2519,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2520,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2521,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2521,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
2521,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2521,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2522,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2523,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2523,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
2523,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2523,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2523,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2523,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2524,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2524,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2524,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2524,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2525,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2525,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2525,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2525,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2525,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2526,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2527,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2528,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2528,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
2529,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2529,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2529,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2529,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2529,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2529,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2529,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2529,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2530,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2530,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2530,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2530,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2531,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2531,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2531,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2532,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2532,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2532,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2533,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2533,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2533,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2534,1,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2534,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2534,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2534,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2535,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2535,2,Vaginal prolapse,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
2536,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2536,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2537,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2537,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2538,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2538,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2538,3,Headache,Headaches NEC,Headaches,Nerv,N
2538,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2538,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2539,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2539,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2540,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2541,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2541,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2542,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2543,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2543,2,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
2543,3,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2543,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
2543,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2543,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2543,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2543,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2544,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2544,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2545,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2545,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2545,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2545,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2546,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2547,1,Lung carcinoma cell type unspecified stage 0,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2548,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2548,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2548,3,Headache,Headaches NEC,Headaches,Nerv,N
2549,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2550,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2551,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2551,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2551,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2551,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2551,5,Headache,Headaches NEC,Headaches,Nerv,N
2551,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2551,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2551,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
2551,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2551,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2552,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2552,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
2553,1,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
2553,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2553,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2554,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2554,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2554,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2554,4,Headache,Headaches NEC,Headaches,Nerv,N
2554,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2554,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2555,1,Testicular germ cell cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2556,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2556,2,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2556,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2557,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,Y
2557,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2558,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2558,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2559,1,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2560,1,Headache,Headaches NEC,Headaches,Nerv,N
2560,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2561,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2561,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2562,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2562,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2563,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2564,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2564,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2565,1,Headache,Headaches NEC,Headaches,Nerv,N
2565,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2565,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2565,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2566,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2567,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2568,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2568,2,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
2569,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2569,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2569,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2569,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2569,5,Eyelids pruritus,Ocular disorders NEC,Eye disorders NEC,Eye,N
2569,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2569,7,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2569,8,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2569,9,Mucosa vesicle,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2569,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2569,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2569,12,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2569,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2569,14,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2570,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2570,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2571,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2571,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2571,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2571,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2572,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2572,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2572,3,Headache,Headaches NEC,Headaches,Nerv,N
2572,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2572,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2572,6,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2573,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2574,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2575,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2576,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2576,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
2576,3,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2576,4,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
2577,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2578,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2578,2,Acute cholecystitis necrotic,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2578,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2578,4,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
2579,1,Bone tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2580,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2581,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2581,2,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2581,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2581,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2581,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2582,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2582,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2582,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2582,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2583,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2584,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2584,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2584,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2584,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2584,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2584,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2585,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2586,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2587,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2587,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2588,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2588,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2588,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2588,4,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2588,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2588,6,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2588,7,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2588,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2589,1,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2590,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2590,2,Pseudomonas test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2591,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2591,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2591,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2591,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2591,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2591,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2591,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2592,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2593,1,Alopecia totalis,Alopecias,Skin appendage conditions,Skin,N
2594,1,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2594,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2595,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2595,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2595,3,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
2595,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2596,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2596,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2596,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2596,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2597,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2597,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2598,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2599,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2599,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2600,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2600,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2600,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2600,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2600,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2601,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2602,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2602,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2603,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2603,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2604,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2604,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2605,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2606,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2606,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2606,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2606,4,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2606,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2606,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2606,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2606,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2607,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2608,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2608,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2608,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2608,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2608,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2608,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2608,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2609,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
2609,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2610,1,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2610,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2611,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2611,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2611,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2611,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2611,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2611,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2612,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2613,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2614,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2614,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2614,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2615,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2615,2,Headache,Headaches NEC,Headaches,Nerv,N
2615,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2615,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2615,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2615,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2616,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
2616,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2616,3,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2616,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2616,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2616,6,Myopathy,Myopathies,Muscle disorders,Musc,N
2616,7,Myopathy,Myopathies,Muscle disorders,Musc,N
2616,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2616,9,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2617,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2618,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2618,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2619,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2620,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2621,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2621,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2621,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2621,4,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
2621,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2621,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2622,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2622,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2622,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2622,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2623,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2623,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2623,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2623,4,Serum ferritin decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2624,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2624,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2624,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2625,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2625,2,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2625,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2626,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2626,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2626,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2627,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2627,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2627,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2627,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2627,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2628,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2628,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2629,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2630,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2631,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2632,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2632,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2632,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2632,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2632,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2632,6,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2632,7,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2632,8,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2632,9,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2632,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2633,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2634,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2634,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2634,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2634,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2634,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2634,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2634,7,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2634,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2634,9,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2635,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2635,2,Arthritis enteropathic,Arthropathies NEC,Joint disorders,Musc,N
2635,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2635,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2635,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2635,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2635,7,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
2635,8,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2635,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2636,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2636,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2636,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
2636,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2637,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2637,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2637,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2637,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2638,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2639,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2639,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2639,3,Nail dystrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2639,4,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2639,5,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2640,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2640,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2640,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2640,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2640,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2640,6,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2641,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2641,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2641,3,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2641,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2641,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2641,6,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2641,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2641,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2641,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2642,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2642,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2642,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2643,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2644,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2644,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2645,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2646,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2646,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2647,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2647,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2647,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2647,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2647,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2647,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2647,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2647,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2647,9,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2648,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2649,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2649,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2649,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2649,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2649,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2649,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2650,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2651,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2651,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2651,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2651,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2652,1,Headache,Headaches NEC,Headaches,Nerv,N
2653,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2653,2,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
2653,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2654,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2655,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2655,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2656,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2656,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2656,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2657,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2657,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2657,3,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
2657,4,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,Y
2658,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2658,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2659,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2659,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2659,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2659,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2659,5,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2659,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2659,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2659,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2659,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2659,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2659,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2659,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
2659,13,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2659,14,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
2659,15,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2659,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2659,17,Sensation of blood flow,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2659,18,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2659,19,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2660,1,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2660,2,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2660,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2660,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2660,5,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2660,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2660,7,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
2660,8,Tuberculosis gastrointestinal,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2660,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2661,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2662,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2662,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2663,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2663,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2663,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2663,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2663,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2663,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2663,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2664,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2664,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2665,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2666,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
2667,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2667,2,Headache,Headaches NEC,Headaches,Nerv,N
2667,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2668,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2668,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
2669,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2669,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2669,3,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2669,4,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2670,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2671,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2672,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2673,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2673,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2673,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2673,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2673,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2673,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2673,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2674,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2674,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2674,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2675,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2676,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2677,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2678,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2678,2,Breast cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2678,3,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
2678,4,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
2678,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2679,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2679,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2679,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
2680,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2680,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2680,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2680,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2681,1,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2682,1,Carotid artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
2683,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2684,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2685,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2686,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2686,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2686,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2686,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2686,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2686,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2686,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2686,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2686,9,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2686,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2687,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2687,2,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
2688,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2689,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2690,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
2691,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2691,2,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
2692,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2692,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2692,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2693,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2693,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2693,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2694,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2695,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2695,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2695,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2696,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2697,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2698,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2698,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2699,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2699,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2699,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2700,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2701,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2701,2,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2702,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2703,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2704,1,Serositis,Inflammations,General system disorders NEC,Genrl,N
2704,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2705,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2705,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2706,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2707,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2707,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2708,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2708,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2708,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2709,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2709,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2710,1,Herpes zoster infection neurological,Herpes viral infections,Viral infectious disorders,Infec,N
2711,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2712,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2712,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2713,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2713,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2713,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2713,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2713,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2713,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2713,7,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2713,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2713,9,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2713,10,Headache,Headaches NEC,Headaches,Nerv,N
2713,11,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2713,12,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2713,13,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2713,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2713,15,Saliva discolouration,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2713,16,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2713,17,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2713,18,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2714,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2715,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2715,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2715,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
2716,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,2,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2716,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2716,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2717,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2717,2,Lip and/or oral cavity cancer,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2717,3,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2718,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
2718,2,Hypoglossal nerve paresis,Hypoglossal nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2719,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2719,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2720,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2720,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2721,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2721,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2721,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2721,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2721,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2721,6,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
2722,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
2722,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
2722,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2722,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2722,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2723,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2724,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,Y
2724,2,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2725,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2725,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2726,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2726,2,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
2726,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2726,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2726,5,Yersinia infection,Yersinia infections,Bacterial infectious disorders,Infec,N
2727,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2728,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2728,2,Stoma site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2729,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2729,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2730,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2731,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2731,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2731,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2732,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2733,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
2733,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2733,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2733,4,Venous injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
2734,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2734,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
2734,3,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2734,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2735,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2736,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2737,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2737,2,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2738,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2738,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
2739,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2740,1,Alopecia universalis,Alopecias,Skin appendage conditions,Skin,N
2741,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2741,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2742,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
2742,2,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2743,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2743,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2744,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2745,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2745,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2746,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2746,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2747,1,Cervix carcinoma stage 0,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2747,2,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
2747,3,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
2748,1,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
2748,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2748,3,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2749,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2750,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2750,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2750,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2750,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2750,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2750,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2751,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2752,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2752,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2753,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2753,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2753,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2754,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2754,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2755,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2756,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2756,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2756,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2756,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2756,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2756,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2756,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2757,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2758,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2759,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2759,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2760,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
2761,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2761,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2761,3,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
2761,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2761,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
2761,6,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
2761,7,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2762,1,Hodgkin's disease mixed cellularity stage unspecified,Hodgkin's disease mixed cellularity type,Lymphomas Hodgkin's disease,Neopl,N
2762,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2762,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2762,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2763,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2763,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2763,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2763,4,Headache,Headaches NEC,Headaches,Nerv,N
2764,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2764,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2764,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2764,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2764,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2764,6,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2765,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2765,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2765,3,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2765,4,Headache,Headaches NEC,Headaches,Nerv,N
2766,1,Testicular malignant teratoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2767,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2767,2,Thyrotoxic crisis,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2768,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2768,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2769,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2770,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2770,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2771,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2771,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2771,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2771,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2771,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2771,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2772,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2772,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2772,3,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2773,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2773,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2774,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2775,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2775,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2775,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2775,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2775,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2775,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2775,7,Headache,Headaches NEC,Headaches,Nerv,N
2775,8,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2775,9,Nasal pruritus,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2775,10,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2775,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2775,12,Saliva discolouration,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2775,13,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2775,14,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2776,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2777,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2778,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2778,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2778,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2778,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2779,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2780,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2781,1,Allergic respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
2781,2,Mineral supplementation,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
2781,3,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2781,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2782,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2783,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2783,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2783,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2784,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2784,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2784,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2784,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2784,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2785,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2785,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2785,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2786,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2787,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2788,1,Carcinoma in situ,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2788,2,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
2789,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2790,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2790,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2790,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2790,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2790,5,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2790,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2790,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2791,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2791,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2791,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2791,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2792,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2793,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2793,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2793,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2793,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2793,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2793,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2794,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2794,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2794,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2795,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2796,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2796,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2797,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2797,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2797,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2798,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
2799,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2800,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2800,2,Platelet aggregation abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2800,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2801,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2801,2,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2801,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2801,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2802,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2803,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2804,1,Prostatectomy,Prostatic therapeutic procedures,Male genital tract therapeutic procedures,Surg,N
2805,1,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
2805,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2805,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2805,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2805,5,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2806,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2806,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2806,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2807,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2807,2,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2807,3,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2807,4,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2807,5,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2807,6,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2807,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2807,8,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2807,9,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2807,10,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2807,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2807,12,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2807,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2807,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2807,15,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2807,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2807,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2807,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2807,19,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2807,20,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2807,21,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2807,22,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
2808,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2808,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2808,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2809,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2809,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2809,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2809,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2809,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2809,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2809,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2809,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2810,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2810,2,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
2811,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2811,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2812,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2813,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2813,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2814,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2814,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2814,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2814,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2814,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2815,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2816,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2817,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2817,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2818,1,Magnetic resonance imaging abdominal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
2818,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2819,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2820,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2820,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2821,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2822,1,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2823,1,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2823,2,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2823,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2823,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2823,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2824,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2825,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2826,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2826,2,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2826,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2827,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2827,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2828,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2829,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2830,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2831,1,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2832,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2832,2,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
2832,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2832,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2833,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2833,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2833,3,Headache,Headaches NEC,Headaches,Nerv,N
2833,4,Sudden onset of sleep,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
2833,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2834,1,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2835,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2836,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2836,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2836,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2836,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2836,5,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2836,6,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2836,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2836,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2837,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2838,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2838,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2838,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
2838,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2838,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2839,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2840,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
2840,2,DiGeorge's syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
2840,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2841,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2841,2,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
2842,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2842,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2842,3,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2842,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2842,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2842,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2842,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2842,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2843,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2843,2,Cystitis-like symptom,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2843,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2844,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2844,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2844,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2845,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2846,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
2847,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2847,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
2848,1,Bence Jones proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2848,2,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2849,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2849,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2849,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2849,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2849,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2849,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2849,7,Granuloma,Inflammations,General system disorders NEC,Genrl,N
2849,8,Malignant ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2849,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2849,10,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2849,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2849,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2850,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2850,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2850,3,"Follicle centre lymphoma, follicular grade I, II, III",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2850,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2850,5,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2851,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2851,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2852,1,Breech presentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
2852,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2852,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2852,4,Paternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
2853,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2853,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2854,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2855,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2855,2,Headache,Headaches NEC,Headaches,Nerv,N
2855,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2856,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2857,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2857,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2857,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2857,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2858,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2859,1,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2860,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2860,2,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
2860,3,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
2860,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2861,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2861,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2861,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2861,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2862,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2863,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2863,2,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2863,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2863,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
2864,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2865,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2865,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2865,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2866,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2866,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2866,3,Prostate cancer stage 0,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
2866,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
2867,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2867,2,Investigation,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2867,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2868,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2868,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2869,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2869,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2870,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2871,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2872,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2872,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2873,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2874,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2874,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2874,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2874,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2874,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2875,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2876,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2876,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2877,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2878,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
2878,2,Infected cyst,Infections NEC,Infections - pathogen unspecified,Infec,N
2878,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2878,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2878,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2878,6,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2879,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2880,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
2880,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2881,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2881,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
2881,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2881,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2881,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2881,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2881,7,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2881,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2881,9,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2881,10,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2881,11,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2881,12,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2881,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2881,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2881,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2882,1,Headache,Headaches NEC,Headaches,Nerv,N
2882,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2882,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2882,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2882,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2882,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2883,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2884,1,Malignant neoplasm of eye,Ocular neoplasms malignant (excl melanomas),Ocular neoplasms,Neopl,N
2885,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
2885,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2885,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2886,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2886,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2886,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2886,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2886,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2886,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2886,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2886,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2886,9,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2886,10,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2886,11,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2886,12,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2886,13,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2886,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2886,15,Neurologic neglect syndrome,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2886,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2886,17,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2886,18,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2886,19,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2886,20,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2886,21,Reflexes abnormal,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2886,22,Tension headache,Headaches NEC,Headaches,Nerv,N
2887,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2887,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
2888,1,Corneal transplant,Corneal and scleral therapeutic procedures,Eye therapeutic procedures,Surg,N
2889,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2890,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2890,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2890,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2890,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2890,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2891,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2891,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2891,3,Salmonella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
2891,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2892,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2892,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2892,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2892,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2892,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2892,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2892,7,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
2892,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2893,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2894,1,Amyotrophic lateral sclerosis,Motor neurone diseases,Neuromuscular disorders,Nerv,N
2894,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2894,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2894,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2894,5,Frontotemporal dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2894,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2894,7,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
2895,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2896,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2897,1,Abdominal wall abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2897,2,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2898,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2899,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2899,2,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2900,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
2900,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2901,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2901,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2901,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2901,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2901,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2901,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2902,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2903,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2903,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2903,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2904,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2904,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2905,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2906,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2906,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2906,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2906,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2906,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2907,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2908,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2908,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2908,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2908,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2909,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2909,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2909,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2909,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2910,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2910,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2910,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2910,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2911,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2912,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2912,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2913,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2913,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2913,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2913,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2913,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2913,6,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2913,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2913,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2913,9,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2913,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2913,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2914,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
2915,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2916,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2917,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2917,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2918,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2919,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2919,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2919,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2919,4,Scleral disorder,"Scleral structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2920,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2920,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2920,3,Small intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2921,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2922,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2922,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2923,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2923,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2924,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2924,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2924,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2924,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2924,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2925,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2925,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2925,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2925,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2925,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2926,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2927,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
2927,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2928,1,Headache,Headaches NEC,Headaches,Nerv,N
2928,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2928,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2928,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2928,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2928,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2929,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
2929,2,Neck deformity,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2929,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2930,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2931,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
2932,1,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
2932,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2932,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2932,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
2932,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2932,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
2932,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2933,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2933,2,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2934,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2934,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2935,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2936,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2936,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2937,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2938,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
2939,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2939,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2940,1,Non-small cell lung cancer stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2941,1,Colon cancer stage III,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2942,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2942,2,Headache,Headaches NEC,Headaches,Nerv,N
2942,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2942,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2942,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2943,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2943,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2943,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2943,4,Vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2944,1,Benign endocrine neoplasm,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
2944,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2944,3,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
2944,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2945,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2946,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2946,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2947,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2947,2,Headache,Headaches NEC,Headaches,Nerv,N
2947,3,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2947,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2947,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2948,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2949,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2949,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2950,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2950,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2951,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2951,2,Migraine,Migraine headaches,Headaches,Nerv,N
2951,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2951,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2952,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2952,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2952,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2953,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2954,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2954,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2954,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2955,1,Headache,Headaches NEC,Headaches,Nerv,N
2955,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2955,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2956,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2956,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2956,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2957,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2958,1,Meningococcal sepsis,Neisseria infections,Bacterial infectious disorders,Infec,N
2959,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2960,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2960,2,Papillitis,Inflammations,General system disorders NEC,Genrl,N
2961,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2961,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2961,3,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2961,4,Oral cavity fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
2961,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2961,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2962,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2962,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2962,3,Wound contamination,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2963,1,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2963,2,Haemochromatosis,Iron excess,Iron and trace metal metabolism disorders,Metab,N
2964,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2965,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2965,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2965,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2965,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2965,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2965,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2966,1,Eyelid infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2967,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2967,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2967,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2967,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2967,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2967,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2967,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2967,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2968,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2968,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2969,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2970,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2970,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2970,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2971,1,Allergic respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
2971,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2971,3,Headache,Headaches NEC,Headaches,Nerv,N
2971,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2971,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2971,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2971,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2972,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2972,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2972,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2972,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
2972,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2973,1,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
2974,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2975,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2976,1,Premature ejaculation,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
2977,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2978,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2978,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2978,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2979,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2979,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2979,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2979,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2979,5,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2980,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2980,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2981,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2981,2,Arthritis enteropathic,Arthropathies NEC,Joint disorders,Musc,N
2981,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2982,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2982,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2982,3,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
2982,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2983,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2983,2,Headache,Headaches NEC,Headaches,Nerv,N
2983,3,Hyperthermia,Body temperature altered,Body temperature conditions,Genrl,N
2983,4,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2984,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2984,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2985,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2986,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2987,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2987,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2987,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2987,4,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
2987,5,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
2987,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2987,7,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
2987,8,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2987,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2988,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
2988,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2989,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2989,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
2990,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2991,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2992,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2992,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2993,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2993,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2993,3,Visual acuity tests abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2994,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2994,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2995,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2995,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2995,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2995,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2995,5,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2995,6,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2995,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
2995,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2996,1,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
2997,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2998,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2998,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2999,1,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3000,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3001,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3001,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3001,3,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3002,1,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
3003,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3003,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3003,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3003,4,Urethral stent insertion,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3003,5,Urethral stent removal,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3004,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3004,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3004,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3004,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3005,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3005,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3006,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3006,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3007,1,Endometrial sarcoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3007,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
3008,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3008,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3008,3,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
3009,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
3010,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3010,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3010,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3010,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3010,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3010,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3010,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3011,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3011,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3011,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3012,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3013,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3013,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
3014,1,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
3015,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3015,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
3015,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3015,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3015,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3015,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3016,1,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
3017,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3018,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3019,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3019,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3019,3,Headache,Headaches NEC,Headaches,Nerv,N
3020,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3020,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3020,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3021,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3021,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3021,3,Bone cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3021,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3021,5,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
3021,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3021,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3021,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3021,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3022,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3023,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3023,2,Headache,Headaches NEC,Headaches,Nerv,N
3023,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3023,4,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
3023,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3023,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3024,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3024,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3024,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3024,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3024,5,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3024,6,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
3024,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3024,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3025,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3026,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3027,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
3027,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3027,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3027,4,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3027,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3027,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3027,7,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3028,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3028,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3028,3,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3028,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3028,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3028,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3028,7,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3029,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3029,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3029,3,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
3029,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3030,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3031,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3032,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3032,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3032,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3032,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3033,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3033,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3033,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3033,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3033,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3034,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3034,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
3034,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3035,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3035,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3036,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3036,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3036,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3036,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3036,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3036,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3036,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3036,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3036,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3036,10,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3036,11,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
3036,12,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
3036,13,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3036,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3036,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3036,16,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3036,17,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3036,18,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
3036,19,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3037,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3037,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3037,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3037,4,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3037,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3037,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3037,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3037,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3037,9,Headache,Headaches NEC,Headaches,Nerv,N
3037,10,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3037,11,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
3037,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3037,13,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3037,14,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3037,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3037,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3037,17,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
3037,18,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3038,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
3039,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3039,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3040,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
3040,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
3041,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3041,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3041,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3041,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3041,5,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3041,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3041,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3041,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3041,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3042,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3042,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3043,1,Headache,Headaches NEC,Headaches,Nerv,N
3043,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3043,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3043,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3043,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3044,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3044,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3044,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3045,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3046,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
3046,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3046,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
3046,4,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
3047,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3048,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3048,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
3048,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3049,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
3049,2,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
3049,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
3050,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
3050,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3050,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3050,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3050,5,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3051,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
3051,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3051,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3051,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3051,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3052,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3052,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3052,3,Headache,Headaches NEC,Headaches,Nerv,N
3052,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3053,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3053,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3053,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3053,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3053,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3053,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3054,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
3054,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3054,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3054,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3055,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3055,2,Cervix inflammation,Cervix infections and inflammations,Female reproductive tract infections and inflammations,Repro,N
3055,3,Coital bleeding,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3055,4,Ectropion of cervix,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
3055,5,Granuloma,Inflammations,General system disorders NEC,Genrl,N
3056,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3056,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3057,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3057,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3057,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3057,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3058,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3058,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3058,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3058,4,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3059,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3059,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3060,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3060,2,Headache,Headaches NEC,Headaches,Nerv,N
3060,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3060,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3061,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3061,2,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3061,3,Middle ear effusion,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
3062,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3062,2,Failed induction of labour,Failed labour,Maternal complications of labour and delivery,Preg,N
3062,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3062,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3063,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3063,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3063,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3064,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3065,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3066,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3067,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3068,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3068,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3069,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
3069,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3069,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3070,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3070,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3070,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3070,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3070,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3071,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3071,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3071,3,Headache,Headaches NEC,Headaches,Nerv,N
3071,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3072,1,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
3072,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3072,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3072,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3073,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3073,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3073,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3073,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3074,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3074,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3074,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3074,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3075,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3075,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3076,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3076,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3076,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3076,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3076,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3076,6,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3076,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3076,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3077,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3077,2,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
3078,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3078,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3079,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3079,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3080,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3080,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
3080,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3080,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3080,5,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3080,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3080,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3080,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3080,9,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
3081,1,Breech presentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
3081,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3081,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3081,4,Paternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
3082,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3083,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3083,2,Ovarian enlargement,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
3084,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3084,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3085,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3086,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
3087,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3087,2,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3088,1,Urine electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
3089,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3089,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3089,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3089,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3089,5,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3090,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3090,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3091,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3092,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3092,2,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
3092,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3092,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3092,5,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3092,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3092,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3093,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3093,2,Headache,Headaches NEC,Headaches,Nerv,N
3093,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3093,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3094,1,Headache,Headaches NEC,Headaches,Nerv,N
3094,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3095,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3095,2,Headache,Headaches NEC,Headaches,Nerv,N
3095,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3095,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3095,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3095,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3096,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3097,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3098,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3098,2,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3098,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3098,4,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3099,1,Neovascular age-related macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3100,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3100,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3100,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3101,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3101,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3101,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3101,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3101,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3102,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3102,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3102,3,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3102,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3102,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3102,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3103,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3103,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3103,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3103,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3104,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3104,2,Pyomyositis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3104,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3104,4,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
3104,5,Soft tissue inflammation,Inflammations,General system disorders NEC,Genrl,N
3105,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3105,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3105,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3105,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3105,5,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3106,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
3106,2,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
3107,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
3108,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
3108,2,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
3108,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3108,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3108,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3109,1,Vernal keratoconjunctivitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
3110,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3110,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3110,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3110,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3110,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3110,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3110,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3110,8,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3111,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3111,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3111,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3111,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3111,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3112,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3113,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3113,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3113,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3113,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3113,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3113,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3114,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3115,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3115,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3115,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3115,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3115,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3115,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3115,7,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3116,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3117,1,Migraine,Migraine headaches,Headaches,Nerv,N
3118,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3119,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3119,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3119,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3119,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
3119,5,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3119,6,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3119,7,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3119,8,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3119,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3120,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3121,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
3121,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3121,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
3121,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3121,5,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3122,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3122,2,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
3123,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3124,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3125,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3125,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3126,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
3126,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3126,3,Headache,Headaches NEC,Headaches,Nerv,N
3126,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3126,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3127,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3127,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3127,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3128,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3128,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3128,3,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
3129,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
3129,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3129,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3130,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
3131,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3132,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3132,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3132,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3133,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3133,2,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3134,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3135,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3135,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3136,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3136,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3136,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3136,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3136,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3136,7,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3136,8,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3136,9,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3136,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3137,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
3138,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3138,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
3139,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3140,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3140,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3141,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
3142,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3142,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3143,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
3143,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
3143,3,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
3144,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3144,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3144,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3144,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3144,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3144,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3144,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3144,8,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3145,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3146,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
3147,1,Ovarian cancer stage III,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
3148,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3149,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3150,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
3150,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3150,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3150,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3150,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3150,6,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
3150,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3151,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3151,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3151,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3151,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3152,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3152,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3153,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3154,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3154,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3154,3,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3154,4,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3154,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3154,6,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,7,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,8,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,9,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,10,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,11,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3154,12,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3154,13,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3154,14,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3154,15,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3154,16,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3154,17,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3154,18,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3154,19,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3154,20,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3154,21,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3154,22,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3154,23,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3154,24,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3154,25,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3154,26,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3154,27,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3154,28,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3154,29,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3154,30,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3154,31,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3154,32,Headache,Headaches NEC,Headaches,Nerv,N
3154,33,Headache,Headaches NEC,Headaches,Nerv,N
3154,34,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3154,35,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3154,36,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3154,37,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3154,38,Migraine,Migraine headaches,Headaches,Nerv,N
3154,39,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3154,40,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3154,41,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3154,42,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3154,43,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3154,44,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3154,45,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3154,46,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3154,47,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3154,48,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3154,49,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3154,50,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3154,51,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3154,52,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3154,53,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3154,54,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3154,55,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3154,56,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3154,57,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3154,58,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3154,59,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3154,60,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3154,61,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3154,62,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3154,63,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3154,64,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3154,65,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3154,66,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3155,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3155,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
3155,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3155,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3156,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3156,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
3156,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3156,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3157,1,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3157,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3157,3,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
3157,4,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
3158,1,Lung squamous cell carcinoma stage I,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3159,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3160,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3160,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3160,3,Retinal vascular thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3160,4,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3160,5,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
3161,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
3161,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3161,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3161,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3161,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3161,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3162,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3163,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3164,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3165,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,Y
3166,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3166,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3166,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3166,4,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3166,5,Pulmonary infarction,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3167,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3167,2,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3167,3,Nipple exudate bloody,Breast signs and symptoms,Breast disorders,Repro,N
3168,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3168,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3168,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3168,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3168,5,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
3168,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3168,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3168,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3168,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3168,10,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3168,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3168,12,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
3168,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3168,14,Total lung capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3169,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3169,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3169,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3169,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3170,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3170,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3170,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3170,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3172,1,Deafness,Hearing losses,Hearing disorders,Ear,N
3173,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3173,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3173,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3174,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3174,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
3174,3,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3175,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3175,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
3175,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3176,1,Lymphangioma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
3177,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3178,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3178,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3178,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3178,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3178,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3178,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3178,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3178,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3178,9,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3178,10,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3178,11,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3178,12,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3178,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3178,14,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3179,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
3179,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3179,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3179,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3179,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3180,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3181,1,Headache,Headaches NEC,Headaches,Nerv,N
3181,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3181,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3181,4,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
3181,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3182,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3182,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3183,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3184,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
3184,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3185,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3186,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3186,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3187,1,Cardiac fibrillation,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3188,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
3188,2,Headache,Headaches NEC,Headaches,Nerv,N
3188,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
3189,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3189,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3189,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3189,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3189,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3189,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3190,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3190,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3190,3,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
3191,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3192,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3193,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3194,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3194,2,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
3195,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3195,2,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
3195,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3196,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3196,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3196,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3196,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3196,5,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3197,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3197,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3197,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3197,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3198,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3198,2,Conjunctivitis allergic,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3198,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3198,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3198,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3199,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3199,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3199,3,Headache,Headaches NEC,Headaches,Nerv,N
3199,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3200,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3201,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3201,2,Ear canal injury,Ear injuries NEC,Injuries NEC,Inj&P,N
3201,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3201,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3201,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3201,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3201,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3201,8,Inner ear disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
3201,9,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3201,10,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
3202,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3202,2,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
3202,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3203,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3203,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3203,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3203,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3204,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
3204,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3205,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3205,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3206,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3207,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3207,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3207,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3208,1,Headache,Headaches NEC,Headaches,Nerv,N
3208,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3208,3,Migraine,Migraine headaches,Headaches,Nerv,N
3208,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3209,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3209,2,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3209,3,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3209,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3209,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3209,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3209,7,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
3209,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3209,9,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
3209,10,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3209,11,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3209,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3209,13,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3209,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3209,15,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3209,16,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3209,17,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3209,18,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3209,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3209,20,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3209,21,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3209,22,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3209,23,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
3209,24,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3209,25,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3209,26,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3209,27,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3209,28,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3209,29,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3209,30,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3209,31,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3209,32,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3210,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3210,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3210,3,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3211,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3212,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3212,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3213,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3213,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3213,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3213,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
3213,5,Procedural pneumothorax,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3213,6,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3213,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
3214,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3215,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3216,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3216,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3216,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3216,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3216,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3217,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3217,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3217,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3218,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3218,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3218,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3218,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3218,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3218,6,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
3219,1,Keratolysis exfoliativa acquired,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3220,1,Oophorectomy,Ovarian therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3221,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3221,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3221,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3221,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3222,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3223,1,Adenocarcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3224,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3224,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3224,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3225,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3226,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3226,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3227,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3227,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
3227,3,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
3227,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
3228,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3228,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3229,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
3229,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3229,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3229,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3229,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3229,6,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3229,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
3229,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3229,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3229,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3229,11,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3230,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
3230,2,Headache,Headaches NEC,Headaches,Nerv,N
3230,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3231,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3232,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3233,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3234,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3235,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3236,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3236,2,Rectal polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
3237,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3238,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3239,1,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3240,1,Headache,Headaches NEC,Headaches,Nerv,N
3240,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3241,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3241,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3242,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3242,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3242,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3243,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3243,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3243,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3244,1,Stress urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
3245,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3246,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3246,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3246,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3247,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
3247,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3247,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3247,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3247,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3247,6,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3247,7,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3247,8,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
3247,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3247,10,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3247,11,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3247,12,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3247,13,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3247,14,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3247,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3247,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3247,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3247,18,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3247,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3247,20,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3247,21,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3247,22,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
3247,23,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3247,24,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3248,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3249,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3249,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3249,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3249,4,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
3249,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3249,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3250,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3251,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3251,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3252,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3252,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3252,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3252,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3252,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3253,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
3253,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3253,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3253,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3254,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3254,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3254,3,Rectal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
3255,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
3256,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
3257,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
3257,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3258,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3258,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3258,3,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
3258,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3259,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3259,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3259,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3259,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3259,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3259,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3260,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3261,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3261,2,Headache,Headaches NEC,Headaches,Nerv,N
3261,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3261,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3261,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3262,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3263,1,Angiotensin converting enzyme increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3263,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3263,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
3263,4,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3263,5,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3263,6,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3263,7,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
3263,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3264,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3264,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
3264,3,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3265,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3265,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
3265,3,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
3266,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3266,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
3267,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3267,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3267,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3267,4,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3268,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3268,2,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3268,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3268,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3268,5,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3268,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3268,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3268,8,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3268,9,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3268,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3268,11,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
3268,12,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3268,13,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
3269,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3269,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3269,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3269,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3270,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3270,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3271,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3272,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3272,2,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
3272,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3273,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3274,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3274,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3275,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3275,2,Mean cell haemoglobin concentration abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3275,3,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3275,4,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3275,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3276,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3276,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3277,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
3277,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3278,1,Alcoholic,Alcohol product use,Lifestyle issues,SocCi,N
3278,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3278,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3278,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
3279,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
3279,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3280,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
3280,2,Cervix carcinoma stage I,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3280,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3280,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3281,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3281,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
3281,3,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3282,1,Mumps antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3282,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3283,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3284,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3284,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
3284,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3284,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3284,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3285,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3285,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3285,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3286,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
3287,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3287,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3287,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3288,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3288,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
3288,3,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3289,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3290,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
3290,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
3290,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3290,4,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3290,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3290,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3290,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3291,1,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3292,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3292,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3293,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3293,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3294,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3295,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3295,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3295,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3296,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
3296,2,Bursitis infective staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3297,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3297,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3297,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3297,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3297,5,Migraine,Migraine headaches,Headaches,Nerv,N
3297,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3297,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3298,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3298,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3298,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
3299,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3300,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3301,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3302,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3302,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
3303,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3304,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3304,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3305,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
3306,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
3307,1,Colon operation,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3307,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3307,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3307,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3308,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3308,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3308,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3308,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3308,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3308,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3308,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3309,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3309,2,Tuberculin test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
3309,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3310,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3310,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3311,1,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3312,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3312,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3313,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3313,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3314,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3315,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
3315,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3315,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3316,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3316,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3316,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
3316,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3316,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3317,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
3317,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3317,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
3318,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3318,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3318,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3319,1,Headache,Headaches NEC,Headaches,Nerv,N
3319,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
3319,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3320,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3320,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3320,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3320,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
3320,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3320,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3320,7,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3320,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3321,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3322,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3323,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
3323,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3323,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3323,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3324,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
3325,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
3326,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3326,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3326,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3326,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3327,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3327,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3327,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3327,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3327,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3327,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3328,1,Acne,Acnes,Skin appendage conditions,Skin,N
3328,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3328,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3328,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3328,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3328,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3328,7,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3329,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
3329,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
3330,1,Bladder neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3330,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3331,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
3331,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3331,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3331,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3331,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3331,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3332,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3333,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3333,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
3333,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3333,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3333,5,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3333,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3333,7,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3333,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3334,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3335,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3336,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3336,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3337,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3338,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
3338,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3338,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3338,4,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3338,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3338,6,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3339,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
3340,1,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
3341,1,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3342,1,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
3342,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3343,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
3344,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3344,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3344,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3344,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3344,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3344,6,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
3344,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3344,8,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
3345,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3345,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3345,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3345,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3346,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3346,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3347,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3348,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3348,2,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
3349,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3349,2,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3350,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3350,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3350,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3350,4,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3350,5,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3351,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3351,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3351,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3351,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3351,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3351,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3352,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3353,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3353,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
3354,1,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
3354,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3355,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3355,2,Deafness,Hearing losses,Hearing disorders,Ear,N
3355,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3356,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3356,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
3356,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
3357,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3357,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3357,3,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
3357,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3357,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3357,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3357,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3357,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3357,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3357,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3357,11,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3357,12,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3357,13,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3357,14,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
3357,15,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
3357,16,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3358,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3358,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
3359,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3359,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3359,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3359,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3359,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3360,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3361,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3361,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3362,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3362,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3362,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3363,1,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
3364,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3364,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3364,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3364,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3365,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3365,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3365,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3365,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
3366,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3367,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3367,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3368,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3368,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3369,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3369,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3369,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3369,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3370,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3370,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3370,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3370,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3371,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3372,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3372,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3372,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3373,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3373,2,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3373,3,Headache,Headaches NEC,Headaches,Nerv,N
3373,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3374,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3375,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3375,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3376,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
3376,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3376,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3376,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3377,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3377,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3378,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3378,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3378,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3378,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3378,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3378,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3378,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3378,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3379,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3379,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3379,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3380,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3380,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
3380,3,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3380,4,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3380,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3380,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3380,7,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3380,8,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3380,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3380,10,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3380,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3380,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3380,13,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3380,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3380,15,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3380,16,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
3381,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3382,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
3382,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3382,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3382,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3383,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3383,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3383,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3383,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
3384,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3384,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3385,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3386,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3386,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3386,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3386,4,Subclavian artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3387,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3387,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3388,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3389,1,Headache,Headaches NEC,Headaches,Nerv,N
3389,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3390,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3391,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
3392,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3392,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3393,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3393,2,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3393,3,Light chain analysis abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
3393,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
3393,5,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
3393,6,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3393,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3394,1,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3395,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
3395,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3396,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3397,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3397,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3398,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3399,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
3400,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
3401,1,Disease susceptibility,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3401,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3402,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3403,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3403,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3403,3,Palatal oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3404,1,Deafness,Hearing losses,Hearing disorders,Ear,N
3405,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3405,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3405,3,Splenic neoplasm malignancy unspecified,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3406,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3407,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3408,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
3408,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3409,1,Deafness,Hearing losses,Hearing disorders,Ear,N
3409,2,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3410,1,Headache,Headaches NEC,Headaches,Nerv,N
3410,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3410,3,Vertebrobasilar artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
3411,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3411,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
3411,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
3411,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3411,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3411,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3412,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3412,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
3413,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3414,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3415,1,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3416,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3417,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
3417,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3418,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3418,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3419,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3419,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3419,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3419,4,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3419,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3419,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3419,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3419,8,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3420,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3420,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3420,3,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3420,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3421,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3422,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3423,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3424,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3425,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3425,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3425,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3425,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3425,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3425,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3425,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
3425,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3426,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3426,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3427,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
3427,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3428,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
3429,1,Bladder transitional cell carcinoma recurrent,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3429,2,Rectal cancer stage III,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
3430,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3430,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3430,3,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3430,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3430,5,Peripheral artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
3430,6,Peripheral revascularisation,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
3431,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
3432,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3432,2,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3433,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3434,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3435,1,Lymphomatoid papulosis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
3436,1,Bladder cancer stage III,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3437,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3438,1,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
3439,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3439,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3439,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3439,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3440,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3441,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3441,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3442,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
3442,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
3442,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3443,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3444,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3445,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3445,2,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
3446,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3446,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3447,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
3448,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3449,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
3449,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3449,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3449,4,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
3449,5,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
3449,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3450,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3451,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3452,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3453,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3454,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
3454,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3454,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3455,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3456,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3456,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3456,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3456,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3457,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3457,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3457,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
3458,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3458,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3458,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3458,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3459,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3459,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3459,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3459,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3460,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3460,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3461,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3462,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3463,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3464,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3464,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3464,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3464,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3464,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3465,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3465,2,Arthritis reactive,Spondyloarthropathies,Joint disorders,Musc,N
3465,3,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
3466,1,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3467,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3467,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3467,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
3467,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3468,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3468,2,Headache,Headaches NEC,Headaches,Nerv,N
3469,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3469,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
3469,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3469,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3469,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3470,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
3471,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3471,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3471,3,Headache,Headaches NEC,Headaches,Nerv,N
3471,4,Medical device implantation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3471,5,Migraine,Migraine headaches,Headaches,Nerv,N
3472,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
3473,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3474,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
3474,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
3474,3,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3475,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3476,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3476,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3476,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3476,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3477,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3477,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
3477,3,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
3477,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3477,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3477,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3477,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3477,8,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
3477,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3477,10,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3477,11,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3477,12,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3477,13,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3477,14,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3477,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
3477,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3477,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3478,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
3479,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3480,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3481,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3482,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3482,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3483,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3483,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3484,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3484,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3484,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3485,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3486,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3487,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3487,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3488,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3489,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3490,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3491,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3491,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3491,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3491,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3491,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3492,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3493,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
3494,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
3495,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3495,2,Elbow operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3495,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3496,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3496,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3496,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3496,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3496,5,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3496,6,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
3496,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3497,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3497,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3498,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3498,2,Bunion operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3498,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3498,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3498,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3498,6,Osteotomy,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
3498,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3498,8,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3498,9,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3498,10,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
3498,11,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3498,12,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3499,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3499,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3500,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3501,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3501,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3501,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3501,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3501,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3502,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3502,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3503,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3503,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3503,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3503,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3503,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3503,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3503,7,Pyoderma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3503,8,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3504,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3505,1,Device issue,Device issues NEC,Device issues,Prod,N
3505,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3506,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3507,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3507,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
3507,3,Headache,Headaches NEC,Headaches,Nerv,N
3507,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3507,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3508,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3509,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3510,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3511,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
3511,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3511,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3512,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3513,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3513,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3513,3,Headache,Headaches NEC,Headaches,Nerv,N
3513,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3513,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
3513,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3513,7,Migraine,Migraine headaches,Headaches,Nerv,N
3513,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3513,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3514,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3515,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3516,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3517,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3517,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3517,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3517,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3517,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3517,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3518,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3519,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3520,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3521,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3521,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3521,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3522,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3523,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3524,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3524,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3525,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3525,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
3525,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
3525,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3525,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
3525,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3526,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3526,2,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3526,3,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3526,4,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
3526,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3526,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3527,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3528,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3528,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3529,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3530,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3531,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3532,1,Elbow operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3533,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3534,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3534,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3535,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3536,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3536,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3537,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3538,1,Hyperthermia,Body temperature altered,Body temperature conditions,Genrl,N
3538,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3539,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3540,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3540,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3540,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3541,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3542,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3542,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3543,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3544,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
3545,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3546,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3547,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3548,1,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3549,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3550,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3551,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3552,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3553,1,Neck surgery,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
3554,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3554,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3555,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3556,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3557,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
3557,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3558,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
3559,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3560,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3561,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3562,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3563,1,Joint arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3564,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3564,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3565,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3566,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3567,1,Cerebral cyst,Nervous system cysts and polyps,Nervous system neoplasms benign,Nerv,N
3567,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3568,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3569,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3569,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3570,1,Elbow operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3571,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3572,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
3572,2,Wrist surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3573,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3574,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3575,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3575,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3575,3,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3576,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3577,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3577,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3578,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3579,1,Arthroscopy,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
3580,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3580,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
3580,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3581,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3582,1,Device loosening,Device issues NEC,Device issues,Prod,N
3582,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3582,3,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3582,4,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3583,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3584,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3585,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3586,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3587,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3588,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3589,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3590,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3590,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3591,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3591,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3592,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3592,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3593,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3593,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3593,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
3593,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3593,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3594,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3594,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3594,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3594,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3594,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3594,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3594,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
3594,8,Migraine,Migraine headaches,Headaches,Nerv,N
3594,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3594,10,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3595,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3595,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
3596,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
3596,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3596,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3596,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
3596,5,Wisdom teeth removal,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3597,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3598,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3599,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3599,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3599,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3599,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3599,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3599,6,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
3600,1,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
3600,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3601,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3601,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3602,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3602,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3602,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3603,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3604,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
3604,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3605,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3606,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3607,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3608,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3608,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3609,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3609,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3609,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3610,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
3610,2,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
3611,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3611,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3612,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3613,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3613,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3614,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3614,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3614,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3615,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3615,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3615,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3616,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3617,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3617,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3617,3,Pneumothorax traumatic,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
3618,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3619,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3619,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3620,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3621,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3622,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3623,1,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3623,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3624,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3625,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3626,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3626,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3627,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3628,1,Peritoneal dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
3628,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3629,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3630,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3631,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3631,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3631,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3631,4,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
3632,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3633,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3634,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3635,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3636,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3637,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3638,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3639,1,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
3639,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3640,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3641,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3642,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3642,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3643,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3643,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3643,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3644,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3645,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3646,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3646,2,Non-Hodgkin's lymphoma stage IV,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
3646,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3646,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3646,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3647,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3647,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3647,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3647,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3648,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3649,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3649,2,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3650,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3651,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3651,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3652,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3653,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3653,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3653,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3653,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3653,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3653,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3653,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3653,8,Pelvic cyst,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
3653,9,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3653,10,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3653,11,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3654,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
3655,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3656,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3657,1,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3658,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3659,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3660,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3661,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3661,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3662,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3663,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3664,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3664,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3664,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3665,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3666,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3667,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3668,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3669,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3669,2,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3669,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3670,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3670,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3671,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3671,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3671,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3671,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3671,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3671,6,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3671,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3671,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3671,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
3671,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3671,11,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3672,1,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
3673,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
3674,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3674,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3675,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3675,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3676,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3677,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3677,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3678,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
3679,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3680,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3680,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3680,3,Headache,Headaches NEC,Headaches,Nerv,N
3680,4,Headache,Headaches NEC,Headaches,Nerv,N
3680,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3680,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3681,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3681,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3681,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3682,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3683,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3683,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3683,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3684,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3684,2,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
3684,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3685,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3686,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3687,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3687,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3688,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3688,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3688,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3689,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
3690,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
3690,2,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
3691,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3691,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
3691,3,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
3692,1,Pituitary tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
3693,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3694,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3695,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3696,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3696,2,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3696,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3697,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3698,1,Typhoid fever,Salmonella infections,Bacterial infectious disorders,Infec,N
3699,1,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
3700,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3701,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
3701,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3702,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3702,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
3703,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3704,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3705,1,Dental cleaning,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
3706,1,Endocrine gland operation,Endocrine gland therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
3706,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3707,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3707,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3708,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3709,1,Headache,Headaches NEC,Headaches,Nerv,N
3709,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
3709,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3709,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3710,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
3711,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
3712,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3712,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3713,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3714,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3714,2,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3714,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3714,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3714,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3715,1,Gallbladder operation,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
3716,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3717,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3718,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
3718,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3719,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3720,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3720,2,Infected varicose vein,Vascular infections,Infections - pathogen unspecified,Infec,N
3721,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3721,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3722,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3722,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3722,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3722,4,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3722,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3722,6,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
3723,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3724,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3724,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3725,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3726,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3726,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3727,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
3727,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
3727,3,Exposure to toxic agent,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
3727,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3727,5,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
3727,6,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
3727,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3727,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3728,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
3728,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3728,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3729,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3729,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3729,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3729,4,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3729,5,Pancreatic operation,Pancreatic therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3730,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3730,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3730,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3730,4,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3730,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3731,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3731,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3731,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3731,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3731,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3731,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3731,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3731,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3732,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3732,2,Mastoiditis,Ear infections,Infections - pathogen unspecified,Infec,N
3733,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3734,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3735,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
3735,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3736,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3737,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3737,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3738,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3738,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3739,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3740,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3741,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3741,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3742,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3742,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3742,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3743,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3743,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3743,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3744,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3744,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
3744,3,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
3744,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3744,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3745,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3746,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3746,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3747,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3748,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3748,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3749,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
3750,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3751,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3752,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3752,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3752,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3753,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3753,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3754,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3755,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3755,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3755,3,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3755,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3756,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
3756,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3756,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3757,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3757,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
3757,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3757,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3757,5,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3758,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3758,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3759,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3760,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3761,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3761,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3761,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3761,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3761,5,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3762,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3762,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3762,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3762,4,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3762,5,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3763,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3763,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3763,3,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3764,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3764,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3764,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
3765,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3766,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3767,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3768,1,Cervical polyp,Cervix neoplasms,Cervix disorders (excl infections and inflammations),Repro,N
3769,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3770,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3771,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3772,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3772,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3772,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3772,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3773,1,Aspiration pleural cavity,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3773,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3773,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3774,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3775,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3776,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3777,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3778,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3779,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3779,2,Nail operation,Nail therapeutic procedures,Skin and subcutaneous tissue therapeutic procedures,Surg,N
3780,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3780,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3781,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3782,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3782,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3783,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
3784,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3785,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3786,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3787,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3788,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3789,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3790,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3791,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3792,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3793,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3794,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3795,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3795,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3795,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3796,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3796,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3797,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3798,1,Face injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
3798,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3798,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3799,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
3800,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3801,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3801,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3801,3,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
3801,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3802,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3803,1,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
3803,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3804,1,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3805,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3806,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3807,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3807,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3807,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3808,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
3809,1,Squamous cell carcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
3809,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
3810,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3810,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
3811,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3811,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3812,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3812,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3813,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3813,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
3814,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3814,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3814,3,Lymphadenectomy,Lymphoid tissue therapeutic procedures,Haematological and lymphoid tissue therapeutic procedures,Surg,N
3814,4,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3814,5,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3814,6,Non-Hodgkin's lymphoma stage II,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
3814,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3814,8,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3815,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3815,2,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
3816,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3817,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3817,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3817,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3818,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3819,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
3819,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
3819,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
3819,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3820,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3820,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
3820,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
3821,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3822,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3822,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3823,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
3824,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3825,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3825,2,Rehabilitation therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3826,1,Diffuse large B-cell lymphoma stage I,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3827,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3828,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3829,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3830,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
3831,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3831,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
3832,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3833,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3834,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3834,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3834,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3834,4,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
3834,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3835,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
3836,1,Headache,Headaches NEC,Headaches,Nerv,N
3836,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3836,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
3836,4,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3837,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3837,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3837,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3837,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
3837,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3838,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3839,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3840,1,Headache,Headaches NEC,Headaches,Nerv,N
3841,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3842,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3843,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3843,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3844,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3845,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
3846,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
3847,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
3847,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
3847,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3847,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
3848,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3849,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3849,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3850,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3851,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3852,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3852,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3852,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
3852,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3852,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3852,6,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
3852,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3852,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3853,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3854,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3855,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
3856,1,Neurectomy,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
3857,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3857,2,Headache,Headaches NEC,Headaches,Nerv,N
3857,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3857,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3857,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3857,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3857,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3858,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3859,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3859,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3859,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3859,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3859,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3860,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3861,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3862,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3863,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3864,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3864,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3864,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3864,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3864,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3864,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3865,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3866,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3866,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3866,3,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
3866,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3867,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3868,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3869,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
3870,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3870,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3871,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3871,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3872,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3872,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3873,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3874,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3874,2,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3875,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3876,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3877,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3878,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
3879,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3879,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3880,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
3880,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3881,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
3882,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3883,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3884,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3884,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3884,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3884,4,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
3884,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3884,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3884,7,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3885,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3885,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3885,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3885,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3886,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3887,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3888,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3889,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3889,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3889,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3889,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3890,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3891,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3892,1,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
3892,2,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
3893,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3893,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3893,3,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
3893,4,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
3894,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3894,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3894,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3895,1,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3895,2,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3895,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
3895,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3895,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3896,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3896,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3897,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3898,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3898,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3898,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3899,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3899,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3899,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3899,4,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
3899,5,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
3900,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
3901,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3902,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3902,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3902,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3903,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
3903,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3904,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3904,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3905,1,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
3906,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3906,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3906,3,Headache,Headaches NEC,Headaches,Nerv,N
3907,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3908,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3908,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
3908,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3908,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3908,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3908,6,Paraparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3909,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3910,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3911,1,Herpes oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
3912,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3913,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
3914,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3915,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3916,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3916,2,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3916,3,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
3917,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
3918,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3918,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
3918,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3918,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3918,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3918,6,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
3918,7,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
3918,8,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
3918,9,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3918,10,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3918,11,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
3918,12,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
3918,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,15,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,17,Idiopathic interstitial pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3918,18,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
3918,19,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3918,20,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3918,21,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3918,22,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3918,23,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3918,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,25,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3918,26,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3918,27,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
3918,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3918,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3918,30,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3918,31,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3918,32,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3919,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3919,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3919,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3920,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3920,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3920,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3920,4,Headache,Headaches NEC,Headaches,Nerv,N
3920,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
3920,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3921,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3922,1,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
3923,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3924,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3925,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
3926,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3926,2,Hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
3926,3,Myopathy,Myopathies,Muscle disorders,Musc,N
3926,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3927,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3927,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3927,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3927,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3928,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3929,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3930,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3930,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3931,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3932,1,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3932,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3933,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3934,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3934,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3935,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3935,2,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3936,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
3936,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3937,1,Skin graft,Skin grafts,Skin and subcutaneous tissue therapeutic procedures,Surg,N
3937,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3938,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3938,2,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3939,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3940,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3940,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3940,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3941,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3941,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3941,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3942,1,Headache,Headaches NEC,Headaches,Nerv,N
3942,2,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
3943,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3944,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3945,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3946,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
3947,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3948,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3948,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
3948,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3949,1,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3950,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
3950,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3951,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3952,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3953,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3954,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3955,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3955,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3955,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3956,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3956,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3956,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3956,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
3956,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
3956,6,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3957,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3958,1,Acne,Acnes,Skin appendage conditions,Skin,N
3959,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3959,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3959,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
3959,4,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
3959,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3959,6,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3960,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3961,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3962,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3963,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3964,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
3965,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3966,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3967,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3967,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
3968,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3969,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3969,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3969,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3970,1,Hodgkin's disease stage II,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
3970,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3970,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3970,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3970,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3971,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3972,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3972,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
3973,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3973,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3974,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3975,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3976,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3977,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3978,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3978,2,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
3979,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3979,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3980,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
3980,2,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3980,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3981,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3982,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
3982,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3983,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
3983,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3984,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3985,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3986,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3986,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3987,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
3987,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3988,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3989,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3989,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
3989,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3990,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3990,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3991,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3991,2,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
3992,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3993,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
3993,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3994,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3995,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
3995,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
3996,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3997,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3998,1,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
3999,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4000,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4001,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4002,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4002,2,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4003,1,Headache,Headaches NEC,Headaches,Nerv,N
4003,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4003,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
4004,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
4005,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4006,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4006,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4006,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4007,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
4008,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4009,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4009,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4009,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4010,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
4010,2,Posturing,Stereotypies and automatisms,Changes in physical activity,Psych,N
4010,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4010,4,Tongue biting,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4010,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4011,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
4012,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4013,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4013,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4013,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4013,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4013,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4013,6,Headache,Headaches NEC,Headaches,Nerv,N
4013,7,Headache,Headaches NEC,Headaches,Nerv,N
4013,8,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
4013,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4013,10,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
4013,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4013,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4013,13,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
4014,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4014,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4014,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4014,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4015,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
4015,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4016,1,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
4017,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4018,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4018,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4018,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4018,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4018,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4019,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4020,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4021,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4021,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
4021,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4021,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4022,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4023,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4023,2,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4023,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
4024,1,Tubular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4025,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4026,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4027,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4028,1,Headache,Headaches NEC,Headaches,Nerv,N
4029,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4030,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4030,2,Headache,Headaches NEC,Headaches,Nerv,N
4030,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
4030,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
4031,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4031,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
4031,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4032,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4033,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4034,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4034,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
4034,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4035,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4036,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4037,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4038,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4038,2,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
4039,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4039,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4039,3,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4039,4,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
4040,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4041,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
4042,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4042,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4042,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4042,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4043,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4044,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4044,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4045,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4046,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4046,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4046,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4047,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4047,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4048,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4048,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4048,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4049,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4049,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4049,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4050,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4051,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4051,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4051,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4052,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4052,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4052,3,Headache,Headaches NEC,Headaches,Nerv,N
4053,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
4054,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4054,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4054,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4054,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4054,5,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4055,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4056,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4056,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4057,1,Peyronie's disease,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
4058,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4059,1,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
4060,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4061,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4062,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4063,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
4064,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
4065,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4065,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4065,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4065,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4065,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4065,6,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4065,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4065,8,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4066,1,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
4067,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4067,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
4067,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4067,4,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
4068,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4069,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
4069,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4069,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4070,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4071,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4071,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4072,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4073,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4073,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4073,3,Ear haemorrhage,Ear disorders NEC,Aural disorders NEC,Ear,N
4073,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4073,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
4073,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
4073,7,Ligament disorder,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
4073,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
4073,9,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
4074,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4075,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4076,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4077,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4077,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4078,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4079,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4080,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4081,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4082,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4083,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4084,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4085,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
4086,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4087,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4088,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4089,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
4090,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4090,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4090,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4090,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4090,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
4090,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4090,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4091,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4092,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4092,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4092,3,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4092,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4092,5,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
4092,6,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
4092,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4092,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4092,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4092,10,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
4092,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4093,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4093,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4093,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4094,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4094,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4094,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4094,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4094,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4094,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4095,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4095,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4096,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
4097,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4097,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
4097,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4097,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4097,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4097,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4098,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4098,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4098,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4099,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4100,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
4101,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4101,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4102,1,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4102,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4102,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4102,4,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
4103,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4103,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4104,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4104,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4105,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4105,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4105,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4105,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4105,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4106,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4106,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4106,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4106,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
4106,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4107,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4108,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4109,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
4110,1,Nail hypertrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4110,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4110,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4110,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4110,5,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
4111,1,Cardiac myxoma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
4112,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4112,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4112,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4112,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
4112,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4113,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
4114,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4115,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4116,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4116,2,Headache,Headaches NEC,Headaches,Nerv,N
4116,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4116,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4117,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4117,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4117,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4117,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4117,5,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4117,6,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4117,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4117,8,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4118,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4119,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
4119,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4119,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4119,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4119,5,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
4119,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4119,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4119,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4119,9,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4119,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4119,11,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4120,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4121,1,Sperm concentration decreased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
4122,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4122,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4122,3,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
4122,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4122,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4122,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4122,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4122,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4122,9,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4123,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
4124,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
4124,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4124,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4124,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4125,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4125,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4126,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
4126,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4126,3,Brachial plexopathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4126,4,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
4126,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4126,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4126,7,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
4126,8,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
4126,9,Median nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
4126,10,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4126,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4126,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4126,13,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4126,14,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4126,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4127,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
4127,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4128,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4128,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4128,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4128,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4128,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4128,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4129,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
4130,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4130,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4130,3,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
4130,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4131,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4131,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4132,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4133,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
4134,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4135,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4136,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4136,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4136,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4137,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4138,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4139,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4140,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4141,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
4141,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4141,3,Suture rupture,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4142,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4143,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4144,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
4144,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4145,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
4145,2,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
4146,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4147,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4148,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4148,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4148,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4148,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4149,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4150,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4150,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4151,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4151,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4151,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4151,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4151,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4151,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
4151,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4151,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4151,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4151,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4151,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4151,12,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4151,13,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
4151,14,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4151,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4152,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4152,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4152,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4152,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4153,1,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4154,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4155,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4156,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4156,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
4156,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4157,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4158,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4158,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4158,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4158,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4158,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4158,6,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4159,1,Colon cancer stage I,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4159,2,Colon neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4160,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4160,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4160,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4161,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
4161,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4161,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4162,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4163,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4164,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4165,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4165,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4166,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4167,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4167,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4167,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4167,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4167,5,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4168,1,Acne,Acnes,Skin appendage conditions,Skin,N
4168,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4168,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4168,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4168,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4169,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4170,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4171,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4172,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
4172,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
4173,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4173,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4173,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4174,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4174,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4175,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4175,2,Headache,Headaches NEC,Headaches,Nerv,N
4176,1,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4177,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4177,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4177,3,Mediastinal shift,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
4178,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4179,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4180,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4181,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4181,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4181,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4182,1,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4182,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4183,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4183,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4184,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4184,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4184,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4184,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4184,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4185,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4186,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4186,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4186,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
4186,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4187,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4188,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4189,1,Congenital laryngeal stridor,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
4189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4189,3,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4190,1,Change in sustained attention,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
4190,2,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
4191,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
4191,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4191,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4192,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4192,2,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4192,3,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4192,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4192,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4193,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4193,2,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4193,3,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4193,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4193,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4193,6,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
4193,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4194,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4195,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4195,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4196,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
4196,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4196,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4197,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
4197,2,Headache,Headaches NEC,Headaches,Nerv,N
4197,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
4197,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4197,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4197,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4198,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
4198,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4199,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4199,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4199,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4199,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4199,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4200,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4200,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4200,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4200,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4200,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4200,6,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
4200,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4200,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
4201,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4201,2,Jaw operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
4201,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4202,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4203,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4203,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4204,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4205,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4206,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4206,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4206,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4206,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4207,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4207,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4207,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4207,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4207,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4208,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4208,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4208,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4209,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4210,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4210,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4210,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4211,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4211,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4211,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4212,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4213,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4214,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4215,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4215,2,Stomach mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4215,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4216,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4216,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4217,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4218,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
4219,1,Neck surgery,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
4220,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4220,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4220,3,Headache,Headaches NEC,Headaches,Nerv,N
4220,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
4220,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4220,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4221,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4222,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4223,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
4223,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4223,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
4224,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
4225,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4226,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4226,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4227,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
4227,2,DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
4228,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4229,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4229,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4229,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4229,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4230,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4231,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4232,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4233,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4233,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
4233,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4234,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
4234,2,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
4234,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4235,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4235,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4236,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4236,2,Intestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
4237,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4238,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4239,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4240,1,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
4241,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4242,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4242,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4243,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4243,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4243,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4243,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4243,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4244,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4244,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4244,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4244,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4244,5,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4245,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4246,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4247,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4247,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4248,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4248,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4248,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4248,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4249,1,Headache,Headaches NEC,Headaches,Nerv,N
4249,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4249,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
4250,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
4250,2,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4251,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4251,2,Multi-organ disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4252,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4253,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4254,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4254,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4255,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
4256,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4257,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
4258,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4258,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4258,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4259,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4259,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4259,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4260,1,Disease susceptibility,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4260,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4260,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4261,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4261,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4261,3,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
4262,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4263,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4264,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4264,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4264,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
4265,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4265,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4265,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4266,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4267,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4268,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4269,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4270,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4271,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4272,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4272,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4272,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4272,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4272,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4272,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4272,7,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4272,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4272,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4273,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4274,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
4274,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
4274,3,Headache,Headaches NEC,Headaches,Nerv,N
4274,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4274,5,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
4275,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4275,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4275,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4275,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4275,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4275,6,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4275,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4276,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4277,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4277,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4278,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4278,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4279,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4279,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4280,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4281,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4281,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4282,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4283,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4284,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4285,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4285,2,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4285,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4286,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4286,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
4286,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4286,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4287,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4287,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
4287,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
4287,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
4288,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
4288,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4289,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
4290,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4290,2,Headache,Headaches NEC,Headaches,Nerv,N
4290,3,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
4290,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4290,5,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4290,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4291,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4292,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4292,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4292,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4293,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4293,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4293,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4293,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4294,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4294,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4294,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
4294,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4296,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4296,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4297,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4297,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4298,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4299,1,Headache,Headaches NEC,Headaches,Nerv,N
4299,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4299,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4299,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4300,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4300,2,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4300,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4300,4,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4300,5,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4300,6,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4300,7,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
4300,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4301,1,Small cell lung cancer extensive stage,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4302,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4302,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4303,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4304,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4305,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
4305,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4306,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4307,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4307,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4308,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4308,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4308,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4309,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4309,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
4310,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4310,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
4310,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4311,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4312,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4312,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4312,3,Headache,Headaches NEC,Headaches,Nerv,N
4312,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4312,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4313,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4313,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4314,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4315,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4316,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4316,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4316,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4316,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4317,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4317,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
4317,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4317,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4317,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4317,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4317,7,Headache,Headaches NEC,Headaches,Nerv,N
4317,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4317,9,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
4317,10,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4317,11,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4318,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4318,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4319,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4319,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4319,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4319,4,Pulmonary granuloma,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4319,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4319,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4319,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4319,8,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4319,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4320,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4320,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4320,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4321,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4321,2,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4321,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4321,4,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4322,1,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4322,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4322,3,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
4323,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4324,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
4325,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4325,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4326,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4327,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4327,2,Staphylococcal abscess,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4328,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4329,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4329,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
4329,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4330,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4330,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
4331,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4332,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
4333,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4333,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
4333,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4334,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4334,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
4335,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4335,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4336,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
4336,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4336,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
4336,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4336,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4336,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4337,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4338,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4338,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4338,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4338,4,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
4339,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4339,2,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4340,1,Intestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
4340,2,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4341,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4341,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4341,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4341,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4342,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4342,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4343,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4344,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4345,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4346,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4346,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4346,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4347,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4347,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4348,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4348,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
4348,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4348,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4348,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4348,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4349,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4350,1,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
4350,2,Headache,Headaches NEC,Headaches,Nerv,N
4350,3,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4350,4,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4351,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
4352,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4352,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4352,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
4352,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4353,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4353,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4354,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4355,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4356,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4356,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4356,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4357,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4357,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4357,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4358,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
4359,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4360,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4360,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4361,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4362,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4363,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4364,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
4364,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
4365,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4365,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4365,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4365,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4365,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4366,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4366,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4366,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4367,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4367,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4368,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4368,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4368,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4368,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4368,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4368,6,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4369,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4370,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4370,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4370,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4371,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4371,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4371,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4371,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4372,1,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4372,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4372,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4372,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4373,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4373,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
4373,3,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4373,4,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
4373,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4373,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4373,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4373,8,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
4374,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4374,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4374,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4374,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4375,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4375,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4376,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4377,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4378,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4378,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4378,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4378,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4379,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4379,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4379,3,Gilbert's syndrome,Inborn errors of bilirubin metabolism,Metabolic and nutritional disorders congenital,Cong,N
4379,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4380,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4380,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4380,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4381,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4381,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4382,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4382,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4383,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4384,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
4384,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4385,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4386,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4387,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
4387,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4387,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4387,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4387,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4387,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4387,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4388,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4389,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4390,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4390,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4391,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4391,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4391,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4392,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4392,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4393,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4393,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4393,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4393,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4394,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4395,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4396,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4396,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4396,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
4396,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
4396,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
4396,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4396,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4396,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4396,9,Supraventricular extrasystoles,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4397,1,Colostomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4397,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4397,3,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4397,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4398,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4398,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4398,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
4398,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
4399,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4399,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4400,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4401,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4401,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4401,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4401,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4402,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4402,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4403,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4404,1,Deafness,Hearing losses,Hearing disorders,Ear,N
4405,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4406,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4407,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4407,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
4407,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4408,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4409,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4410,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4410,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
4411,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
4411,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4412,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
4412,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4412,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4412,4,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4412,5,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
4412,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4413,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4414,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4415,1,Acquired immunodeficiency syndrome,Retroviral infections,Viral infectious disorders,Infec,N
4415,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4415,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4415,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4416,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4416,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4416,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4416,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4416,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4416,6,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
4417,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4417,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4418,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4418,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4418,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4419,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
4420,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4420,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4421,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
4422,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4422,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4423,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4423,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4423,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4424,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4424,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4425,1,Articular calcification,Joint related disorders NEC,Joint disorders,Musc,N
4425,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4426,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4426,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4427,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4427,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4428,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4429,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4430,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4431,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4432,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4432,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4432,3,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4432,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4432,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4433,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4433,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4434,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4434,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4435,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4435,2,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4435,3,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4436,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4436,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4437,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
4437,2,Device issue,Device issues NEC,Device issues,Prod,N
4437,3,Device issue,Device issues NEC,Device issues,Prod,N
4437,4,Device issue,Device issues NEC,Device issues,Prod,N
4437,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4437,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4438,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4438,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4439,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4439,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
4439,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
4440,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4440,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4440,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4440,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4440,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4441,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4442,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
4442,2,Leg amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4443,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4444,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
4445,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4446,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4446,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4446,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
4446,4,Fundoscopy abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
4446,5,Headache,Headaches NEC,Headaches,Nerv,N
4446,6,Headache,Headaches NEC,Headaches,Nerv,N
4446,7,Headache,Headaches NEC,Headaches,Nerv,N
4446,8,Headache,Headaches NEC,Headaches,Nerv,N
4446,9,Headache,Headaches NEC,Headaches,Nerv,N
4446,10,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4446,11,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4446,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4446,13,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4446,14,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4446,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4446,16,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4446,17,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4446,18,Refraction disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
4446,19,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4446,20,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4446,21,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4446,22,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4446,23,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4446,24,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4446,25,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4447,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4448,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4449,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4449,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4449,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4449,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4449,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4450,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4450,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4450,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4451,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4451,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4452,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4453,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4453,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4453,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4453,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4454,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4455,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4456,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4457,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4458,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4459,1,Uterine infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
4460,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4461,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4461,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4461,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4462,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4462,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4463,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4464,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4465,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4465,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4465,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
4466,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4466,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
4467,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4467,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4467,3,Headache,Headaches NEC,Headaches,Nerv,N
4467,4,Slow response to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4468,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4469,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4470,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4471,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4472,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4472,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4473,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
4474,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4474,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4474,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4474,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4474,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4474,6,Headache,Headaches NEC,Headaches,Nerv,N
4474,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4474,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4474,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4474,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4474,11,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
4474,12,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4475,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4475,2,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,Y
4476,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
4477,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4477,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4478,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
4478,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4478,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4478,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4479,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4479,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4479,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4479,4,Headache,Headaches NEC,Headaches,Nerv,N
4479,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
4479,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4480,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
4481,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4482,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4482,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4483,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
4483,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4483,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4483,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4483,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4484,1,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
4484,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4485,1,Cartilage operation,Cartilage therapeutic procedures,Soft tissue therapeutic procedures,Surg,N
4486,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4487,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4487,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4488,1,Facial nerve disorder,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
4488,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4489,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4489,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4489,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4489,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4490,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4491,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4491,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4492,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4493,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4494,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4495,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4495,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4496,1,Headache,Headaches NEC,Headaches,Nerv,N
4496,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4497,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4497,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4498,1,Polycythaemia vera,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4499,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4500,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4501,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4502,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4502,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4503,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4503,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4503,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4504,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4504,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4504,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4505,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
4506,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4507,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4508,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4509,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4509,2,Vaginal lesion,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4509,3,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4510,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4511,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4512,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4513,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4513,2,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
4513,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4513,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4514,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4515,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
4516,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4517,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4517,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
4518,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4518,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
4518,3,Headache,Headaches NEC,Headaches,Nerv,N
4518,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4518,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4519,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4520,1,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4521,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4521,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4521,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4521,4,Headache,Headaches NEC,Headaches,Nerv,N
4522,1,Migraine,Migraine headaches,Headaches,Nerv,N
4522,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
4523,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4523,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4523,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4523,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4523,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4524,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
4524,2,Sputum purulent,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4524,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4525,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4526,1,Streptococcal abscess,Streptococcal infections,Bacterial infectious disorders,Infec,N
4527,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4528,1,External ear cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4528,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
4529,1,Headache,Headaches NEC,Headaches,Nerv,N
4529,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4530,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4530,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4530,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4530,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4530,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4530,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4530,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4530,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4530,9,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4530,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4530,11,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4530,12,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4530,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4530,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4531,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4531,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
4531,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4531,4,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4531,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4532,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4533,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4533,2,Eyelids pruritus,Ocular disorders NEC,Eye disorders NEC,Eye,N
4534,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4535,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
4535,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4535,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4535,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4535,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4536,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
4536,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
4537,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
4537,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4537,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4537,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4538,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4538,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4538,3,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4538,4,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4538,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
4539,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
4540,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4541,1,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4542,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4542,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4542,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4543,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4544,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4544,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
4545,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4545,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4545,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4545,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4545,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4545,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4545,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4546,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4546,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4547,1,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
4548,1,Device issue,Device issues NEC,Device issues,Prod,N
4548,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4548,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4548,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4548,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4548,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4549,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4549,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4549,3,Pertussis,Bordetella infections,Bacterial infectious disorders,Infec,N
4549,4,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
4550,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4550,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4550,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4551,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4552,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4553,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4553,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4554,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4555,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4555,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4556,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4556,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4556,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4556,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4556,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4556,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4557,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4557,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4557,3,Oesophageal adenocarcinoma stage III,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
4557,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4558,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4558,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
4558,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4559,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4560,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4560,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4561,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4561,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4562,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4562,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4563,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
4563,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4564,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4564,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4564,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4565,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4565,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4565,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4566,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
4567,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4568,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4568,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
4568,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4568,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4569,1,Device issue,Device issues NEC,Device issues,Prod,N
4569,2,Device issue,Device issues NEC,Device issues,Prod,N
4569,3,Device issue,Device issues NEC,Device issues,Prod,N
4569,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
4569,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4570,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
4571,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4572,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4572,2,Headache,Headaches NEC,Headaches,Nerv,N
4572,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4572,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
4572,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4573,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4573,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4574,1,Angiolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
4574,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4575,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4576,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4576,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4576,3,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4577,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4577,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4577,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4577,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
4577,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4577,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4577,7,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4578,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4578,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
4578,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4579,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4580,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4580,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4580,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4580,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4581,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4581,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4581,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4581,4,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4581,5,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4581,6,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4581,7,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4581,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4581,9,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
4581,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4581,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4581,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4581,13,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4581,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4581,15,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4581,16,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4581,17,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4581,18,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4581,19,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4581,20,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4581,21,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4582,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4582,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
4583,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4583,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4583,3,Injection site exfoliation,Injection site reactions,Administration site reactions,Genrl,N
4583,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4583,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
4583,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4584,1,Derealisation,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
4584,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4584,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4584,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4584,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4584,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4584,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4585,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4585,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
4585,3,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4586,1,Headache,Headaches NEC,Headaches,Nerv,N
4586,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4586,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4587,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4587,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4588,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
4588,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4588,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4589,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4590,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4590,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4590,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4591,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
4591,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4592,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4593,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4594,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4595,1,Foetal cystic hygroma,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
4595,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
4595,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
4595,4,Turner's syndrome,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
4596,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4597,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4597,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4598,1,Migraine,Migraine headaches,Headaches,Nerv,N
4598,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4599,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4599,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4600,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4600,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4600,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4600,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4600,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4600,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
4601,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4601,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4601,3,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4601,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4602,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
4603,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4604,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4605,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
4605,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4605,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4605,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4605,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4605,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4605,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4605,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4606,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4607,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4607,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4608,1,Adenocarcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4608,2,Salivary gland cancer,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4609,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
4609,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4609,3,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4609,4,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
4609,5,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
4610,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4611,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4611,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4611,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4611,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4611,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4611,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4612,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4612,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4612,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4612,4,Headache,Headaches NEC,Headaches,Nerv,N
4612,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4612,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4613,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4614,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4615,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4615,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4616,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4617,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4618,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4619,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4619,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4619,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4619,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4619,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4619,6,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
4619,7,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4619,8,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4620,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4620,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4620,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4620,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4621,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4622,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
4622,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4623,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4623,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4623,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4623,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4623,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4623,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4624,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4624,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4624,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4624,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
4624,5,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
4624,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4625,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
4626,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4626,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4627,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4627,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4627,3,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
4628,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4628,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4628,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4629,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4629,2,Headache,Headaches NEC,Headaches,Nerv,N
4630,1,Salivary gland mass,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
4631,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
4632,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4632,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4633,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4633,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4633,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4633,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4633,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4633,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4634,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4635,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4635,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
4635,3,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4635,4,Globulins increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4635,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4635,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4635,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4635,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4635,9,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4636,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4637,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4637,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
4637,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4637,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4638,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
4639,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4640,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4640,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4640,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4640,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4640,5,Painful respiration,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
4640,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4640,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4641,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4642,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4642,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4642,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4642,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
4643,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4643,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4643,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4643,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4643,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4643,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4643,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4644,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4644,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4645,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4646,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4646,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4646,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4647,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4647,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4647,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4648,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4648,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4649,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4649,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4650,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4650,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4650,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4651,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
4651,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4651,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4652,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4652,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4652,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4653,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
4653,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4653,3,Blood fibrinogen increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
4653,4,Blood immunoglobulin M increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
4653,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4653,6,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4653,7,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4653,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4653,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4653,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4653,11,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4653,12,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4653,13,Mean cell haemoglobin concentration increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4653,14,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4653,15,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4653,16,Serum ferritin decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4653,17,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
4654,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4655,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4655,2,Globulins increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4655,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4655,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4656,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4657,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4658,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4658,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4659,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4660,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
4660,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4660,3,Gastric volvulus,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4661,1,Device issue,Device issues NEC,Device issues,Prod,N
4661,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4661,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4661,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
4661,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4661,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4662,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4662,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4662,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4663,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4663,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4663,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4663,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4663,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4664,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
4664,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
4664,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4665,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4665,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4666,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4667,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4668,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4669,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4669,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4669,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
4669,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
4669,5,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4670,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4670,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4670,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4670,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4671,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4671,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4672,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4672,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4673,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4673,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4674,1,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4674,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4675,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4675,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4675,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4675,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4675,5,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4676,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4676,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4677,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4677,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
4677,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
4677,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4677,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4677,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4677,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4677,8,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
4678,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4678,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4678,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4678,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4678,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4678,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4678,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4679,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4679,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
4679,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4680,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4680,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4680,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
4680,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4681,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4681,2,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4681,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
4681,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4681,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4681,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4682,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
4683,1,Congenital cardiovascular anomaly,Cardiovascular disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
4683,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4683,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
4684,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
4684,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4685,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4685,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4685,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4685,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4685,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4685,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4685,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4685,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4685,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4685,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4685,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4686,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4687,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
4688,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
4689,1,Cardiac operation,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
4690,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4691,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
4691,2,Headache,Headaches NEC,Headaches,Nerv,N
4691,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4691,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4691,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4692,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4693,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4694,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4694,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4694,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4694,4,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4694,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4694,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4695,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4696,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4696,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4696,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4696,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4697,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4697,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4698,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
4699,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
4700,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4700,2,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4700,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4700,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4700,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4700,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
4700,7,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4700,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4701,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4702,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4703,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
4703,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4704,1,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4705,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4705,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4705,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
4706,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4706,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4706,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4707,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4708,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4708,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4708,3,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
4708,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4708,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4709,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
4710,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4711,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
4712,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4712,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4712,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4712,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4712,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4713,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4713,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4714,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
4715,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4715,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
4715,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4715,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
4715,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
4716,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4717,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4718,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4718,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
4718,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4718,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4718,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
4718,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4719,1,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4720,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4720,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4720,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4720,4,Cervix enlargement,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
4720,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4720,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4720,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4720,8,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
4720,9,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
4720,10,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
4720,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4720,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4720,13,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
4720,14,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
4720,15,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4720,16,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
4720,17,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
4720,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4720,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4720,20,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
4720,21,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
4720,22,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4721,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
4722,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4723,1,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
4724,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4724,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4725,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4726,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4727,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4727,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4728,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4729,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4729,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4729,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4729,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4729,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
4729,6,Platelet aggregation test,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
4729,7,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
4729,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4730,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4730,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
4730,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4731,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4732,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4733,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4733,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4733,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4733,4,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4734,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
4735,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
4736,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4736,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4736,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4736,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4737,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4737,2,Tongue movement disturbance,Tongue signs and symptoms,Tongue conditions,Gastr,N
4738,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4739,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4740,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4740,2,Animal bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4740,3,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4740,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4740,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4740,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4740,7,Headache,Headaches NEC,Headaches,Nerv,N
4740,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4740,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4740,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4740,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4740,12,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
4741,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4742,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4743,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4744,1,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
4745,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4745,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
4745,3,Oesophageal mass,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4745,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
4745,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4746,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4746,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4746,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4747,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4748,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4749,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4750,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4751,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
4752,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4752,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4752,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4752,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4752,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4752,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4752,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4752,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4752,9,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4753,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4754,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4754,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4754,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4755,1,Antigliadin antibody positive,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
4755,2,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
4755,3,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4755,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4755,5,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4755,6,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
4755,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4755,8,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4755,9,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4755,10,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4755,11,QRS axis abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
4755,12,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4755,13,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
4756,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4756,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4756,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
4756,4,Skull fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
4756,5,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
4756,6,Traumatic renal injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
4757,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4757,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
4758,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4758,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4758,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4758,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
4759,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4759,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4759,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
4760,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4760,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4761,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4761,2,Headache,Headaches NEC,Headaches,Nerv,N
4761,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4761,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4762,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4762,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4762,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4763,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
4764,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4764,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4764,3,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4765,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4766,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4766,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4767,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4767,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
4768,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4768,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
4768,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4768,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4768,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4768,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4768,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4769,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4769,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4769,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4770,1,Radiculitis brachial,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
4771,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4772,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4773,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4773,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4773,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4773,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4773,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4773,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4773,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4774,1,Testicular embryonal carcinoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4775,1,Elbow operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4775,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
4775,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4776,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
4776,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
4777,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4777,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
4777,3,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4777,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4777,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4777,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4777,7,Mean cell haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4777,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4778,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4779,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4780,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4781,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4782,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4783,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
4783,2,Headache,Headaches NEC,Headaches,Nerv,N
4784,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4784,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
4784,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4784,4,Headache,Headaches NEC,Headaches,Nerv,N
4784,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4784,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4784,7,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4784,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4784,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4784,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4784,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4784,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4784,13,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4784,14,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4784,15,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4784,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4784,17,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4785,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4785,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4786,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4786,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4787,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4788,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4789,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4790,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4791,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4792,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4792,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4792,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4792,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4792,5,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4792,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4792,7,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4792,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4792,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4792,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4792,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4793,1,CSF lymphocyte count abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
4793,2,CSF white blood cell count positive,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
4793,3,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
4793,4,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4794,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4795,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4796,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4797,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4797,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4798,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4798,2,Colonoscopy,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
4798,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
4798,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4799,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4799,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4799,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4799,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4799,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4800,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4801,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4801,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4801,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4801,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4801,5,Mean cell haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4802,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
4803,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4804,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4804,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4805,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4805,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4805,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4805,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4806,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
4807,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4807,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
4808,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4808,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4808,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4809,1,Brain operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
4809,2,Cerebrospinal fluid drainage,Cerebrospinal fluid therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
4809,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4810,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
4810,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
4810,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4810,4,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4810,5,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4810,6,Kidney enlargement,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
4810,7,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
4810,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4810,9,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
4810,10,Traumatic renal injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
4811,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4811,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
4812,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
4812,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4813,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4813,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4813,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
4813,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4814,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
4814,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4814,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4815,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
4816,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4816,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4816,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4816,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4816,5,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4816,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4816,7,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
4817,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4817,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
4817,3,Ear infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4817,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
4817,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4817,6,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
4817,7,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4817,8,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4818,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
4818,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4819,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4819,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4819,3,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4820,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
4820,2,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4820,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
4820,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4821,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4822,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
4822,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4822,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4822,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4823,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4823,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4824,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4825,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4826,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
4826,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4826,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4826,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4827,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4828,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4828,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4829,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
4830,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4830,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
4830,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4831,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
4832,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4833,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4834,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4834,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
4834,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
4835,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4835,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4835,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4835,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4835,5,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4835,6,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
4835,7,Headache,Headaches NEC,Headaches,Nerv,N
4835,8,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
4835,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4836,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4837,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4837,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4837,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
4838,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4839,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4839,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
4840,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4840,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
4840,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
4840,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4840,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4840,6,Gingival erythema,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
4840,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4840,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4840,9,Nocturnal dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4840,10,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4840,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4840,12,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
4840,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4841,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4842,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4843,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
4843,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4843,3,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4844,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4845,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
4846,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4847,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4847,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4847,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
4847,4,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
4847,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4847,6,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4847,7,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4847,8,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4847,9,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4847,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4847,11,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
4847,12,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
4847,13,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4847,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
4847,15,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
4847,16,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4848,1,Obstruction gastric,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4849,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4849,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4850,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4850,2,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,N
4851,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4851,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
4852,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4853,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4854,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4854,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4855,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
4855,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4855,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4856,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4857,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4857,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4857,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
4857,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4857,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4858,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4858,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4858,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4858,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4858,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4858,6,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4858,7,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
4858,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4858,9,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
4859,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4859,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4859,3,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4859,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4859,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4859,6,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4859,7,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
4859,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4859,9,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4859,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4859,11,Respiratory alkalosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
4859,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
4859,13,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
4859,14,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4859,15,Urinary retention postoperative,Urinary tract procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4859,16,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4860,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
4861,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4862,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
4863,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4864,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4865,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4865,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
4866,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
4866,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
4866,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4866,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4866,5,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
4867,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4867,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4867,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4867,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4868,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4868,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
4868,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4868,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4869,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4870,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4870,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4870,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
4870,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4870,5,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
4870,6,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
4870,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
4870,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4870,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4870,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4871,1,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
4871,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4872,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
4873,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4874,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4875,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4875,2,Eye ulcer,Ocular disorders NEC,Eye disorders NEC,Eye,N
4875,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4875,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
4875,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4875,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4875,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4875,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4876,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4876,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4876,3,Spinal cord injury cervical,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
4877,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
4877,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4877,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
4878,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4878,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4879,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4879,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4879,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4879,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4880,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4880,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4881,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
4882,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
4882,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4883,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4883,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4883,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4884,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
4885,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4885,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4885,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4885,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4886,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4886,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4887,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
4888,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4888,2,Neonatal respiratory arrest,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
4889,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4889,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4889,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4890,1,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
4891,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
4892,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4893,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
4894,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4894,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4894,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4894,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4895,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
4895,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
4896,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
4897,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
4897,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4897,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4897,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
4898,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4898,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4899,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
4900,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4901,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4902,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4902,2,Headache,Headaches NEC,Headaches,Nerv,N
4902,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
4902,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4902,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4902,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4903,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4903,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4903,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4903,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4903,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4903,6,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
4904,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4904,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4905,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4906,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4906,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4907,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
4907,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4907,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4907,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4908,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4909,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4909,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4909,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4909,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
4910,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4910,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
4910,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4910,4,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4910,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4910,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4911,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4912,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4912,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4912,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
4912,4,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
4912,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4912,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4913,1,Headache,Headaches NEC,Headaches,Nerv,N
4913,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4913,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4914,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
4914,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4914,3,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
4915,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
4915,2,Circumoral oedema,Angioedemas,Angioedema and urticaria,Skin,N
4915,3,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
4915,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
4915,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4916,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4917,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4918,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
4918,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4919,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4920,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
4920,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4921,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4922,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4923,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4924,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
4925,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4926,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
4926,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
4927,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
4928,1,Pulmonary granuloma,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4929,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
4930,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4930,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4930,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
4931,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4932,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4933,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
4933,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
4934,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4934,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
4934,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4935,1,Bone cyst,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4936,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4936,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4937,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4938,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4939,1,Post procedural pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4939,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4940,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4940,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
4940,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4941,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
4942,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
4942,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
4943,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4944,1,Bullous impetigo,Staphylococcal infections,Bacterial infectious disorders,Infec,N
4945,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4945,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4946,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4947,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
4948,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
4949,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4949,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4949,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4949,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4950,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4951,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4951,2,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4952,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4953,1,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
4954,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4955,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4955,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4955,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4956,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4956,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4956,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4957,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4957,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4957,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4957,4,Neck surgery,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
4957,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
4958,1,Hepatic vascular thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
4959,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
4960,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
4961,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4961,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4962,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4963,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4963,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4964,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,Y
4965,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4966,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
4966,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4966,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4966,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4967,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4968,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4969,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4970,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
4971,1,Cardiac myxoma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
4971,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4971,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4971,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4972,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4973,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4973,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4974,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
4975,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
4976,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
4977,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4978,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4979,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4979,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4980,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4980,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4980,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
4980,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4980,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
4980,6,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
4980,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
4980,8,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
4980,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4980,10,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4981,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
4981,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4982,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4982,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4983,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4984,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4985,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4986,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
4987,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
4987,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
4988,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4989,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
4990,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
4991,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4992,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4992,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
4992,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
4992,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4992,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4992,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4993,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
4994,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4995,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
4996,1,Ankle operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
4997,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
4998,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4998,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4998,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4998,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4998,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4998,6,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4998,7,Pericardial disease,Pericardial disorders NEC,Pericardial disorders,Card,N
4998,8,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4998,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
4999,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5000,1,Cardiac myxoma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
5000,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5000,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5000,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5000,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5000,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5000,7,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5000,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5001,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
5001,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5002,1,Gastrointestinal tract adenoma,Gastrointestinal neoplasms benign NEC,Gastrointestinal neoplasms benign,Neopl,N
5003,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5003,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5003,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5003,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5004,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5004,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5004,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5004,4,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5004,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5004,6,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5004,7,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5004,8,Blood fibrinogen increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5004,9,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5004,10,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5004,11,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5004,12,Blood magnesium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5004,13,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5004,14,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5004,15,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5004,16,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5004,17,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5004,18,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5004,19,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5004,20,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5004,21,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5004,22,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5004,23,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5004,24,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5004,25,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5004,26,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
5004,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5005,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
5006,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5007,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5008,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5008,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5008,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5009,1,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5009,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5010,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5011,1,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
5011,2,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
5011,3,Wagner's disease,Retinal disorders congenital,Eye disorders congenital,Cong,N
5012,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5012,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5013,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5013,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5014,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5014,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5014,3,CSF oligoclonal band present,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
5014,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5014,5,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5014,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5014,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5014,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5014,9,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
5015,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5015,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5015,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5015,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5015,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5015,6,Red blood cell sedimentation rate abnormal,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
5015,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5015,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5016,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5017,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5018,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
5018,2,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5019,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5019,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5020,1,Abscess of salivary gland,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
5020,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5021,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5021,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5022,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5022,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5022,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5023,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5023,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5023,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5023,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5024,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5024,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5025,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
5026,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5027,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5027,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5027,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5028,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5028,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5028,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5029,1,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5030,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5030,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5031,1,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,Y
5031,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5032,1,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,Y
5032,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5033,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
5034,1,CSF oligoclonal band present,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
5034,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5035,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5036,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5036,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
5037,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5037,2,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5037,3,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5037,4,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
5037,5,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5037,6,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5037,7,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5037,8,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5037,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5037,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5037,11,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5038,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
5038,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5039,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5040,1,Breast calcifications,Breast disorders NEC,Breast disorders,Repro,N
5040,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5040,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
5040,4,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5040,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5040,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5041,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5041,2,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
5042,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5042,2,Mesothelioma malignant,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
5043,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5044,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5044,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5044,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5044,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5044,5,Headache,Headaches NEC,Headaches,Nerv,N
5045,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5046,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5046,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5046,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5046,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5046,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5046,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5046,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5047,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5047,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5047,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5047,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5047,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
5047,6,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
5048,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
5048,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5049,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5049,2,Calculus urinary,Urinary tract lithiasis NEC,Urolithiases,Renal,N
5049,3,Headache,Headaches NEC,Headaches,Nerv,N
5049,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5049,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5049,6,Viral labyrinthitis,Viral infections NEC,Viral infectious disorders,Infec,N
5050,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5050,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5050,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5051,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5051,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5051,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5051,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5051,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5052,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5052,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5052,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5052,4,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5052,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5052,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5052,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
5052,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
5052,9,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5052,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5053,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5053,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5053,3,HIV test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
5053,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5053,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5053,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
5054,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
5055,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5055,2,Confusion postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5055,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
5056,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
5056,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5056,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5057,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5058,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5058,2,Unevaluable investigation,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5059,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
5060,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5061,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
5062,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5062,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5063,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5063,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5063,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5064,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5064,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5064,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5065,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5066,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5066,2,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
5067,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
5067,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5068,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5068,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5069,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5069,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5069,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5069,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5070,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5070,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5071,1,Subcorneal pustular dermatosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
5072,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5073,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5073,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5073,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
5074,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5074,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5074,3,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
5074,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5074,5,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
5074,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5074,7,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
5075,1,Device issue,Device issues NEC,Device issues,Prod,N
5075,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5075,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5075,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5076,1,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5077,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5078,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5079,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5079,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5079,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5079,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5079,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5079,6,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
5080,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5080,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5080,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5080,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5080,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
5081,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5081,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
5081,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5082,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5082,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5082,3,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
5082,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5082,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5083,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5084,1,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
5084,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5084,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5085,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5085,2,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5085,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5085,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5085,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5085,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5085,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5086,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
5086,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5086,3,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
5086,4,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5086,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5087,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
5087,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5087,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5087,4,Restrictive pulmonary disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5088,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
5089,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
5089,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
5090,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5090,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5090,3,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
5090,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5090,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5090,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5090,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5090,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5090,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5091,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
5092,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5092,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5093,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5093,2,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5093,3,Urachal sinus infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5094,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
5095,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5096,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
5097,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5098,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5099,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5099,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5099,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5100,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5101,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5101,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5101,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5101,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5101,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
5102,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
5102,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5102,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5103,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5103,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
5104,1,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
5105,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5105,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
5106,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5107,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5108,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5108,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5109,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5109,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5110,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5111,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5111,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5111,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
5111,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5112,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5113,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5113,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5113,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5114,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5115,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5115,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5116,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5117,1,Laryngeal cancer stage IV,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5117,2,Laryngeal dysplasia,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5117,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5117,4,Vocal cord leukoplakia,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5118,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5119,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5120,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
5120,2,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
5121,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5121,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5121,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5122,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5123,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5123,2,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5123,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5124,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5124,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5125,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5126,1,Bronchitis chronic,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5126,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
5126,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5126,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5126,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5126,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5127,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5127,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5128,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5129,1,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
5130,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5130,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5130,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
5130,4,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
5130,5,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5130,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5130,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5130,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5130,9,Myopathy,Myopathies,Muscle disorders,Musc,N
5130,10,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5130,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5130,12,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5131,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5131,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5132,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
5133,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5134,1,Oligodendroglioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
5135,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
5136,1,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5137,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5137,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5138,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
5138,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5138,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5138,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5139,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
5139,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5140,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5140,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5140,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5140,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5141,1,Viral skin infection,Viral infections NEC,Viral infectious disorders,Infec,N
5142,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5143,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5143,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5143,3,Colon neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5143,4,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5143,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5143,6,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5143,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
5143,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5143,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5143,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5143,11,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
5143,12,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5143,13,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5144,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5145,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5146,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
5147,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5148,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5150,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5151,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
5152,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5153,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5154,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5155,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5156,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5157,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5157,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5157,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
5157,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5157,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5157,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5158,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
5159,1,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5160,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
5161,1,CSF lymphocyte count increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
5161,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5161,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
5161,4,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
5162,1,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5163,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5164,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5164,2,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
5164,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5165,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5166,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5166,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5166,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5167,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5167,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5167,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5167,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5167,5,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5168,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5169,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5169,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
5170,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
5170,2,Headache,Headaches NEC,Headaches,Nerv,N
5170,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5170,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5170,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5170,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
5170,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5170,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5171,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5172,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5172,2,Headache,Headaches NEC,Headaches,Nerv,N
5173,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5174,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5174,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5174,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5175,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5175,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5175,3,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5175,4,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5175,5,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5175,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5175,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5176,1,Basosquamous carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5176,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
5177,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5177,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5177,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5177,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5177,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5177,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5177,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5177,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5178,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5179,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5179,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5179,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5179,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5180,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5181,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5182,1,Bladder transitional cell carcinoma stage II,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5182,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5183,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5184,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5185,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5186,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5186,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
5187,1,Hodgkin's disease stage IV,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
5188,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5188,2,Precursor T-lymphoblastic lymphoma/leukaemia,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
5189,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5189,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5189,3,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
5189,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5190,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5190,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5190,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5190,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5191,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5191,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5191,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5192,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
5192,3,Migraine,Migraine headaches,Headaches,Nerv,N
5192,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5192,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
5192,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5193,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5194,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5194,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5194,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5194,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5194,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5195,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5196,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
5196,2,Dementia with Lewy bodies,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
5196,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
5197,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5197,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5197,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5197,4,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
5198,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5199,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
5200,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5201,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5202,1,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5203,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5204,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
5204,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5205,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5205,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5206,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5207,1,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
5208,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5208,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5209,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5209,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5209,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5209,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5209,5,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
5210,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5210,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5210,3,Headache,Headaches NEC,Headaches,Nerv,N
5210,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
5210,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5210,6,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5211,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5212,1,Miller Fisher syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
5213,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
5214,1,Exposure via contaminated device,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
5214,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5214,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5214,4,Product contamination microbial,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5214,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5215,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5216,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
5217,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5218,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5218,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5219,1,Erysipelas,Streptococcal infections,Bacterial infectious disorders,Infec,N
5220,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
5220,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5221,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5221,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5222,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5222,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5223,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5224,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5225,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
5225,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5226,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5227,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5228,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5229,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5230,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
5230,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5231,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5231,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
5231,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5231,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
5231,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5231,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5232,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
5232,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5233,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5234,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5234,2,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5235,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5235,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5236,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5236,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5237,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5238,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5239,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5240,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5240,2,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5241,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
5242,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5242,2,Meniere's disease,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
5243,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
5243,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
5243,3,Neuropathic muscular atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5244,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
5244,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5244,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5244,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5245,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5245,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5245,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5245,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5246,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5246,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5246,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5246,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5246,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5247,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5248,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5249,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5249,2,Headache,Headaches NEC,Headaches,Nerv,N
5250,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5250,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5250,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5251,1,Stoma site discomfort,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
5251,2,Stoma site pain,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
5252,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5253,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5253,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5253,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5254,1,Haemangioma of liver,Hepatobiliary neoplasms benign,Hepatic and biliary neoplasms benign,Neopl,N
5254,2,Headache,Headaches NEC,Headaches,Nerv,N
5254,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5254,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5254,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5254,6,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5255,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
5256,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5256,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5256,3,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
5256,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5257,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5257,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5257,3,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
5258,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5258,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5259,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5260,1,Ductal adenocarcinoma of pancreas,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5261,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5262,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
5262,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5262,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
5262,4,Umbilical cord around neck,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
5263,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5263,2,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
5263,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5263,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5263,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5263,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5264,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5265,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5266,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5267,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5268,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5268,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5268,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5269,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
5269,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5269,3,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
5269,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5270,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,Y
5270,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5270,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5270,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5270,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5271,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5272,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
5273,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
5274,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5274,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5274,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5274,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5274,5,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5274,6,Lymph node abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5274,7,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5274,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5274,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5274,10,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5274,11,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
5274,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5274,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5274,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5274,15,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5274,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5275,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5275,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5276,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5277,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5277,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5278,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5279,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
5279,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5279,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5279,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5279,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5280,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5281,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5281,2,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
5281,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5281,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5282,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5282,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
5282,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5282,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
5282,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5283,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
5283,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5283,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5284,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5284,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5284,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5284,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5285,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5286,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5286,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5286,3,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
5287,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5287,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5287,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5287,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5288,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5288,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5288,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5289,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5289,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5290,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5291,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5292,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
5292,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5292,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5292,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5293,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5293,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5294,1,Scarlet fever,Streptococcal infections,Bacterial infectious disorders,Infec,N
5295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5295,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5295,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5296,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
5296,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5296,3,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5297,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5298,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5299,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5299,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5300,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5301,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5301,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5301,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5301,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
5302,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5302,2,Headache,Headaches NEC,Headaches,Nerv,N
5302,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
5302,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5302,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5303,1,Cutaneous T-cell lymphoma stage IV,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,Y
5304,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5305,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5306,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
5307,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5307,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5308,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
5308,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5308,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5308,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5309,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
5310,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
5310,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5310,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5311,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5312,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5312,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5313,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5313,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5314,1,Metastatic lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
5315,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
5316,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5316,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5316,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5316,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5316,5,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5316,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5316,7,Tuberculous pleurisy,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5316,8,Visual acuity tests abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
5317,1,Migraine,Migraine headaches,Headaches,Nerv,N
5318,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5318,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5318,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5318,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5318,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5319,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5319,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5319,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5320,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
5320,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5320,3,Peritoneal carcinoma metastatic,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5321,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5321,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5321,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5321,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5321,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5322,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
5323,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5324,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5324,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5324,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5325,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5325,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5325,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5325,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5325,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5326,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5327,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5328,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5328,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5328,3,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5328,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5328,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
5328,6,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5328,7,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5328,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5329,1,Migraine,Migraine headaches,Headaches,Nerv,N
5330,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5330,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5330,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5331,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5332,1,Antibody test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
5332,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5332,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5332,4,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5332,5,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
5332,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5332,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
5332,8,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
5332,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5332,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5332,11,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5332,12,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5332,13,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5332,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5333,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
5333,2,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5333,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5334,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5335,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5336,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5336,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5336,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5336,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5337,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5337,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5337,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5337,4,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5337,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5337,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5337,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5338,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5339,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5339,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5340,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
5340,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
5340,3,Electrocardiogram Q waves,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5340,4,Hyperdynamic left ventricle,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5340,5,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
5340,6,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5340,7,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5340,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5340,9,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5340,10,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5340,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5340,12,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
5340,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5340,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5340,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5341,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
5341,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5341,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5341,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5342,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5342,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5342,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5342,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5343,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5344,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
5345,1,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
5346,1,Squamous cell carcinoma of the oral cavity,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5347,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5347,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
5347,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5347,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5347,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5347,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5348,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5349,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5349,2,Headache,Headaches NEC,Headaches,Nerv,N
5349,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5350,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5351,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5351,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5351,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5352,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5352,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
5353,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5353,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
5354,1,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
5355,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5355,2,Jaw operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
5355,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5355,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5356,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5356,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5356,3,Headache,Headaches NEC,Headaches,Nerv,N
5356,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5356,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5357,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5358,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
5359,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5360,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5360,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5361,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5362,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5362,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5363,1,Ocular rosacea,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5364,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5365,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5366,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5367,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5367,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5368,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5369,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5369,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5369,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5369,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5369,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5370,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5371,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
5372,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5373,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5373,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5373,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5373,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5374,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5374,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5374,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5374,4,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
5374,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5375,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
5375,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5375,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5376,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5377,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5377,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5377,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5377,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5377,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5378,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
5379,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5380,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5381,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5382,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5382,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5382,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5382,4,Headache,Headaches NEC,Headaches,Nerv,N
5382,5,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5382,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5382,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5383,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5383,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5383,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5384,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5384,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5384,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5384,4,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5384,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
5385,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5386,1,Bone giant cell tumour benign,Bone neoplasms benign (excl cysts),Skeletal neoplasms benign,Neopl,N
5387,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5387,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5387,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
5387,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5388,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
5388,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5388,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
5388,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5388,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5389,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5389,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5389,3,"Hallucination, olfactory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5389,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
5389,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5389,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5390,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5391,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5392,1,Bone giant cell tumour,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
5393,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5394,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5394,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5394,3,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5394,4,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
5394,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5395,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5395,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5395,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5395,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5396,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5396,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5397,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5398,1,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5399,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5399,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5400,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5401,1,Lung squamous cell carcinoma stage II,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5402,1,Basal ganglia haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5402,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
5402,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5402,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5402,5,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
5402,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5403,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5403,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5403,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5403,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
5404,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5404,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5405,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5405,2,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5406,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5407,1,Squamous cell carcinoma of the oral cavity,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5408,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5408,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5408,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5408,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5408,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5408,6,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
5409,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5410,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5411,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5412,1,Testicular seminoma (pure) stage I,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5413,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
5413,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
5413,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5413,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5413,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5413,6,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5413,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5414,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5414,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5415,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
5415,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5415,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
5415,4,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5416,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5416,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5417,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5417,2,Pleomorphic adenoma,Lip and oral cavity neoplasms benign,Gastrointestinal neoplasms benign,Neopl,N
5418,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5419,1,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
5420,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5420,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5420,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5421,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
5422,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5423,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5424,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
5424,2,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
5425,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5426,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5427,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5428,1,Hyponatraemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5428,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5428,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5429,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5429,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5430,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5431,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5431,2,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
5431,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5432,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
5432,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5433,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5433,2,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
5434,1,Migraine,Migraine headaches,Headaches,Nerv,N
5434,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5434,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5435,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5435,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5436,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5437,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5437,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5438,1,Enlarged uvula,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
5438,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5439,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5440,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5440,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5441,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
5441,2,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
5442,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5442,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5442,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
5443,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
5444,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5445,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
5445,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5446,1,Chronic lymphocytic leukaemia stage 0,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
5447,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5448,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5448,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5449,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5449,2,Fungal oesophagitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
5449,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
5449,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5450,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5451,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5452,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5453,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5453,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5453,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
5453,4,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5454,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5455,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5456,1,Headache,Headaches NEC,Headaches,Nerv,N
5456,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5457,1,Gallbladder operation,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
5457,2,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
5457,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5458,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5459,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5459,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5459,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5460,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5461,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5461,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5462,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
5462,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5463,1,Thrombotic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5464,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
5464,2,Precancerous cells present,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5465,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5465,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5466,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5467,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
5467,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5467,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5468,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5468,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5468,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5468,4,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
5469,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5469,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
5470,1,Genitourinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5470,2,Headache,Headaches NEC,Headaches,Nerv,N
5470,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5470,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5470,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5471,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5471,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
5471,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5472,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
5473,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5473,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
5473,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5473,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5473,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5474,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5474,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5474,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
5474,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5475,1,Pneumonia necrotising,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5476,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
5477,1,Headache,Headaches NEC,Headaches,Nerv,N
5477,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5478,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5478,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5479,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5480,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5480,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5480,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5480,4,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
5480,5,Facial spasm,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5480,6,Headache,Headaches NEC,Headaches,Nerv,N
5480,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5480,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5480,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5480,10,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
5480,11,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5480,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5480,13,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5481,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5482,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
5483,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
5484,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5484,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5484,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5484,4,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5484,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5484,6,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5484,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5484,8,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5484,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5484,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5484,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5484,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5484,13,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5484,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
5484,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5484,16,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5484,17,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5485,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5486,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
5486,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5487,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5487,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5487,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5488,1,Headache,Headaches NEC,Headaches,Nerv,N
5489,1,Breast necrosis,Breast disorders NEC,Breast disorders,Repro,N
5490,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5491,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5491,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5491,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5491,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5492,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5493,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5494,1,Anal hypoaesthesia,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
5494,2,Genital hypoaesthesia,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5494,3,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5494,4,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5494,5,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5494,6,Intervertebral disc space narrowing,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5494,7,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5494,8,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5494,9,Post procedural discharge,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5494,10,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5494,11,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
5494,12,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
5494,13,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5495,1,Atypical mycobacterium test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
5495,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5495,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5495,4,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5496,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5496,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5496,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5497,1,Fractured sacrum,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5497,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5497,3,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
5497,4,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5498,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5498,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5499,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5499,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5500,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5500,2,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
5500,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5500,4,Headache,Headaches NEC,Headaches,Nerv,N
5501,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5501,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
5501,3,Headache,Headaches NEC,Headaches,Nerv,N
5501,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5502,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5502,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5502,3,Headache,Headaches NEC,Headaches,Nerv,N
5502,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
5502,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5502,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5502,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5503,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5503,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5504,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
5505,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5506,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5507,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,Y
5507,2,Headache,Headaches NEC,Headaches,Nerv,N
5508,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5509,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5509,2,Headache,Headaches NEC,Headaches,Nerv,N
5509,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5509,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5509,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5509,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5510,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5511,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
5511,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5511,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5512,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
5513,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5514,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5514,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5514,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5515,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5516,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5517,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5517,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5517,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5517,4,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5517,5,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5517,6,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5517,7,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5518,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5519,1,Deafness,Hearing losses,Hearing disorders,Ear,N
5519,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5520,1,Abscess intestinal,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5520,2,Intestinal anastomosis,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
5520,3,Intestinal stenosis,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5521,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
5521,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5522,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5522,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5522,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5522,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5522,5,Headache,Headaches NEC,Headaches,Nerv,N
5522,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5522,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5522,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5523,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
5524,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5525,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5525,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5525,3,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
5525,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5525,5,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5526,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5526,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
5527,1,Cutaneous T-cell lymphoma stage I,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
5528,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5529,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5530,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5531,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5531,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5531,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5532,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5533,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5533,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5533,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5534,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5534,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5535,1,Brachial plexopathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5535,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5536,1,Deafness,Hearing losses,Hearing disorders,Ear,N
5536,2,Lymphoid tissue hyperplasia,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5536,3,Middle ear effusion,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
5537,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5538,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5538,2,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5538,3,Ulcer haemorrhage,Ulcers NEC,Tissue disorders NEC,Genrl,N
5539,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5539,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5540,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
5541,1,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,Y
5541,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5542,1,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5543,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5543,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5543,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5544,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5545,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
5545,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5545,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
5545,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5546,1,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
5547,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5547,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5548,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5548,2,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5548,3,Eustachian tube obstruction,Eustachian tube disorders,Middle ear disorders (excl congenital),Ear,N
5548,4,Headache,Headaches NEC,Headaches,Nerv,N
5548,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5548,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5548,7,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5549,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5549,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5549,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5549,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
5550,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5550,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5550,3,Headache,Headaches NEC,Headaches,Nerv,N
5550,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5550,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5551,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5551,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5551,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5551,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5551,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5552,1,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5552,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5552,3,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
5553,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5553,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5553,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5553,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
5554,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
5554,2,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5554,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5555,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
5555,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5555,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5555,4,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5555,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5556,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
5556,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5556,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5556,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5556,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5556,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5556,7,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
5556,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5556,9,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5556,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5557,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5557,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5558,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
5559,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5559,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
5559,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
5559,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5559,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
5560,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5560,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5560,3,Sensory ganglionitis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
5561,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5561,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5561,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5561,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5561,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5561,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5562,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5562,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5562,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5562,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5563,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5564,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
5564,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5564,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5564,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5565,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
5566,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
5567,1,Headache,Headaches NEC,Headaches,Nerv,N
5567,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5567,3,Migraine,Migraine headaches,Headaches,Nerv,N
5567,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5568,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
5569,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5570,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5570,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5571,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5571,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5571,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5572,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
5572,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5573,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
5573,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5574,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
5574,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
5574,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
5575,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5575,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5576,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5576,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5576,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
5576,4,Headache,Headaches NEC,Headaches,Nerv,N
5576,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5576,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5577,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
5578,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
5578,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5578,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5578,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5579,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5580,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5581,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5582,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5582,2,Fallopian tube disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
5582,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5582,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5582,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5582,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5582,7,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
5582,8,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5582,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5583,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5583,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5583,3,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5583,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5583,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
5583,6,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5584,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
5584,2,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
5584,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5585,1,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5585,2,Peripheral embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5586,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
5586,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5587,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5587,2,Tubo-ovarian abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
5588,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5588,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5588,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5588,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5588,5,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
5588,6,Headache,Headaches NEC,Headaches,Nerv,N
5588,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5588,8,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5588,9,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5588,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5589,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5589,2,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5589,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5590,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5591,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5591,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5591,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5591,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5592,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
5592,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5593,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5593,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5593,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5593,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5593,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5593,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5593,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5593,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5594,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5595,1,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5595,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5595,3,Cranial nerve palsies multiple,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
5596,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5597,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5598,1,Acne,Acnes,Skin appendage conditions,Skin,N
5598,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5599,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5599,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
5599,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5600,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5601,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
5601,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5601,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5601,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5602,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5602,3,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5602,4,Axial spondyloarthritis,Spondyloarthropathies,Joint disorders,Musc,N
5602,5,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5602,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5602,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5602,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5603,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5603,2,Lesion excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5604,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5604,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5605,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5605,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5606,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5606,2,Squamous cell carcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
5607,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5608,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5608,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5608,3,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5608,4,Headache,Headaches NEC,Headaches,Nerv,N
5608,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5608,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5609,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5610,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
5610,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
5611,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5612,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5612,2,Lhermitte's sign,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5612,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5612,4,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
5613,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5613,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
5613,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5613,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5613,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5613,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5613,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5613,8,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5614,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
5615,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5615,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
5615,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5616,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5616,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5617,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5617,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5617,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5617,4,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5617,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5617,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5618,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5618,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5618,3,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5618,4,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
5618,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5618,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5618,7,Streptococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
5619,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5619,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5619,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
5620,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5620,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5620,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5620,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5620,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5621,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5621,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5621,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5621,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5621,5,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
5621,6,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
5621,7,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5621,8,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5621,9,Myosclerosis,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5621,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5622,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5622,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5622,3,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5622,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5622,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5622,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5622,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5623,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
5623,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5623,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5623,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5623,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5623,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
5624,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5625,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5625,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5625,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5625,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5625,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5625,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5626,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5627,1,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
5627,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5627,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5627,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5627,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5627,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5627,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5628,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
5629,1,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
5629,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5629,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5630,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5631,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
5631,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
5631,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5632,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5632,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5632,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
5632,4,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5632,5,Tic,Tic disorders,Changes in physical activity,Psych,N
5633,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
5633,2,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
5633,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5634,1,Migraine,Migraine headaches,Headaches,Nerv,N
5634,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5635,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
5636,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
5636,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5636,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5636,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5636,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5637,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
5637,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5637,3,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5637,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5638,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
5639,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5640,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5641,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5641,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5641,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
5641,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5642,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
5642,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5642,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5643,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5643,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5644,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
5645,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5646,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5647,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
5647,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5648,1,Follicle centre lymphoma diffuse small cell lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5649,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5650,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5650,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5651,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5652,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5653,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
5653,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5653,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
5654,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5655,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
5655,2,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
5655,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5656,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5657,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5657,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5657,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5658,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5658,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5658,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5658,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5658,5,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
5658,6,Headache,Headaches NEC,Headaches,Nerv,N
5658,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5658,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5658,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5658,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5658,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5658,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5658,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5659,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5659,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5660,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5660,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5661,1,Headache,Headaches NEC,Headaches,Nerv,N
5661,2,Ophthalmic migraine,Migraine headaches,Headaches,Nerv,N
5661,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5661,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5662,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5663,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5664,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
5664,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5664,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
5665,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5666,1,Deafness,Hearing losses,Hearing disorders,Ear,N
5666,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
5666,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
5667,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
5668,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5669,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
5669,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5669,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
5669,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5670,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
5670,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5671,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5672,1,Congenital cerebrovascular anomaly,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
5672,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5672,3,Paternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
5672,4,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
5673,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5673,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5674,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5674,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5675,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5676,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5677,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
5677,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5677,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5678,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
5679,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5679,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5679,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5680,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5680,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5680,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5680,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5680,5,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5680,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5681,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5682,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5682,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5682,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5682,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5682,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5682,6,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
5682,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5682,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5682,9,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5683,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5683,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5684,1,Migraine,Migraine headaches,Headaches,Nerv,N
5685,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5685,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5685,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5686,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5687,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5687,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5687,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5688,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5688,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5688,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5688,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5688,5,Salivary gland pain,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
5689,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5690,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
5690,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5691,1,Headache,Headaches NEC,Headaches,Nerv,N
5692,1,Interferon gamma release assay positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
5693,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5693,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
5693,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
5694,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5694,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5695,1,Burning mouth syndrome,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5695,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5695,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5696,1,Post procedural swelling,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5696,2,Sports injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5697,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5698,1,Headache,Headaches NEC,Headaches,Nerv,N
5698,2,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5699,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5699,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
5700,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
5701,1,Benign neoplasm of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5702,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5702,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5703,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
5703,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5704,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5705,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
5706,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
5707,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5707,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5708,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5708,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
5709,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
5710,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5711,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
5711,2,Diabetic foot,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5712,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5712,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5712,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5713,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5714,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5715,1,Device issue,Device issues NEC,Device issues,Prod,N
5715,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5715,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5715,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5715,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5715,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5716,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
5717,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5718,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
5719,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5719,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5719,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5719,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5719,5,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
5720,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5720,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
5721,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5721,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5721,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5721,4,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5722,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5722,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5722,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5722,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5723,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
5724,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5725,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5725,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
5725,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5725,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5726,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
5727,1,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5728,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5728,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5728,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
5728,4,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
5728,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5729,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5730,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5731,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5731,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5731,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5731,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5732,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5732,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5732,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5733,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5733,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5733,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5734,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5734,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5734,3,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
5734,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5735,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5735,2,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5735,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5735,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5735,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5735,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5735,7,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5736,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5737,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5737,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5737,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5737,4,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
5737,5,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5737,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5738,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5739,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5740,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5741,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5741,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
5742,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
5743,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5743,2,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
5744,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5745,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5745,2,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
5745,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
5746,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
5747,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5747,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5747,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5747,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5747,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5747,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5747,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5747,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5747,9,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5747,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
5747,11,Nail cuticle fissure,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5747,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5747,13,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
5747,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5747,15,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5748,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
5749,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5749,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5750,1,Ear congestion,Ear disorders NEC,Aural disorders NEC,Ear,N
5750,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5751,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5752,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5753,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5754,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5755,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5755,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5756,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,Y
5756,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5756,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5757,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5757,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5757,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5758,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5758,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5759,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5759,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5760,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5760,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5760,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5760,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5760,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5760,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5760,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5761,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5762,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5763,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
5763,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5763,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
5763,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5764,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5765,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
5765,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
5765,3,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5765,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5766,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5767,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5767,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5768,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5769,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
5770,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5770,2,Ruptured ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
5771,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5771,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5771,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5771,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5771,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5772,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5772,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5772,3,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
5772,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5772,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5772,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5772,7,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5772,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5773,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5773,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
5773,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5773,4,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
5773,5,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5773,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5773,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5773,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5774,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5774,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5774,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
5774,4,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
5774,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5774,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
5774,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5775,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5775,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5775,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
5776,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5777,1,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
5778,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5778,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5779,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5780,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5781,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5781,2,Malignant pleural effusion,Pleural neoplasms,Pleural disorders,Resp,N
5781,3,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
5782,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
5783,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
5784,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5784,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
5784,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5784,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5784,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5784,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
5785,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5785,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5785,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5785,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
5785,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
5785,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5785,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5785,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
5785,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5786,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5786,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5786,3,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5786,4,Benign gastrointestinal neoplasm,Gastrointestinal neoplasms benign NEC,Gastrointestinal neoplasms benign,Neopl,N
5786,5,Biopsy colon abnormal,Gastrointestinal histopathology procedures,Gastrointestinal investigations,Inv,N
5786,6,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5786,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5786,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5786,9,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5786,10,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5786,11,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
5786,12,Gastrointestinal scarring,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5786,13,Lymphoid tissue hyperplasia,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5786,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5786,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5786,16,Water pollution,Non-occupational and unspecified environmental problems,Environmental issues,SocCi,N
5787,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5787,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5788,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5788,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
5789,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5789,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5789,3,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
5790,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5790,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5791,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5791,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
5791,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5792,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
5792,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5792,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5792,4,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
5792,5,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5792,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5792,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5792,8,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
5792,9,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5792,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5792,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5793,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
5794,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5794,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5794,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5794,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5795,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5795,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5795,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
5796,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
5796,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
5797,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5798,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
5799,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5800,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5801,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5801,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5801,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
5801,4,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
5801,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5801,6,Tic,Tic disorders,Changes in physical activity,Psych,N
5802,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5802,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
5803,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
5803,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
5804,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
5804,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5804,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5805,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5806,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5807,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
5807,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
5807,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5808,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5809,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5809,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5810,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5811,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5811,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
5811,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5811,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
5811,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5811,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5811,7,Headache,Headaches NEC,Headaches,Nerv,N
5811,8,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
5811,9,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
5811,10,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
5811,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5811,12,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
5812,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
5812,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5812,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
5813,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5813,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5813,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5813,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5814,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
5815,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5815,2,Headache,Headaches NEC,Headaches,Nerv,N
5815,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5816,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5816,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5816,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5816,4,Headache,Headaches NEC,Headaches,Nerv,N
5816,5,IIIrd nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
5816,6,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5816,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5817,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5818,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5819,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5819,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5820,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5821,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5821,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5822,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5823,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5824,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5825,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
5825,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
5826,1,Small intestine adenocarcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5827,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
5827,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5828,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5829,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
5830,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5831,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5831,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
5831,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5831,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5831,5,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
5831,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5831,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5832,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5832,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5832,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5833,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5834,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5834,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
5834,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5834,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5835,1,Headache,Headaches NEC,Headaches,Nerv,N
5835,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5836,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5837,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
5838,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
5839,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5840,1,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
5840,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5840,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
5840,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5840,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5840,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5840,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5840,8,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
5841,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
5842,1,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5842,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5842,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5843,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5844,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5845,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
5845,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5845,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5845,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5846,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5847,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5848,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
5848,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5848,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5848,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5849,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5850,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
5851,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5851,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5851,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
5851,4,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5851,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5851,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
5852,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5852,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
5852,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5852,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5853,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5853,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5854,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5855,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5856,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5856,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5857,1,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5858,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
5858,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5858,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5858,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5858,5,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
5859,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
5860,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
5861,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
5862,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5862,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5863,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5863,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
5864,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5865,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5865,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5865,3,Vasculitis necrotising,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
5866,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5867,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5867,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5867,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
5867,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5868,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5868,2,Pityriasis,Scaly conditions,Epidermal and dermal conditions,Skin,N
5869,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
5869,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5870,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5871,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5872,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5872,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5872,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5873,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
5873,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5873,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5874,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
5874,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5874,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5875,1,Malignant melanoma stage I,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5876,1,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5877,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5878,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5879,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
5879,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5879,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5880,1,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5880,2,Ocular melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
5881,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5881,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5881,3,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
5881,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
5882,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5883,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
5884,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5885,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5886,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
5887,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5887,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5888,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5888,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5888,3,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
5889,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5891,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
5891,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
5891,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5891,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
5892,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5892,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5892,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5893,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
5894,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5894,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
5895,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
5896,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5897,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5897,2,Female genital tract fistula,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
5897,3,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5897,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5897,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5898,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5898,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
5899,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5900,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5900,2,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
5900,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5900,4,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
5900,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5901,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5902,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5902,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5903,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5904,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5905,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
5906,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5906,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5907,1,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5907,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
5907,3,Diet noncompliance,Dietary and nutritional issues,Lifestyle issues,SocCi,N
5907,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5907,5,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5907,6,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5908,1,Postoperative wound complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5908,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5909,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5909,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5909,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
5909,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
5910,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5911,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5911,2,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
5911,3,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
5912,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5912,2,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5913,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5913,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5913,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5913,4,Small fibre neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5914,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
5915,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5915,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5916,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
5916,2,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5916,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5916,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5916,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5917,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
5918,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5918,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
5919,1,Orthopaedic procedure,Bone therapeutic procedures NEC,Bone and joint therapeutic procedures,Surg,N
5919,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5920,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5920,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5920,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5921,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5921,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5922,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
5922,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
5922,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5922,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
5922,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
5922,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5923,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
5924,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5925,1,Allergic oedema,Allergic conditions NEC,Allergic conditions,Immun,N
5925,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5925,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5925,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
5926,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5926,2,Diaphragmatic disorder,Diaphragmatic disorders,Thoracic disorders (excl lung and pleura),Resp,N
5927,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
5927,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
5927,3,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5928,1,T-cell type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
5929,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
5929,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
5930,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5931,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5932,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5933,1,Meningitis listeria,Listeria infections,Bacterial infectious disorders,Infec,N
5934,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
5934,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5935,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
5935,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
5936,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5936,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5936,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5936,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5936,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
5936,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5937,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5938,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5939,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
5940,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
5940,2,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
5940,3,Malignant polyp,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5941,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5941,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
5941,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5941,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5942,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
5943,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5943,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
5944,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5944,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5944,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
5945,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5946,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
5946,2,Migraine,Migraine headaches,Headaches,Nerv,N
5947,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5947,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5948,1,B-cell small lymphocytic lymphoma,B-cell small lymphocytic lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
5949,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
5949,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5949,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5950,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5951,1,Iris adhesions,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
5951,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5951,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
5951,4,Pupillary block,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
5951,5,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5951,6,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5952,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5952,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5952,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5952,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
5952,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5952,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
5952,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5952,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5953,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5954,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
5955,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5955,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5955,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5956,1,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5956,2,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5956,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5956,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5957,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
5957,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5958,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5958,2,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
5958,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5958,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5959,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5959,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5959,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5959,4,Social anxiety disorder,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
5960,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5960,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5961,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
5962,1,Anaplastic large cell lymphoma T- and null-cell types,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
5963,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
5964,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5964,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
5964,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5965,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5965,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5965,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
5965,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5965,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5965,6,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5966,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
5966,2,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
5966,3,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5967,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5967,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5967,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5968,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
5969,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
5970,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5971,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
5971,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5971,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
5971,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5971,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5971,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
5971,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5971,8,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5971,9,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
5971,10,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
5971,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5971,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5971,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5971,14,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5971,15,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
5971,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5971,17,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
5971,18,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5971,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5972,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5972,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5972,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5973,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5973,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
5973,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5973,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5973,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
5973,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5973,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
5974,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5974,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5975,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5976,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
5977,1,Tuberculin test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
5978,1,Oral lichenoid reaction,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
5979,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5979,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
5979,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5980,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
5980,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
5980,3,Herpes simplex viraemia,Herpes viral infections,Viral infectious disorders,Infec,N
5981,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
5981,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
5982,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
5983,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5983,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5983,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
5983,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5983,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
5984,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5984,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
5984,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5984,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5985,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5985,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
5985,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
5985,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
5986,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
5986,2,Meningioma benign,Meningiomas benign,Nervous system neoplasms benign,Neopl,N
5986,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5987,1,Penile squamous cell carcinoma,Penile neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
5988,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
5988,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
5989,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
5989,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5990,1,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
5991,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
5991,2,Post procedural inflammation,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
5991,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5992,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
5992,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
5992,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5993,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
5993,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
5993,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5993,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
5993,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5994,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
5995,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5996,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5996,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5996,3,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
5997,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5997,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5998,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
5998,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
5998,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5999,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
5999,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
5999,3,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5999,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6000,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6000,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6000,3,Enzyme level abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
6001,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6001,2,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
6002,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6003,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6003,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6003,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6004,1,Aquagenic wrinkling of palms,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
6005,1,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
6006,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6007,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
6008,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6008,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6008,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6008,4,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6008,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6008,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6009,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
6010,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6011,1,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
6012,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6012,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6012,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6013,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6013,2,Headache,Headaches NEC,Headaches,Nerv,N
6013,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
6013,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6013,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6014,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6015,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6016,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6016,2,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
6016,3,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
6016,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
6016,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6016,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6016,7,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
6016,8,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6016,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6016,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6016,11,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6016,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6016,13,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6016,14,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6017,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6017,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6017,3,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6018,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6019,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
6020,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6020,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6021,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
6022,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
6022,2,Eye infection staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6023,1,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6024,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6024,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6024,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6025,1,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6026,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6026,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
6027,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6028,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6028,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
6029,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6030,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6031,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6031,2,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
6032,1,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
6032,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6033,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6033,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6033,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6033,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6034,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6035,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6036,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6037,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6038,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6038,2,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
6038,3,Enthesopathy,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
6038,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6038,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6038,6,Sacral pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6039,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6040,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
6041,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
6042,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6042,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6042,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6042,4,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6043,1,Rectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
6044,1,Gastrointestinal submucosal tumour,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6044,2,Malignant melanoma stage II,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
6045,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6045,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6045,3,Solar dermatitis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6045,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6046,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6046,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
6047,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6047,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6047,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6048,1,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
6049,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6049,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6049,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6050,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
6051,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6052,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
6052,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6052,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6053,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
6054,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6055,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
6055,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6055,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6055,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6055,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6055,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6056,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6056,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6056,3,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,N
6056,4,Infected neoplasm,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
6056,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
6057,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6057,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6057,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6057,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6057,5,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6058,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6059,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
6059,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6060,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
6060,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6061,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6061,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
6062,1,Nodular melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
6063,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6063,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6064,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6064,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
6064,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
6064,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
6064,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6064,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
6065,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6065,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6065,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6065,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6066,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
6066,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6066,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
6066,4,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
6067,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
6068,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
6068,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6068,3,Stenosis,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6068,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6069,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6069,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6069,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6070,1,Bacillus infection,Bacillary infections,Bacterial infectious disorders,Infec,N
6071,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
6071,2,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
6072,1,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6073,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6073,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6073,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6074,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6075,1,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
6076,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6076,2,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
6077,1,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
6078,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6079,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6079,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
6080,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6080,2,Migraine,Migraine headaches,Headaches,Nerv,N
6080,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6080,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6081,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6081,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6082,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
6082,2,Growth failure,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6082,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
6082,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
6082,5,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6082,6,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
6082,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6083,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6084,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6084,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
6084,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
6084,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6084,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6084,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6084,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6084,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6084,9,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6085,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
6085,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6085,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6085,4,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
6085,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
6085,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6085,7,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
6085,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6085,9,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6086,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
6087,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6087,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6087,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6088,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6088,2,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
6089,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6089,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6089,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6089,4,Headache,Headaches NEC,Headaches,Nerv,N
6090,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6090,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6090,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
6091,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
6092,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6092,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6092,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6092,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6092,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6092,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6092,7,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6093,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6093,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6093,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6093,4,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6094,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6094,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6095,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6095,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6095,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6095,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6095,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6095,6,Sensitivity to weather change,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6095,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6096,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6096,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
6097,1,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
6097,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
6097,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6098,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6099,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6099,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
6099,3,Tuberculosis gastrointestinal,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6100,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
6100,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6100,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6100,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6101,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
6101,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
6101,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6101,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6102,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6102,2,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
6102,3,Headache,Headaches NEC,Headaches,Nerv,N
6102,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6103,1,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
6104,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
6104,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6104,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6105,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
6106,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
6106,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
6106,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6107,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6107,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6107,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6108,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6108,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
6109,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6110,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6110,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6111,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6112,1,Brain operation,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
6113,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6114,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6115,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6116,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6116,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6117,1,Ear haemorrhage,Ear disorders NEC,Aural disorders NEC,Ear,N
6117,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6117,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6117,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6118,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6118,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
6119,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6120,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6121,1,Brain stem haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6122,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
6123,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
6124,1,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
6124,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6125,1,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6126,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6127,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6127,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6128,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
6129,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
6130,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
6130,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6130,3,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
6131,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6132,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6132,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
6133,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6133,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6133,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
6133,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6134,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6135,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6135,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6136,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6136,2,Phlebitis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
6136,3,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6137,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6138,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6138,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6139,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6140,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6140,2,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6141,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
6141,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
6141,3,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
6142,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6143,1,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6144,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
6145,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6145,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6145,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6146,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6146,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6147,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6147,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6147,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6147,4,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6147,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6147,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6147,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6147,8,Gastrointestinal tract irritation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
6147,9,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6147,10,Increased viscosity of upper respiratory secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6147,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6147,12,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6147,13,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6147,14,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
6147,15,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
6147,16,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6148,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6149,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6149,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
6150,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6150,2,Tuberculosis gastrointestinal,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6151,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6151,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
6151,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
6151,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6152,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
6152,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6153,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6153,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
6154,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6155,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6156,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6156,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6156,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6156,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6156,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6157,1,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6158,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6159,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6159,3,Migraine,Migraine headaches,Headaches,Nerv,N
6159,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6159,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6160,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
6161,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6161,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6161,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6161,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
6161,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6161,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6161,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6161,8,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6162,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6163,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6163,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6163,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6163,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6164,1,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6165,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
6165,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6165,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6166,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6167,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
6168,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6168,2,Headache,Headaches NEC,Headaches,Nerv,N
6168,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6168,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6168,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6168,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6169,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6169,2,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
6170,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6170,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6170,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6170,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6170,5,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6170,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
6170,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6170,8,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6170,9,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
6170,10,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
6170,11,Hyperintensity in brain deep nuclei,Structural brain disorders NEC,Structural brain disorders,Nerv,N
6170,12,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
6170,13,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6170,14,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6170,15,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6170,16,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6170,17,Romberg test positive,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
6171,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6171,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
6172,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6173,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
6173,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
6173,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6173,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6173,5,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,N
6173,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
6174,1,Headache,Headaches NEC,Headaches,Nerv,N
6174,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6174,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6174,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6175,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6175,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6175,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6176,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
6176,2,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
6176,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
6177,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6177,2,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
6177,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6178,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6178,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6178,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6179,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6179,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6179,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6179,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6179,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
6179,6,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6180,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6180,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
6180,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6180,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
6181,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6182,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6182,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6182,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6182,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6182,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6182,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6182,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6183,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6183,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6183,3,Headache,Headaches NEC,Headaches,Nerv,N
6183,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
6183,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6183,6,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6183,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6183,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6184,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6185,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6185,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6186,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6186,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6186,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6186,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6186,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
6186,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6187,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6188,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
6188,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6189,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6189,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6189,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6190,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6190,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6190,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6190,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
6190,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6190,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6190,7,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
6190,8,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6190,9,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
6190,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6190,11,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6190,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6190,13,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6190,14,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
6190,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6190,16,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6190,17,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
6190,18,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6190,19,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6190,20,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
6190,21,Thoracic vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
6191,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6192,1,Fistula inflammation,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6192,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6193,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6193,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6194,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6194,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6194,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6195,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6196,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6196,2,Headache,Headaches NEC,Headaches,Nerv,N
6196,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6196,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6197,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
6197,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6198,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6198,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6198,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6199,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6199,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6199,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6200,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6201,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
6201,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
6202,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6202,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6202,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6203,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6204,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6205,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6206,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6206,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6206,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6206,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6206,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6207,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
6208,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6208,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6209,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6209,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6209,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6210,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6210,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6210,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6210,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6211,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6211,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6211,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6212,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
6213,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6214,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
6214,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
6215,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6215,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6215,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
6215,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6215,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6215,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6215,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6215,8,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6216,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6216,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6216,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6216,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6216,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6217,1,Headache,Headaches NEC,Headaches,Nerv,N
6217,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
6217,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6218,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6218,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6219,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
6219,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6220,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6220,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
6220,3,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
6220,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6221,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
6222,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6222,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6222,3,Headache,Headaches NEC,Headaches,Nerv,N
6222,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6222,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6222,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6223,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6223,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6223,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6223,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6224,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
6225,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6226,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6226,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6227,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6227,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
6227,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6227,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6228,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6228,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6228,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6228,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6228,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6228,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6229,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6229,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6230,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6231,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6231,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6231,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6231,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6231,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6231,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6232,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6232,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6232,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6232,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6232,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6233,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6233,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6233,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6233,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6233,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6234,1,Device issue,Device issues NEC,Device issues,Prod,N
6234,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6234,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6234,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6234,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6234,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6235,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6235,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6235,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6236,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6236,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
6236,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6236,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6236,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6236,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6236,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6237,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6237,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6238,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6238,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6238,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6239,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6239,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6239,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6239,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6240,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6241,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6242,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
6242,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6243,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6243,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6244,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6244,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6245,1,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6245,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6246,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
6246,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6246,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6247,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
6247,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6248,1,Headache,Headaches NEC,Headaches,Nerv,N
6248,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6248,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6249,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6249,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6249,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6249,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6249,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6250,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6251,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6251,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6251,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6252,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6252,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6252,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
6253,1,Acquired corneal dystrophy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
6253,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
6253,3,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
6253,4,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
6253,5,Corneal thickening,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
6253,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6253,7,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
6253,8,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
6253,9,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6254,1,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6255,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
6256,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6257,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6257,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6257,3,Headache,Headaches NEC,Headaches,Nerv,N
6257,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6258,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6259,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6259,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6260,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6260,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6260,3,Deafness,Hearing losses,Hearing disorders,Ear,N
6260,4,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6260,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6260,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6261,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6262,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6263,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6263,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6263,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6263,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6264,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6264,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6264,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6265,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6265,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6265,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6266,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6266,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6266,3,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6266,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6266,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6266,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6267,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6267,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
6267,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6267,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6267,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6268,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6268,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6268,3,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6268,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6268,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6268,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6268,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6268,8,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
6268,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6269,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6270,1,Penile cancer,Penile neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
6271,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6272,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
6272,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6272,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6273,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6273,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6273,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6273,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6273,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6274,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6274,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6274,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6274,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6274,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6275,1,Small cell lung cancer limited stage,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
6276,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6276,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6277,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6277,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6277,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6277,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6278,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
6278,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6279,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
6279,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6280,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6280,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
6280,3,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6280,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
6281,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
6282,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6283,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6283,2,Headache,Headaches NEC,Headaches,Nerv,N
6283,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6283,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6283,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6283,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6283,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6283,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6284,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6284,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6285,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6286,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6286,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6286,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6286,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6286,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6287,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6287,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6288,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
6289,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6289,2,Headache,Headaches NEC,Headaches,Nerv,N
6289,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6290,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6291,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6291,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
6291,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6291,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6291,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6292,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6292,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6293,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6293,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6293,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6294,1,Headache,Headaches NEC,Headaches,Nerv,N
6294,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6295,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6295,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6295,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6295,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6296,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6297,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6298,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6298,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6298,3,Acne cystic,Acnes,Skin appendage conditions,Skin,N
6298,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6299,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6300,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6301,1,Headache,Headaches NEC,Headaches,Nerv,N
6301,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6301,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6301,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6302,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6302,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6303,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6303,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6303,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6304,1,Acne,Acnes,Skin appendage conditions,Skin,N
6304,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
6304,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6304,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6304,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
6304,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6304,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6305,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6305,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6306,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6306,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
6307,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6307,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6308,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6308,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6308,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6308,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6309,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6309,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6309,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6309,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6310,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6310,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6310,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6310,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6311,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6311,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6311,3,Headache,Headaches NEC,Headaches,Nerv,N
6312,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6312,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6312,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6312,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6312,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6312,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6312,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6312,8,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6312,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6312,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6312,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6312,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6312,13,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6313,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6313,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
6314,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6314,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6314,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
6314,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6314,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6315,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6315,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6316,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6316,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6316,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6316,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6317,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6317,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6318,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6318,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6319,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6319,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6320,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6320,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6320,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6321,1,Headache,Headaches NEC,Headaches,Nerv,N
6322,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6322,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6323,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6323,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6324,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6324,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6324,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6325,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6325,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6325,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6326,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6326,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
6326,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6326,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6327,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
6328,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
6328,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6328,3,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
6328,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
6328,5,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6328,6,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
6328,7,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6328,8,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6328,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6328,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6328,11,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6329,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
6329,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6329,3,Migraine,Migraine headaches,Headaches,Nerv,N
6329,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6329,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6329,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6330,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6330,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6331,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6331,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6331,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6332,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6333,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6333,2,Tension headache,Headaches NEC,Headaches,Nerv,N
6334,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6334,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6334,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6334,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6334,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6335,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6336,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6336,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
6336,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6336,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6337,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6337,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6338,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
6338,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6339,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6339,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6340,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6340,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6340,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
6340,4,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6341,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6341,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6341,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6341,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6342,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
6343,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6343,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
6344,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6344,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6344,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6345,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6346,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6346,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6346,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6346,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6346,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6347,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6348,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6348,2,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
6348,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6349,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
6349,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
6350,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6350,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
6351,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6351,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
6352,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6352,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6353,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6353,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6354,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6354,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
6355,1,Headache,Headaches NEC,Headaches,Nerv,N
6355,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6355,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6355,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6356,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6356,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
6357,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
6358,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6359,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6359,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6359,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6359,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6359,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6359,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6360,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6360,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6360,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6361,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6361,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6361,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6361,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6362,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6363,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6363,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6364,1,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
6365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6365,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6366,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6366,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6366,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6367,1,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
6367,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
6367,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6368,1,Headache,Headaches NEC,Headaches,Nerv,N
6368,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6369,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6369,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6369,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6370,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
6371,1,Prolapse,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6372,1,Disability,Disability issues,Lifestyle issues,SocCi,N
6372,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6373,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6373,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6373,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6373,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6373,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6373,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6373,7,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6373,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6374,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6374,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6374,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6375,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6376,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6376,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6376,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6376,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6377,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6377,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6378,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6378,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6378,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6379,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6379,2,Headache,Headaches NEC,Headaches,Nerv,N
6379,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6379,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6380,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6381,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6381,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6381,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6382,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6382,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6382,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6383,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
6384,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6384,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
6385,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6385,2,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
6385,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
6386,1,Nasal mucosal blistering,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6386,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6386,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6387,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6387,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6387,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6388,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6389,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6389,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6389,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6390,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6391,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6391,2,Headache,Headaches NEC,Headaches,Nerv,N
6391,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6391,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6391,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6392,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6393,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6393,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6393,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6393,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6393,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6394,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6394,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6394,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6394,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6394,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6394,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6394,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6395,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6395,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6396,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6396,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6397,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6397,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6397,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6398,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6399,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6399,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6399,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6399,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6400,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6400,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6400,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6401,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6401,2,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6401,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6401,4,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
6401,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6402,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6402,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6402,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6402,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6402,5,Migraine,Migraine headaches,Headaches,Nerv,N
6402,6,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6403,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6404,1,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6404,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6404,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6405,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6405,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6405,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6405,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6406,1,Fibrosarcoma,Fibrosarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
6407,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6407,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6407,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6407,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6407,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
6407,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6408,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6408,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6408,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6408,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6409,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6409,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6410,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6411,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6412,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
6413,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6413,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6413,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6414,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6414,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6414,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6414,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6415,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6415,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6415,3,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6416,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6417,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
6417,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6417,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6418,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6418,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6418,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6419,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6419,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6419,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6419,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6420,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6420,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6420,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6421,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6422,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6422,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
6423,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6423,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6423,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6423,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6424,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6424,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6424,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6424,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6424,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6424,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6424,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6424,8,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6424,9,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
6424,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6424,11,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6425,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
6426,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6426,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6427,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6428,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6429,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6429,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6429,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6429,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6429,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6429,6,Headache,Headaches NEC,Headaches,Nerv,N
6429,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6429,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6429,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6429,10,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6430,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6431,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
6432,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6432,2,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
6433,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6434,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6434,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
6435,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6435,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6436,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6436,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6437,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6437,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6437,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6437,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6437,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6437,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6437,7,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6437,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6437,9,Headache,Headaches NEC,Headaches,Nerv,N
6437,10,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6437,11,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6437,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6437,13,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6437,14,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6437,15,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6437,16,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6437,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6437,18,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6437,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6437,20,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6438,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6438,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6438,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
6439,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6439,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
6440,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6440,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6440,3,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
6440,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6440,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6440,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6440,7,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6441,1,Headache,Headaches NEC,Headaches,Nerv,N
6441,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6441,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
6442,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6442,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6442,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6442,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6442,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6443,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6444,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6444,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6445,1,Chalazion,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6446,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6446,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6446,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6446,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6447,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6447,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6448,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
6448,2,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
6449,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
6449,2,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6449,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6450,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6450,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6450,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6451,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6452,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6452,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6453,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6453,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6453,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6453,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6453,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6454,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
6454,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6455,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6455,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6455,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6456,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6456,2,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
6456,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6456,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6456,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6457,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6457,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6457,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6457,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6458,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6458,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6458,3,Genital blister,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
6458,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6458,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6458,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6459,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6459,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6459,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6459,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6460,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6460,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6460,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6460,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6461,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6461,2,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6461,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6462,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6462,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6463,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6464,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6465,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6466,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6466,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6466,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6466,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6467,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6468,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6468,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6468,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6468,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6468,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6469,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6469,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6469,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6469,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6469,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6469,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6470,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6471,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6471,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6471,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6472,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6472,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6473,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6473,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6474,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6474,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6474,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6475,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6475,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6476,1,Headache,Headaches NEC,Headaches,Nerv,N
6477,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6477,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6478,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6478,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6478,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6478,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6478,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6478,6,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
6479,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6479,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6480,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6480,2,Headache,Headaches NEC,Headaches,Nerv,N
6481,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6481,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6482,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6483,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6483,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6483,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6484,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6484,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6485,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6485,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6486,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6486,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6486,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6487,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6487,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6488,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6488,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6489,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6489,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6489,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6490,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6490,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6491,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
6492,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6492,2,Headache,Headaches NEC,Headaches,Nerv,N
6492,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6492,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6492,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6492,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6493,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6493,2,Headache,Headaches NEC,Headaches,Nerv,N
6493,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6494,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6495,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6496,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6497,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6498,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6498,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6499,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6499,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6500,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6500,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6501,1,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
6502,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6502,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6502,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6503,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6503,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6503,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6503,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6503,5,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6503,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6503,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6504,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6505,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6505,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6506,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6506,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6506,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6506,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6507,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6507,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6508,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6509,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6509,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
6509,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6509,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6509,5,Headache,Headaches NEC,Headaches,Nerv,N
6509,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6509,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6509,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6509,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6510,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
6510,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6510,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6510,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6511,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6512,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
6513,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6513,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
6513,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6513,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
6513,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6514,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6515,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6516,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6516,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6517,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6517,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6517,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6517,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6517,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6518,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6518,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6519,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6520,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
6521,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6521,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6521,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6522,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6522,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6523,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6523,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6523,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6523,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6524,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6524,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6524,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6524,4,Headache,Headaches NEC,Headaches,Nerv,N
6524,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6524,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6525,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6525,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
6525,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6525,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6526,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6526,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6527,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6527,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
6527,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6528,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6528,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6529,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6529,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6530,1,Headache,Headaches NEC,Headaches,Nerv,N
6531,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6532,1,Headache,Headaches NEC,Headaches,Nerv,N
6533,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6533,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6534,1,Malignant melanoma stage III,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
6535,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6535,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6536,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6536,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6536,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6537,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
6538,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6538,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6539,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6539,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6539,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6540,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6541,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6542,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6542,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6542,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6542,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6542,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6543,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
6543,2,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
6544,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6544,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6545,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6546,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6546,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6547,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6547,2,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6547,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6548,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6549,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6549,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
6549,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6550,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6550,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6550,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6550,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6550,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6550,6,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6551,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6551,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6551,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6552,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6552,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6552,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6552,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6552,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6553,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6553,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6553,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6553,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6553,5,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
6554,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
6554,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
6555,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6556,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6557,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6557,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6557,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6558,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6558,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6558,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6559,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6559,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6559,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6559,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6560,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6560,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6561,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6561,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6561,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6562,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6562,2,Migraine,Migraine headaches,Headaches,Nerv,N
6562,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6563,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6563,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6563,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6563,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6564,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6565,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6565,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6565,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6566,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6567,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6567,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6568,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6569,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6569,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6569,3,Headache,Headaches NEC,Headaches,Nerv,N
6569,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6570,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6570,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6570,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6570,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6571,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6571,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6571,3,Headache,Headaches NEC,Headaches,Nerv,N
6571,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6572,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6573,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6573,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6573,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6573,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6574,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6574,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6574,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6575,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6575,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6576,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6577,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6578,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6579,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6579,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6579,3,Migraine,Migraine headaches,Headaches,Nerv,N
6579,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6579,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6580,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6581,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6581,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6582,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6582,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6582,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6582,4,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
6582,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6582,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6583,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6584,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6584,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6584,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6585,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6586,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6586,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6587,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6587,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6588,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6588,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6588,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
6589,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
6589,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6590,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6590,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6590,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6590,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6590,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6591,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6592,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6592,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6592,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
6593,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6594,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6594,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6595,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6595,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6595,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6596,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
6596,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6596,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6597,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6598,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6599,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6599,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6599,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6600,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6600,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6601,1,Headache,Headaches NEC,Headaches,Nerv,N
6602,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6602,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6602,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6602,4,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6603,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6603,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
6603,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6603,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6603,5,Vitamin B12 decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
6604,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6604,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6604,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6605,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6606,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6606,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6606,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
6606,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6607,1,Headache,Headaches NEC,Headaches,Nerv,N
6607,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6607,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6608,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6608,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6609,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6609,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6609,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6610,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6610,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6610,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6610,4,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6611,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6611,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6611,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6612,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6612,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6612,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6612,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6613,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6613,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6614,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6615,1,Headache,Headaches NEC,Headaches,Nerv,N
6615,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6616,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6616,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6616,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6616,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6617,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
6618,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6618,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6618,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6619,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6619,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6619,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6619,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
6620,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6620,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6620,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6620,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6621,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6621,2,Sinus arrest,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6622,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6622,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6622,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6622,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6622,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6622,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6622,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6623,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6624,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6624,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6624,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
6624,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6625,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6625,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6625,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6625,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6625,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6626,1,Headache,Headaches NEC,Headaches,Nerv,N
6626,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6627,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6627,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6628,1,Migraine,Migraine headaches,Headaches,Nerv,N
6628,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6629,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6629,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6630,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6630,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6631,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6631,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6632,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6632,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6633,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6633,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6634,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6634,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6635,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6635,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6635,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6635,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6636,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
6636,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6636,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6636,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
6637,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
6637,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6637,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6638,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6638,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6639,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6640,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6640,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6640,3,Chronic spontaneous urticaria,Urticarias,Angioedema and urticaria,Skin,N
6640,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6640,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6640,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6640,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6640,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
6640,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6640,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
6640,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6640,12,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6640,13,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6640,14,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6641,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6641,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6641,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6641,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6641,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6642,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6643,1,Headache,Headaches NEC,Headaches,Nerv,N
6643,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6644,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6644,2,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
6644,3,Headache,Headaches NEC,Headaches,Nerv,N
6644,4,Headache,Headaches NEC,Headaches,Nerv,N
6644,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6644,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6644,7,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6644,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6644,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6644,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6645,1,Aortitis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
6646,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
6647,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6647,2,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
6648,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6648,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6649,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
6649,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
6650,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6650,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6650,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6650,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6650,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6650,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6650,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6650,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6651,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
6651,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
6651,3,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6652,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6652,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6652,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6652,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6652,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6652,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6652,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6652,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6653,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6653,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6653,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6653,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6653,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6653,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6653,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6653,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6654,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6654,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6654,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6654,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6654,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6654,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6654,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6654,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6655,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6656,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6657,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6657,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6657,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
6657,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6657,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6657,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6658,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6658,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6658,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6659,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6659,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6659,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6660,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6661,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
6662,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
6662,2,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6662,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6662,4,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
6662,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6662,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6662,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6663,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6663,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6663,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6664,1,Headache,Headaches NEC,Headaches,Nerv,N
6664,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6664,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6664,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6665,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6665,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
6665,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6666,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6666,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6667,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6667,2,Device failure,Device issues NEC,Device issues,Prod,N
6667,3,Device leakage,Device issues NEC,Device issues,Prod,N
6667,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6667,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6667,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6667,7,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6667,8,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6667,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6667,10,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
6667,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6668,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6669,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6669,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6670,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6671,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6672,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6672,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6673,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6673,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6673,3,Headache,Headaches NEC,Headaches,Nerv,N
6673,4,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6673,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6674,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6674,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6675,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6676,1,Inflammatory pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6676,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6677,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6677,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6678,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6678,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6679,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6679,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6679,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6680,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6680,2,Headache,Headaches NEC,Headaches,Nerv,N
6681,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6681,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6682,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6682,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6682,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6682,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6683,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6683,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6683,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6684,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6684,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6685,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
6686,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6686,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6686,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
6686,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6686,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6687,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6687,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6688,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6688,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6689,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6690,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6691,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6692,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6692,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6693,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6693,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6693,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6694,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
6694,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6694,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6694,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6694,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6694,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6694,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6694,8,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6694,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6695,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6695,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6696,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6696,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6696,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6696,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6697,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6697,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6697,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6698,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6698,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6698,3,Headache,Headaches NEC,Headaches,Nerv,N
6698,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6699,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6699,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6700,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6700,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6701,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6701,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6702,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6702,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6702,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
6702,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
6702,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
6702,6,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
6702,7,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6702,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6702,9,Tandem gait test abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
6702,10,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6702,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6703,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6703,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6703,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6703,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6704,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6704,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6705,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6705,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6705,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6706,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6706,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6706,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6707,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
6707,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6707,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6707,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6707,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
6707,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6707,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6707,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
6707,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
6707,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
6707,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6707,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
6707,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6707,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
6707,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6707,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
6707,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6707,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
6707,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6707,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6707,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6708,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6708,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6708,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6709,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6709,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6710,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6711,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6712,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6713,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6713,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6714,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
6715,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6716,1,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
6717,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6717,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6718,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6718,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6719,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6719,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6719,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6720,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6720,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6721,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6722,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6722,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6722,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6722,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6722,5,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6723,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6723,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6723,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6724,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6724,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6724,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6724,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6725,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6726,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
6726,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6727,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6727,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6728,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6728,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6728,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6728,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6728,5,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6728,6,Headache,Headaches NEC,Headaches,Nerv,N
6728,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6728,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6728,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6728,10,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6729,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6729,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6729,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6729,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6729,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6730,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6730,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6730,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6730,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6731,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6731,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6732,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6732,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6732,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6732,4,Migraine,Migraine headaches,Headaches,Nerv,N
6732,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6732,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6733,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6733,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6734,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6734,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
6734,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6734,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6734,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6734,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6734,7,Headache,Headaches NEC,Headaches,Nerv,N
6734,8,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
6734,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6734,10,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6734,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6734,12,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6734,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6734,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6734,15,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6734,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6735,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6735,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6736,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6736,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6737,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6737,2,Headache,Headaches NEC,Headaches,Nerv,N
6737,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6737,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6737,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6738,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6739,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6739,2,Acne,Acnes,Skin appendage conditions,Skin,N
6739,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6739,4,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
6739,5,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6739,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6739,7,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
6739,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6739,9,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
6739,10,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6740,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6740,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6741,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6742,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6742,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6743,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6743,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6744,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6744,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6744,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6745,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
6745,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6745,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6745,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
6745,5,Reflux laryngitis,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
6746,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6746,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
6746,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6746,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6746,5,Mitral valve prolapse,Mitral valvular disorders,Cardiac valve disorders,Card,N
6746,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6746,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6746,8,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
6746,9,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
6746,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
6747,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6748,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
6748,2,Headache,Headaches NEC,Headaches,Nerv,N
6748,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6748,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6748,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6748,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6749,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6750,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6750,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6750,3,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6751,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6751,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6751,3,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6752,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
6752,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6752,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6752,4,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
6752,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6753,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6753,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
6753,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6753,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6753,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6753,6,Ulnar nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
6754,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6754,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6754,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6754,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6754,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
6754,6,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
6754,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6754,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6755,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6755,2,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6755,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6755,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6755,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6755,6,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
6755,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
6755,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6755,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6755,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
6756,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6756,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6756,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6757,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6757,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6757,3,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6757,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6757,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6757,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6758,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6759,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6759,2,Headache,Headaches NEC,Headaches,Nerv,N
6759,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6759,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6760,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6760,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6761,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6761,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6761,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6761,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6761,5,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
6761,6,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6761,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6761,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6761,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6761,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6761,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6761,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6761,13,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6762,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6762,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6762,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
6762,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6763,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6763,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6763,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6763,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6763,5,Skin lesion inflammation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6764,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6764,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6764,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6765,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6765,2,Headache,Headaches NEC,Headaches,Nerv,N
6765,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6765,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6765,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6765,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6765,7,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6766,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6766,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6766,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6766,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6766,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6767,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6768,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
6768,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6769,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6769,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6769,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6769,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6770,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
6770,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
6770,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6770,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6770,5,Subcorneal pustular dermatosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
6770,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6771,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
6772,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6772,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6773,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6773,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6773,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6774,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6774,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6775,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6775,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6775,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6775,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6776,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6776,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6777,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6777,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
6777,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6777,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6777,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6778,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6779,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6779,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6779,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6780,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6780,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6781,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6781,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6782,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6783,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6784,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6785,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6785,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6786,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6787,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6787,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6787,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6788,1,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6788,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
6788,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6789,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6789,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6790,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6790,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6790,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6791,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6792,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6793,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6793,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6793,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6793,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6793,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6793,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6793,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6794,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6794,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6794,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6795,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6795,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6796,1,Subcorneal pustular dermatosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
6796,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6797,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6797,2,Headache,Headaches NEC,Headaches,Nerv,N
6797,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6797,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6798,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6798,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6798,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6799,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6799,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6799,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6799,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6799,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6799,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6800,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6800,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6800,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6800,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6800,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6801,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6801,2,Headache,Headaches NEC,Headaches,Nerv,N
6802,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6802,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
6802,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6802,4,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6802,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6802,6,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6803,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6804,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6804,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6804,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6805,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6806,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6806,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6807,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6807,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
6807,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6807,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6808,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6808,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6809,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6809,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6809,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6810,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6810,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6811,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6811,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
6812,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6812,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6812,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6812,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6813,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6814,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
6815,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6815,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
6815,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6816,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6816,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6817,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6817,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6817,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
6818,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6819,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6819,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6819,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6820,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6820,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6820,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6820,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6820,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
6820,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6820,7,Migraine,Migraine headaches,Headaches,Nerv,N
6820,8,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6820,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6820,10,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6821,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6821,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6821,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6822,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6822,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6822,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6822,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6822,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6823,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6823,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6824,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6824,2,Headache,Headaches NEC,Headaches,Nerv,N
6824,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6824,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6825,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6825,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6826,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6827,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6827,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6827,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6828,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6828,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6829,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6830,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6830,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6830,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6831,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6831,2,Headache,Headaches NEC,Headaches,Nerv,N
6831,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
6831,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
6832,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6833,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6834,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6834,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6834,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6834,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6834,5,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
6834,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6835,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6835,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6836,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
6837,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6837,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6838,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6838,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6838,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6838,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6839,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6840,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6841,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6841,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6841,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
6841,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
6841,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6842,1,Headache,Headaches NEC,Headaches,Nerv,N
6842,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6842,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6842,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6843,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6843,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6843,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6844,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6844,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6845,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6845,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6845,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6845,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6845,5,Headache,Headaches NEC,Headaches,Nerv,N
6845,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6845,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6845,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6845,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6845,10,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6845,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6846,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
6846,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
6847,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6847,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6847,3,Headache,Headaches NEC,Headaches,Nerv,N
6847,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6847,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6847,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
6847,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6848,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6848,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
6848,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6848,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6848,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6848,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6849,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6849,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6849,3,Headache,Headaches NEC,Headaches,Nerv,N
6850,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6850,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6851,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6851,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
6851,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6851,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
6851,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6851,6,Neuroendocrine cell hyperplasia of infancy,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
6851,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6851,8,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
6852,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6852,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6853,1,Capillary fragility,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
6853,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6853,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6853,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6853,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6854,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6854,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6854,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6854,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6855,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6855,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6856,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6856,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6857,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6858,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6858,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6859,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6859,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6860,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6861,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6861,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6861,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6861,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6862,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
6863,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6864,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6864,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
6865,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6866,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
6866,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6866,3,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6866,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
6867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6867,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6867,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6868,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6868,2,Migraine,Migraine headaches,Headaches,Nerv,N
6869,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
6869,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6870,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6870,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6870,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6870,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6871,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6871,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6871,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6872,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
6872,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6873,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
6873,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6873,3,Headache,Headaches NEC,Headaches,Nerv,N
6873,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6873,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6874,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
6874,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6875,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6875,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6875,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6876,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6876,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6876,3,Headache,Headaches NEC,Headaches,Nerv,N
6876,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6877,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6877,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6878,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6878,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6879,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6879,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6880,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
6881,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6881,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6882,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6882,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6883,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6883,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6884,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6884,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6885,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
6885,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6885,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6886,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6886,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6886,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6887,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6887,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6888,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6888,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6889,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6889,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6889,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6890,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6890,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6891,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6891,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6892,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6892,2,Headache,Headaches NEC,Headaches,Nerv,N
6892,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6893,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6893,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6894,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6894,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6895,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
6895,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6895,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6895,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6896,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6896,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6896,3,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
6897,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6897,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6898,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
6898,2,Headache,Headaches NEC,Headaches,Nerv,N
6898,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6899,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6900,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6900,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
6900,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6900,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6901,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6902,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6902,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6902,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6903,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6904,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6904,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
6904,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6904,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6905,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6905,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6906,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
6907,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6907,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6907,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6907,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6908,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6908,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6908,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6908,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6908,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6909,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6910,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6911,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6911,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6911,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6911,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6911,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6911,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6912,1,Headache,Headaches NEC,Headaches,Nerv,N
6912,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6912,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6913,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
6913,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
6914,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6914,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6915,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6916,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6917,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6918,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6918,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6919,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
6919,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6919,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
6919,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
6919,5,Headache,Headaches NEC,Headaches,Nerv,N
6919,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6920,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6920,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6920,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6920,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6920,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6920,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
6920,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6920,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6920,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
6920,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6920,11,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
6920,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6920,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6921,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6921,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6921,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6922,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
6922,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6922,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6922,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6923,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
6923,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
6924,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6924,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
6924,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6924,4,Headache,Headaches NEC,Headaches,Nerv,N
6924,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
6924,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6924,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6924,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6925,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
6925,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
6925,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6925,4,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6925,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6925,6,Lacrimation decreased,Lacrimation disorders,Eye disorders NEC,Eye,N
6925,7,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
6925,8,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6925,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6926,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6927,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
6928,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
6929,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6929,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6929,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6929,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6930,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6930,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6931,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6931,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6931,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6932,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
6932,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6932,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6932,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6933,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6933,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
6933,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6933,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6934,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6934,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
6934,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
6934,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6935,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
6935,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6935,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6936,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
6936,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6936,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6936,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6936,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6936,6,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
6936,7,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
6936,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6937,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6937,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
6937,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6938,1,Headache,Headaches NEC,Headaches,Nerv,N
6938,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6938,3,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
6938,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6939,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6939,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6939,3,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
6939,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6939,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6940,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6940,2,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
6940,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6940,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
6941,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6941,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6942,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
6942,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6943,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
6943,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6943,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6944,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6944,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6944,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6944,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
6945,1,Headache,Headaches NEC,Headaches,Nerv,N
6945,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6946,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6946,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6947,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
6947,2,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
6948,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6948,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6949,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
6949,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6950,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6950,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
6951,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
6951,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
6951,3,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
6951,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6951,5,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
6951,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
6951,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
6952,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6952,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6953,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
6954,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6954,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
6955,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6956,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6957,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6957,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6958,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
6958,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6959,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6959,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6959,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
6960,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6960,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6961,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6961,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6961,3,Headache,Headaches NEC,Headaches,Nerv,N
6961,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6961,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6961,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6961,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6962,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6962,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6962,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6963,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6963,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6963,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6964,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6964,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6965,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6965,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6966,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6966,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6967,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
6967,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6968,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6968,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6969,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6969,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6969,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6969,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
6969,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6969,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6970,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6971,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6971,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6972,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6973,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6974,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6975,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6976,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6977,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6978,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
6979,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6979,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
6979,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6980,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
6981,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6981,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6981,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
6981,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6981,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
6982,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6982,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6983,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
6983,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6983,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6984,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
6985,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6986,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
6986,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
6986,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
6986,4,Headache,Headaches NEC,Headaches,Nerv,N
6986,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6986,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6986,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
6987,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6987,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6987,3,Upper-airway cough syndrome,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6988,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6989,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6990,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
6990,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
6990,3,Injection site pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
6990,4,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
6990,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
6991,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
6992,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
6993,1,Device issue,Device issues NEC,Device issues,Prod,N
6993,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6994,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
6994,2,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
6995,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
6995,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
6995,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6995,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6996,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6996,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
6997,1,Headache,Headaches NEC,Headaches,Nerv,N
6998,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6999,1,Hepatosplenic T-cell lymphoma,Adult T-cell lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
7000,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7000,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7001,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7001,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
7001,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7001,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7002,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7002,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7003,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7003,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7004,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7004,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7005,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7005,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7005,3,Headache,Headaches NEC,Headaches,Nerv,N
7005,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7005,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7005,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7005,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7006,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
7006,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7006,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7006,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7006,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7006,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
7006,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7007,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7007,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7007,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
7007,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
7007,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7008,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7009,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7010,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7011,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7012,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7013,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7013,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
7014,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7014,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7015,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7015,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7015,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7015,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7015,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7015,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7015,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7016,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7016,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7017,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7017,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7018,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7018,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7018,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7019,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7020,1,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
7020,2,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
7020,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7020,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7021,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7022,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7023,1,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
7024,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7024,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7024,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7024,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7024,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7025,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7025,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7025,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7025,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7026,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7026,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7026,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7027,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7027,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7027,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7027,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7027,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7027,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7028,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7028,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7028,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7028,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7029,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7029,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7029,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7030,1,Headache,Headaches NEC,Headaches,Nerv,N
7030,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7030,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7030,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7030,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7030,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7031,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7031,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7032,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7032,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7032,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7033,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7034,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7034,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7035,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7035,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7036,1,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
7037,1,Burning mouth syndrome,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7037,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
7037,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7038,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7038,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7039,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7039,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7039,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
7040,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7040,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7041,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7042,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7042,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7042,3,Migraine,Migraine headaches,Headaches,Nerv,N
7042,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7042,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7042,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7043,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7043,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7044,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7044,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7045,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7045,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7046,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7046,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7047,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7047,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7048,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7049,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7049,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7050,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7050,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7050,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7051,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7051,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7052,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7053,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7054,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7055,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7055,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7055,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7056,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
7056,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
7057,1,Headache,Headaches NEC,Headaches,Nerv,N
7057,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7058,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7058,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7059,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7059,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7059,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7060,1,Headache,Headaches NEC,Headaches,Nerv,N
7060,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7060,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7060,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7061,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7061,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7061,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7062,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7062,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7062,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7063,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7063,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7064,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7064,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7064,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7064,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7064,5,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7064,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7065,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7065,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7065,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7066,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7066,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7066,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7067,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7067,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7068,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7068,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7069,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7069,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7070,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7070,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7070,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7070,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7071,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7072,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7072,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
7072,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
7073,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7074,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7075,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7075,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7075,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7075,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7075,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7075,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7076,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7076,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7076,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7076,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7077,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7077,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7078,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7078,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7079,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7079,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7079,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7079,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7080,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7080,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7081,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7081,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7081,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7081,4,Headache,Headaches NEC,Headaches,Nerv,N
7081,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7081,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7081,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7081,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7081,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7082,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7082,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7082,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7083,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7083,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7084,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7084,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7085,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7086,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7086,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7086,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7086,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7087,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7087,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7088,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7089,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7090,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
7091,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7091,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7092,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7092,2,Headache,Headaches NEC,Headaches,Nerv,N
7092,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7092,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7093,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7093,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7094,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7094,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7094,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7094,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7095,1,Migraine,Migraine headaches,Headaches,Nerv,N
7096,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7096,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7097,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7097,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7098,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
7098,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7099,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7099,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7100,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7100,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7101,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7102,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7103,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7104,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7104,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7105,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7105,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7105,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7105,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7105,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7105,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7106,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7106,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7106,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7106,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7106,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7106,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7106,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
7106,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7106,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7107,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7108,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7108,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7108,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7108,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7108,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7108,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
7109,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7109,2,Psychological trauma,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
7110,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7110,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7111,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7111,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7111,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7112,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7112,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
7112,3,Headache,Headaches NEC,Headaches,Nerv,N
7112,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7113,1,Genital discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
7113,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7114,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7114,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7115,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7116,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
7116,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7117,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7117,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7117,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7117,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7117,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7118,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7118,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7119,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7121,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7121,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7121,3,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7121,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7121,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7121,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7122,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7123,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7123,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7124,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7125,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7125,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7126,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
7127,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7127,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7127,3,Headache,Headaches NEC,Headaches,Nerv,N
7127,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7127,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7127,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
7127,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7128,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7128,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7128,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7129,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7130,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7130,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7131,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7131,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
7131,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7131,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7132,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7132,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7133,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7134,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7134,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7135,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7135,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7136,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7136,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7137,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7138,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7139,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7139,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7140,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7140,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7140,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7141,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7142,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7142,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7144,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7145,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7145,2,External ear cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7146,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
7147,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7148,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7149,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7149,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7150,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7151,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
7152,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7152,2,Psoriasis area severity index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7153,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7153,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7154,1,Respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
7154,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7154,3,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7155,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7155,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7156,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7157,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7158,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7158,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7158,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7159,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7159,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7159,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7159,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7159,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7159,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7160,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7160,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7161,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7161,2,Headache,Headaches NEC,Headaches,Nerv,N
7162,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7162,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7163,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7163,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7164,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7164,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7165,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
7166,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7166,2,Headache,Headaches NEC,Headaches,Nerv,N
7166,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7166,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7166,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7167,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7167,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7168,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
7168,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7168,3,Polyserositis,Inflammations,General system disorders NEC,Genrl,N
7168,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7168,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7169,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7170,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
7171,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7171,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7172,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7172,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7173,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7173,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7173,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7174,1,Headache,Headaches NEC,Headaches,Nerv,N
7174,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7174,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7174,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7174,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7175,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
7175,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7176,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7176,2,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7176,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7176,4,Headache,Headaches NEC,Headaches,Nerv,N
7176,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7176,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7177,1,Injection site joint warmth,Injection site reactions,Administration site reactions,Genrl,N
7177,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7177,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7177,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7178,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7178,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7178,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7178,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7179,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7179,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7179,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7179,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7180,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7180,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7181,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7182,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7182,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7182,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7183,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7184,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7186,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7187,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7188,1,Headache,Headaches NEC,Headaches,Nerv,N
7188,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
7188,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7188,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7188,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7188,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7189,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7189,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
7189,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7189,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7190,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7190,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7191,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7191,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7191,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7192,2,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
7192,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7192,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7193,1,Migraine,Migraine headaches,Headaches,Nerv,N
7193,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7194,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7195,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7196,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7196,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
7197,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
7197,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
7198,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7199,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7199,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7199,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7200,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7200,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7201,1,Headache,Headaches NEC,Headaches,Nerv,N
7201,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7202,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7202,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7202,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7202,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7203,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7203,2,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7203,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7203,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
7203,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7203,6,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
7203,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7204,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7204,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7204,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7204,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7204,5,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7205,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7206,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7206,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7206,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7207,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7208,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7208,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7208,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7208,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7208,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7208,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7208,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7208,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7208,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7208,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7208,11,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7208,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7210,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7211,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
7212,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7212,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
7212,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7212,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7212,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
7212,6,Histrionic personality disorder,Personality disorders with dramatic behaviour (Cluster B),Personality disorders and disturbances in behaviour,Psych,N
7212,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7212,8,Hypermobility syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
7212,9,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7212,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7212,11,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
7212,12,Ligament injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
7212,13,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
7212,14,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7212,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7212,16,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
7212,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7212,18,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
7212,19,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7212,20,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7212,21,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
7212,22,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7212,23,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7212,24,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7213,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7213,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7213,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
7213,4,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7214,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7215,1,Headache,Headaches NEC,Headaches,Nerv,N
7215,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7215,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7216,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7217,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7217,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7217,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7218,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7218,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7219,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7220,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7220,2,Headache,Headaches NEC,Headaches,Nerv,N
7220,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7220,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7221,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7222,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7223,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7223,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7223,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7223,4,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7224,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
7224,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7225,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7225,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7225,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7226,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7226,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7226,3,Xerosis,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7227,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7227,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
7227,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7227,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7227,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7227,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
7228,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7229,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7229,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7229,3,Protein total abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
7230,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7231,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7232,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7233,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7234,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7234,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7234,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7235,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7235,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7235,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7235,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7235,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7235,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
7235,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7235,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7235,9,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7235,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7235,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7235,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7235,13,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
7235,14,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7235,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7235,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7236,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7236,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7237,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7238,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7239,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7239,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7239,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7239,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7240,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7241,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
7242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7242,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7242,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7243,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7244,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7245,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7246,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
7246,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7247,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7247,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7247,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7248,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7249,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7249,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7250,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
7250,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7250,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7251,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7251,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7252,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7252,2,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7253,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7253,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7253,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7253,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7253,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7253,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7254,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7255,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7256,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7256,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7257,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7258,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
7258,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7259,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7259,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7260,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7260,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7261,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7261,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7261,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7261,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7262,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7263,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
7264,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7265,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7265,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7265,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7266,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7266,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7267,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7267,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7267,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7268,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7269,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7269,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7270,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7270,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7271,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7271,2,Juvenile psoriatic arthritis,Psoriatic arthropathies,Joint disorders,Musc,N
7271,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
7271,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7272,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7272,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7272,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7272,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7273,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7274,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7274,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7275,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7276,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7277,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7278,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7278,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7279,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7279,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7279,3,Headache,Headaches NEC,Headaches,Nerv,N
7280,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7281,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7282,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7282,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7282,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7283,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7284,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7285,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7285,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7285,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7286,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7286,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7287,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7288,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7289,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7290,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7291,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7292,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7292,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7292,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7292,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7292,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7292,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7293,1,Citrate toxicity,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
7293,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7293,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7293,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7294,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
7294,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
7294,3,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
7295,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7296,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7296,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7297,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7297,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7298,1,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
7298,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
7298,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
7299,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7300,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7301,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7302,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7302,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7302,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7302,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7303,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7303,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7304,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7304,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7304,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7304,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7304,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7304,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7305,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7305,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7306,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7306,2,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
7306,3,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7306,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7307,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7307,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7307,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7307,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7307,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7308,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7308,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7309,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7310,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7310,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7311,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7312,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7313,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7313,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7314,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7314,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7314,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7314,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7315,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7315,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7315,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7315,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7315,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7315,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7316,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7316,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7317,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7317,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7318,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7318,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7319,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
7320,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
7320,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
7321,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7322,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7323,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7324,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7324,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7325,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7325,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7326,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7326,2,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7327,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7327,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7328,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7328,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7329,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7329,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7329,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7329,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
7329,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7330,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7331,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
7332,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7333,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7333,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7333,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7333,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7334,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7334,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7334,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7335,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7335,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7335,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7336,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7336,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7336,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7337,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7337,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7337,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7338,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
7338,2,Fallopian tube disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
7338,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7338,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7338,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7338,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7338,7,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
7338,8,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7338,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7339,1,Antinuclear antibody increased,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7339,2,Double stranded DNA antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7339,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7340,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
7341,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7341,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7341,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7342,1,Rhinitis allergic,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
7343,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7343,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7343,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7344,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7344,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7344,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7345,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7346,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7346,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7346,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
7347,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7347,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7347,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7348,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7348,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7349,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7349,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
7349,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
7349,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7350,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7350,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7351,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7351,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7351,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7352,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7353,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7354,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7355,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7355,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7355,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7355,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7355,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7355,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7355,7,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
7355,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7355,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7355,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7356,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7356,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7357,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7357,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
7357,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7357,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7358,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
7359,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7359,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7360,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
7361,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
7362,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7362,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7363,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7363,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7364,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7365,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7365,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7366,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7366,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7366,3,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7366,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
7366,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7367,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7367,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7368,1,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7368,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7368,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7369,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7369,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7370,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7371,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7371,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7371,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7371,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7371,5,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7372,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7373,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
7374,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7374,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7374,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7374,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7374,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7374,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7375,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7375,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7375,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7375,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7376,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7376,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7376,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7377,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7378,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7378,2,Headache,Headaches NEC,Headaches,Nerv,N
7379,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
7379,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7379,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7380,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7380,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
7381,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7381,2,Headache,Headaches NEC,Headaches,Nerv,N
7381,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7382,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7382,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7383,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7383,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7383,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7384,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7384,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7385,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7386,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7387,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7387,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7387,3,Headache,Headaches NEC,Headaches,Nerv,N
7387,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7387,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7387,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7387,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7388,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7389,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7389,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7390,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7390,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7391,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7391,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7392,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7393,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
7393,2,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
7393,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7393,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7393,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7393,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7394,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
7394,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7395,1,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
7395,2,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7395,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
7395,4,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
7396,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7396,2,Nasal turbinate hypertrophy,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
7397,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7397,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7398,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7398,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7399,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7400,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7400,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7400,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7401,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7401,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
7401,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7401,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7402,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7403,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
7404,1,Oral lichenoid reaction,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
7404,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7405,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7405,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7405,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7406,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7406,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7407,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7407,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7408,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7408,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7408,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7409,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
7409,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7410,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7410,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7410,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7410,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
7411,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7412,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7412,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7413,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7413,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7414,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7414,2,Acne,Acnes,Skin appendage conditions,Skin,N
7414,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7414,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7414,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7414,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7415,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
7415,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7415,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7416,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7416,2,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
7417,1,Eyelid rash,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7417,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
7417,3,Necrotising ulcerative gingivostomatitis,Fusobacterium infections,Bacterial infectious disorders,Infec,N
7417,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
7417,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7417,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7417,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7417,8,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
7418,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7418,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7418,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7419,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7420,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7420,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7421,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7421,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7421,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7421,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7421,5,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7421,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7421,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
7421,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7422,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7422,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7423,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
7424,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7425,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
7425,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7426,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7426,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7426,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
7426,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7426,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7427,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7427,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7427,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7428,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7428,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7428,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7429,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7429,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7430,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7430,2,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7431,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7432,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7433,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7433,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7433,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7434,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7435,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7435,2,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
7436,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7437,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7438,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
7438,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7438,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
7439,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7439,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7439,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7440,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7440,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7440,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7441,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7442,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7443,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7443,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7444,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7444,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7444,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7445,1,Headache,Headaches NEC,Headaches,Nerv,N
7445,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7446,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7446,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7447,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7447,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7447,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7448,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7448,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
7449,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
7450,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7450,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7450,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7451,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7451,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7451,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7451,4,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
7452,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
7452,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7453,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7453,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7453,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7454,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
7454,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7454,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7454,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7455,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7455,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7455,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7455,4,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
7455,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7455,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7456,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7456,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7457,1,Age-related macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
7457,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7457,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7458,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7458,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7459,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7459,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7460,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7461,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7462,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7463,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7464,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7464,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7465,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7465,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7466,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7467,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7468,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7468,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7469,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7469,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7470,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7471,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7471,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7472,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7473,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7473,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7473,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
7473,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7473,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7473,6,Headache,Headaches NEC,Headaches,Nerv,N
7473,7,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
7473,8,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
7473,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7473,10,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7473,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7473,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7473,13,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7474,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7474,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7475,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7475,2,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7476,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7476,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
7476,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
7476,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7476,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7477,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7477,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7478,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7478,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7478,3,Headache,Headaches NEC,Headaches,Nerv,N
7478,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7478,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7478,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7479,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7480,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7481,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7482,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7482,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7483,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7483,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7484,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7484,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7484,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7485,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7485,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7486,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7487,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7487,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7487,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7488,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7488,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7489,2,Headache,Headaches NEC,Headaches,Nerv,N
7489,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7489,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7489,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7489,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7490,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7490,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7490,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7491,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7492,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
7492,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7492,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7492,4,Headache,Headaches NEC,Headaches,Nerv,N
7492,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7492,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7493,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
7494,1,Abdominal fat apron,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
7494,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
7494,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7494,4,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7494,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7494,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7494,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7494,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7494,9,Kyphosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
7494,10,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
7494,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7494,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7495,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7495,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7495,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7495,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7496,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7497,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7497,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7498,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7499,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7500,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7500,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7500,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7500,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7500,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7501,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7501,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7501,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7501,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7502,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7503,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7503,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7503,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7504,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
7504,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7505,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7505,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7506,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7506,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7507,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7507,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7507,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7507,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
7507,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7508,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7508,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7508,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7509,1,Myxofibrosarcoma,Fibrous histiocytomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
7510,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7510,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7511,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
7511,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7511,3,Headache,Headaches NEC,Headaches,Nerv,N
7511,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7511,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7512,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7512,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7512,3,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
7513,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7513,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
7513,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7513,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
7514,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7515,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7515,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7515,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7515,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7516,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7516,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7516,3,Headache,Headaches NEC,Headaches,Nerv,N
7516,4,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7517,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7517,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7517,3,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7517,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7518,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7518,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7518,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7519,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7519,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7519,3,Headache,Headaches NEC,Headaches,Nerv,N
7519,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7519,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7520,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
7520,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
7520,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7521,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7521,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7521,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7522,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7523,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7524,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7525,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7526,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7526,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7526,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7526,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7527,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7527,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7528,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
7529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7530,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7530,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7530,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7531,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7531,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7532,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
7533,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7533,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7534,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7534,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7535,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7535,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7536,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7536,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7537,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7537,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
7537,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7538,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7538,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7538,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7538,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7539,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7540,1,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
7541,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7541,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7542,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
7543,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7544,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7545,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7546,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7546,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7546,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7546,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7547,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7548,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7548,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7548,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7549,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7550,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
7550,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7551,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7551,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
7551,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
7551,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7551,5,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
7552,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7553,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7553,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7553,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7554,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7554,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7555,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7555,2,Headache,Headaches NEC,Headaches,Nerv,N
7556,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7556,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7557,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7557,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7557,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7558,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7558,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7559,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7559,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7559,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7559,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7560,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7560,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7561,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7562,1,Headache,Headaches NEC,Headaches,Nerv,N
7562,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7562,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7562,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7563,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7563,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7563,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7564,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7566,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7566,2,Fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7567,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7567,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7567,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7568,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7568,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7569,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
7569,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
7570,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7571,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7571,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
7572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7572,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7573,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7573,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7574,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7574,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7574,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7574,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7575,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
7576,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7576,2,Headache,Headaches NEC,Headaches,Nerv,N
7577,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7577,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7577,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7578,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7578,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7579,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7580,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7581,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7582,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7583,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7583,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7583,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7584,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7584,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7585,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7585,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7585,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7585,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
7585,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7586,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7586,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7586,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
7586,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7586,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7586,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7587,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7588,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7588,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7588,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7589,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
7590,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7591,1,Headache,Headaches NEC,Headaches,Nerv,N
7591,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7592,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7592,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7592,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7592,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7592,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
7593,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7593,2,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7593,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7593,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7593,5,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7593,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7593,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7593,8,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
7593,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7593,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7593,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7593,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7593,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7593,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7593,15,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
7593,16,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7594,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7594,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7594,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7595,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7596,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
7597,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7597,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7598,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7598,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7599,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
7600,1,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
7600,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7601,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7601,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7601,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
7601,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
7602,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7603,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
7604,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7604,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7605,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7605,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7605,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7606,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7606,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7606,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7607,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7607,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7608,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7609,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
7609,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7610,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7610,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7611,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7611,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7611,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7612,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7612,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7613,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
7613,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7614,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7614,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7615,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7615,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
7616,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,Y
7616,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7617,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7617,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7618,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7618,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7619,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7619,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7619,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
7619,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
7620,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7620,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7621,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7621,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7622,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7623,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7623,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7623,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7623,4,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
7623,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7623,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7623,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7624,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7625,1,Headache,Headaches NEC,Headaches,Nerv,N
7625,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7625,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
7625,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7626,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7627,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7627,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7628,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
7629,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7629,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7630,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7630,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7630,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7631,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7631,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7631,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
7631,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7631,5,Headache,Headaches NEC,Headaches,Nerv,N
7631,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7631,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7631,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7632,1,Peripheral nerve operation,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
7633,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7633,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7634,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7634,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7635,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7635,2,Allergy to animal,Allergic conditions NEC,Allergic conditions,Immun,N
7635,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7635,4,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
7635,5,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7635,6,Device defective,Device physical property and chemical issues,Device issues,Prod,N
7635,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7635,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7635,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7635,10,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7636,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
7637,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7637,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7638,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7638,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7639,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7640,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7641,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
7641,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7641,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7642,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7642,2,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
7642,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7643,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7644,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7644,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
7644,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7645,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7645,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7646,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7646,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7646,3,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7647,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
7647,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7648,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7649,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
7649,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7650,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7650,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7650,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7650,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7650,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7650,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7651,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7652,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7652,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7653,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7653,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7653,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7653,4,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
7654,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7654,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7654,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7655,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7655,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7656,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7656,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7657,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7657,2,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
7657,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7658,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7658,2,Malignant melanoma stage I,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7659,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7660,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7660,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7661,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7661,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7662,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7662,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7663,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7663,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7664,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7664,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7665,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7665,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7665,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
7665,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7665,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
7665,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7665,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7666,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7666,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7667,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7667,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7668,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7669,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7669,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7670,1,Headache,Headaches NEC,Headaches,Nerv,N
7670,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7671,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7672,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
7672,2,Headache,Headaches NEC,Headaches,Nerv,N
7672,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7673,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7673,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7673,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
7673,4,Headache,Headaches NEC,Headaches,Nerv,N
7673,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7673,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7674,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
7675,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7675,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7675,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7675,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7675,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7675,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7675,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7676,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7676,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7676,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7676,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7676,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7677,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7677,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7678,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
7678,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7679,1,Clinically isolated syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
7679,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
7679,3,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
7679,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7680,1,Acute sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7681,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7682,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7683,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7684,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7685,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
7686,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7686,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7686,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7687,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7687,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7688,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
7689,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7689,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7690,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7690,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7691,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7691,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7692,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7693,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
7693,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7693,3,Headache,Headaches NEC,Headaches,Nerv,N
7693,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
7693,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7693,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7693,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
7694,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7694,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7694,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7694,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7695,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7695,2,Ingrown hair,Pilar disorders NEC,Skin appendage conditions,Skin,N
7695,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
7695,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
7695,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7695,6,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
7696,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7696,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7697,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7697,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7697,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7697,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
7697,5,Headache,Headaches NEC,Headaches,Nerv,N
7697,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7697,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7697,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7697,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7697,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7698,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7698,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7699,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7699,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7700,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7700,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7700,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7700,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7701,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7702,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7702,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7702,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
7702,4,Headache,Headaches NEC,Headaches,Nerv,N
7702,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7702,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7703,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7703,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7704,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
7704,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
7705,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7705,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7705,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7705,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7705,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7706,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
7706,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7707,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7707,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7707,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7707,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7708,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7708,2,Malignant melanoma stage I,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7709,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7709,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7710,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7710,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7710,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7711,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
7712,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7712,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7713,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7714,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7714,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7715,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7715,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7716,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7716,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7716,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7716,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
7716,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7716,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7717,1,Headache,Headaches NEC,Headaches,Nerv,N
7717,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7717,3,Migraine,Migraine headaches,Headaches,Nerv,N
7717,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7717,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7718,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
7719,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7720,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7721,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7722,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
7722,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7722,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7722,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7722,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7722,6,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
7723,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7723,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7723,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7724,1,Headache,Headaches NEC,Headaches,Nerv,N
7724,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
7724,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7724,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7725,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7726,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7727,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7727,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
7728,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7728,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7729,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7730,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7730,2,Streptococcal endocarditis,Streptococcal infections,Bacterial infectious disorders,Infec,N
7731,1,Migraine,Migraine headaches,Headaches,Nerv,N
7732,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7733,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7734,1,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
7734,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7735,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
7735,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7735,3,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
7735,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7735,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7735,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
7736,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
7736,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
7737,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7737,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7738,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7739,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7739,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7740,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7740,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7741,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7741,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7741,3,Headache,Headaches NEC,Headaches,Nerv,N
7741,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7741,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7742,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7742,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7742,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7743,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7744,1,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
7745,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7745,2,External ear disorder,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
7745,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7745,4,Headache,Headaches NEC,Headaches,Nerv,N
7745,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7745,6,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
7746,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7746,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
7746,3,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
7746,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7747,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7747,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7748,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7748,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7749,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7749,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7750,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7751,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7751,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7752,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7752,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7753,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7754,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7755,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7756,1,Headache,Headaches NEC,Headaches,Nerv,N
7756,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7756,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7756,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7757,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7757,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7758,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7758,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7759,1,Headache,Headaches NEC,Headaches,Nerv,N
7759,2,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
7759,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
7759,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7759,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7760,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7760,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
7760,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7760,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7760,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
7760,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
7760,7,Xanthopsia,Visual colour distortions,Vision disorders,Eye,N
7761,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
7762,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7762,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7762,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7763,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7763,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7763,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7764,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
7765,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
7766,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7767,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7767,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7767,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7767,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7768,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
7769,1,Malignant melanoma in situ,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7769,2,Superficial spreading melanoma stage unspecified,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7770,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
7771,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
7772,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7772,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7772,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7772,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
7772,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7772,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7773,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7773,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7774,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
7775,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7776,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7776,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7777,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7778,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7778,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7778,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7779,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7779,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7779,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7779,4,Headache,Headaches NEC,Headaches,Nerv,N
7779,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7780,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7780,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7780,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7780,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7780,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7780,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7781,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7781,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7781,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7782,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7782,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7783,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
7783,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7784,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
7784,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7784,3,Ultrasound liver abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
7785,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7785,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7786,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7787,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7787,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7787,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7787,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7788,1,Drug tolerance increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7788,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7789,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7790,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7790,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7791,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7791,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7792,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7792,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
7792,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7792,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7792,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7793,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7793,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
7794,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7795,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7796,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7797,1,Thyroiditis subacute,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
7798,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7798,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7798,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7798,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7799,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
7799,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
7800,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
7800,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7801,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7801,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7802,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
7803,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7803,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7803,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7804,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7804,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7805,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7805,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7805,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7805,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7805,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7805,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
7805,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7805,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7805,9,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
7805,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
7805,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7805,12,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7805,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7805,14,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7806,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7806,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7806,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7806,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7807,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7807,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7808,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
7809,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
7809,2,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
7809,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7809,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
7809,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
7810,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7810,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7810,3,Headache,Headaches NEC,Headaches,Nerv,N
7810,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7811,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
7811,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7812,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7812,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7813,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7813,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7813,3,Headache,Headaches NEC,Headaches,Nerv,N
7813,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7813,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7814,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7815,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7816,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7816,2,Disability,Disability issues,Lifestyle issues,SocCi,N
7816,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7816,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7816,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
7816,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7816,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7817,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7818,1,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7818,2,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7818,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7819,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
7819,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7819,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
7820,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7820,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7821,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
7822,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7822,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
7823,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7824,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7824,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
7825,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
7825,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
7825,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7826,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7827,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7828,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7828,2,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
7828,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7828,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7829,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7829,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
7830,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
7831,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7832,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7832,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7833,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7834,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7834,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7835,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7836,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
7836,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7836,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7837,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7837,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7838,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7838,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
7839,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7840,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7841,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
7842,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7843,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7844,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
7845,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7845,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7846,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
7847,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7847,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7847,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7847,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
7847,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
7847,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7847,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7847,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
7848,1,Abscess drainage,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7849,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7849,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7849,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7850,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7850,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
7851,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7852,1,Paradoxical psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7852,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7853,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
7854,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7854,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7855,1,Migraine,Migraine headaches,Headaches,Nerv,N
7855,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7856,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
7856,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7856,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7856,4,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
7857,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
7858,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7858,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7858,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7859,1,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
7859,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
7859,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7859,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7860,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
7861,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
7861,2,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7862,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7862,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7862,3,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
7863,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
7863,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
7864,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
7864,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7864,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7865,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7866,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7867,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7867,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7868,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7868,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7869,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
7869,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7870,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
7870,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7870,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7871,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7871,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7872,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7873,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
7874,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7874,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7875,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7875,2,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
7875,3,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
7876,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7877,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7878,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
7878,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
7878,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7878,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7879,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7879,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7880,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
7881,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7882,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7882,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7883,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
7883,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7883,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
7884,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7885,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
7885,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
7885,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
7885,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7886,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7886,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
7886,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7886,4,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
7886,5,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7886,6,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7886,7,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7887,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7887,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7887,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7888,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7889,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7890,1,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
7890,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7891,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7891,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7892,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7892,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7893,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7894,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7895,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7895,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7895,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7896,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7896,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7897,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7897,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7897,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7898,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7899,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7900,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7900,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7900,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7901,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7901,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7901,3,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7902,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7902,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
7903,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7904,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
7904,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7905,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
7906,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7907,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
7908,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7909,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7909,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7910,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7910,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7911,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7911,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
7912,1,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
7913,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7914,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
7915,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7916,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7916,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7916,3,Headache,Headaches NEC,Headaches,Nerv,N
7916,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7917,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
7918,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
7919,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
7919,2,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
7920,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7920,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7920,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7920,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7921,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
7922,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
7922,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7922,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7923,1,Ocular melanoma,Ocular melanomas,Ocular neoplasms,Neopl,N
7923,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
7924,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7924,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7925,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7925,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7925,3,Headache,Headaches NEC,Headaches,Nerv,N
7925,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
7925,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7926,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
7927,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
7927,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
7928,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7929,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7930,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
7931,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7932,1,Lung carcinoma cell type unspecified stage I,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
7933,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7933,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7934,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7935,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
7936,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
7936,2,Shoulder arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
7937,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7937,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
7938,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
7938,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7939,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
7939,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7939,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7939,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7940,1,Marjolin's ulcer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
7940,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
7940,3,Resorption bone increased,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
7940,4,Skin squamous cell carcinoma metastatic,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
7941,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
7941,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7941,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7941,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7942,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7943,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
7943,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7944,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
7945,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
7945,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
7945,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
7945,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
7945,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
7946,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7947,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7948,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7948,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7949,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
7949,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7949,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7949,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7949,5,Nail dystrophy,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
7949,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7949,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7950,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7950,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7950,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7951,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7951,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7951,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7951,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7951,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7952,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
7953,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7953,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7954,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
7955,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
7956,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
7956,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
7956,3,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7956,4,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
7956,5,Post procedural fever,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
7957,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7957,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7958,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7958,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7958,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7958,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7959,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7960,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7960,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7960,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7961,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
7962,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7962,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7963,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
7963,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7963,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7963,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7964,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7965,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7966,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7966,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7967,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7967,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7968,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7968,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7969,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
7969,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7969,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
7970,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7970,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
7971,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
7971,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7971,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7972,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
7973,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7973,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7974,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
7975,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
7976,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
7976,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7977,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
7978,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
7979,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7979,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7979,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
7979,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7980,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
7980,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7981,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
7982,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7982,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7983,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
7984,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7984,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7985,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7985,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
7986,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
7987,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7987,2,Cryoglobulinaemia,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
7987,3,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
7987,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7988,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
7989,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7989,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7990,1,Rectal neoplasm,Colorectal and anal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7991,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7992,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7993,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
7994,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7994,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7995,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7996,1,Headache,Headaches NEC,Headaches,Nerv,N
7997,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7997,2,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
7997,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7997,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
7997,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
7998,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7998,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7999,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7999,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8000,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8001,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
8002,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8002,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8003,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
8003,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8003,3,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
8003,4,Stoma creation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8004,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8005,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8006,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
8006,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8007,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8007,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8008,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8008,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
8008,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
8008,4,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
8008,5,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8008,6,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
8009,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8009,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8010,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8010,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8010,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
8010,4,Stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
8010,5,Stomal hernia,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
8011,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8011,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8011,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8011,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
8012,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
8012,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8012,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
8013,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8013,2,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
8013,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8013,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
8013,5,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8013,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8013,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8013,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
8013,9,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8014,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8014,2,Headache,Headaches NEC,Headaches,Nerv,N
8015,1,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
8016,1,Deafness,Hearing losses,Hearing disorders,Ear,N
8017,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8017,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8018,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8019,1,Headache,Headaches NEC,Headaches,Nerv,N
8019,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8019,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8020,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8020,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8021,1,Penile oedema,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
8021,2,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
8022,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8022,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
8022,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
8022,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8022,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
8022,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
8023,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
8024,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8024,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8024,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8025,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8026,1,Hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
8027,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8027,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8027,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8028,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8028,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8028,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8028,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8029,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8029,2,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8029,3,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
8029,4,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8030,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8030,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8030,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8030,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8030,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8030,6,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8030,7,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8030,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8030,9,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
8030,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8030,11,Meniscus injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
8030,12,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
8030,13,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8030,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8030,15,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
8030,16,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
8030,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8030,18,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8030,19,Rheumatoid nodule,Rheumatoid arthropathies,Joint disorders,Musc,N
8030,20,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8030,21,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8030,22,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8031,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8032,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8032,2,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
8033,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8033,2,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8034,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8034,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8035,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8036,1,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
8036,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8037,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
8038,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8039,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8040,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8041,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8041,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8041,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8042,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8043,1,Spinal stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8044,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8045,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
8046,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8047,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8047,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8048,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8048,2,Headache,Headaches NEC,Headaches,Nerv,N
8049,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8050,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8051,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8052,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8052,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8053,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8054,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8055,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8056,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8056,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8056,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8056,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8057,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8058,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8059,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8059,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8060,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8060,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8060,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8061,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8061,2,Migraine,Migraine headaches,Headaches,Nerv,N
8061,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8061,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8062,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8063,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8064,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8064,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
8064,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8065,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8065,2,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
8065,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8066,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8066,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8066,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8067,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
8068,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
8068,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8068,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8069,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8070,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8070,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8071,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8071,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8072,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
8073,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8074,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8074,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8074,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8075,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8075,2,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
8076,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8076,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8077,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8078,1,Headache,Headaches NEC,Headaches,Nerv,N
8078,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8078,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8079,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
8080,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8080,2,Coccydynia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8080,3,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
8080,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8080,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
8080,6,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
8080,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8080,8,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
8081,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
8082,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8083,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8084,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8084,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8084,3,Headache,Headaches NEC,Headaches,Nerv,N
8084,4,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
8085,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8086,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
8086,2,Mixed anxiety and depressive disorder,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8087,1,Gastrointestinal surgery,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
8087,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8088,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8088,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
8088,3,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
8088,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8088,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8088,6,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
8088,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8088,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
8088,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
8088,10,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
8088,11,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8088,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
8089,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8089,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8089,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
8090,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8090,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8091,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8091,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8091,3,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8091,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8091,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8091,6,Headache,Headaches NEC,Headaches,Nerv,N
8091,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8091,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8091,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8091,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8091,11,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8091,12,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8091,13,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8091,14,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
8091,15,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
8091,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8091,17,Vulvovaginal injury,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
8091,18,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
8092,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8093,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8094,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
8094,2,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
8095,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8096,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8097,1,Headache,Headaches NEC,Headaches,Nerv,N
8097,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8097,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8098,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8098,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8099,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8099,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8100,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8100,2,Headache,Headaches NEC,Headaches,Nerv,N
8100,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8100,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8101,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8102,1,Headache,Headaches NEC,Headaches,Nerv,N
8102,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8103,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8103,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8103,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8103,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8104,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8105,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8105,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8106,1,Medical procedure,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8107,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8107,2,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
8108,1,Headache,Headaches NEC,Headaches,Nerv,N
8109,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8110,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
8111,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8111,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
8111,3,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8111,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8111,5,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8111,6,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
8112,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8112,2,Investigation,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
8112,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8113,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8114,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8115,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
8115,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8116,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
8116,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8116,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8117,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8117,2,Headache,Headaches NEC,Headaches,Nerv,N
8118,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8119,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8120,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8121,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8121,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8122,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8123,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8124,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8125,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8126,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8127,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
8127,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8128,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8129,1,Multiple system atrophy,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
8130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8130,2,Headache,Headaches NEC,Headaches,Nerv,N
8131,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8131,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
8131,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
8132,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8132,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8133,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8133,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8133,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8134,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8135,1,Granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
8136,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8137,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8138,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
8139,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8140,1,Jaw operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8141,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8141,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8141,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8142,1,Epiglottitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8142,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
8142,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8142,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8142,5,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8142,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
8142,7,Target skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8143,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
8143,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8143,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8143,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
8144,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8144,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8144,3,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
8145,1,Headache,Headaches NEC,Headaches,Nerv,N
8146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8146,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8147,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8148,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
8149,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8149,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
8149,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8150,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8150,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8151,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8152,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
8153,1,Infected fistula,Infections NEC,Infections - pathogen unspecified,Infec,N
8153,2,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
8154,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
8154,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8155,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8156,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8156,2,Headache,Headaches NEC,Headaches,Nerv,N
8156,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8157,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8157,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8157,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8157,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
8157,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8157,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8158,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8158,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8158,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8159,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8159,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8159,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8159,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8159,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8159,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8160,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8160,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8160,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8160,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8160,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8161,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8161,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8162,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8163,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8163,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8164,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8165,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8166,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8167,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8168,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
8168,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8169,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8169,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8170,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8170,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8171,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8172,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8172,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8172,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8172,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8173,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8173,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8174,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8174,2,Heart failure with preserved ejection fraction,Left ventricular failures,Heart failures,Card,N
8175,1,Headache,Headaches NEC,Headaches,Nerv,N
8176,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8176,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8176,3,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
8177,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8178,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8179,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8180,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8180,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8181,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8182,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8182,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8183,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8184,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8185,1,Nodular melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
8186,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8187,1,Migraine,Migraine headaches,Headaches,Nerv,N
8188,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8189,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8189,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8189,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8189,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8190,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8190,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8190,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8191,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8192,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8193,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8193,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8193,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8194,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
8195,1,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8196,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8197,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8198,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8199,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8200,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8201,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8201,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8202,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8203,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8203,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8204,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8205,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
8205,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8205,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8206,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8207,1,Nodular melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
8208,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8208,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8208,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
8209,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8209,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8209,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8210,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8211,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
8211,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8211,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
8212,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8212,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8213,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8214,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8214,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
8215,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
8216,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8217,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
8218,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8218,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8218,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
8218,4,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8218,5,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8218,6,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
8218,7,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
8218,8,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
8218,9,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8218,10,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8218,11,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
8218,12,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
8218,13,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8218,14,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8218,15,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8218,16,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8218,17,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8218,18,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8218,19,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8218,20,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8218,21,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
8218,22,Headache,Headaches NEC,Headaches,Nerv,N
8218,23,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8218,24,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
8218,25,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
8218,26,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
8218,27,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8218,28,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
8218,29,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8218,30,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8218,31,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
8218,32,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8218,33,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
8218,34,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
8218,35,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8218,36,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8218,37,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8219,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8219,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8219,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8219,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8220,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8220,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8220,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8220,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8220,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
8221,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8222,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8223,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8223,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8224,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8224,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8224,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8224,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8224,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8224,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8224,7,Headache,Headaches NEC,Headaches,Nerv,N
8224,8,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8224,9,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8224,10,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8224,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8224,12,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8224,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8225,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8225,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8225,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8226,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8227,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8228,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8229,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8230,1,Tongue abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8231,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8232,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8232,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8232,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8232,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8232,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8232,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8232,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8232,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8232,9,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
8233,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8234,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8235,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
8236,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8237,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8237,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8238,1,Abdominal wound dehiscence,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8238,2,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8238,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8238,4,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8238,5,Bedridden,Disability issues,Lifestyle issues,SocCi,N
8238,6,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8238,7,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
8238,8,Extremity contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8238,9,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
8238,10,Granuloma gluteale infantum,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8238,11,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
8238,12,Inflammation,Inflammations,General system disorders NEC,Genrl,N
8238,13,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8238,14,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
8238,15,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
8238,16,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8238,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8238,18,Pelvic discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
8238,19,Pelvic discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
8238,20,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
8238,21,Physical deconditioning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8238,22,Proctectomy,Anorectal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
8238,23,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8238,24,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8238,25,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8238,26,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8238,27,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8238,28,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
8238,29,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
8238,30,Wound decomposition,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8239,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8240,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
8240,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8240,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8240,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8240,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8240,6,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
8240,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8240,8,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8241,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8242,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8243,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8243,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8243,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8243,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8243,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8243,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8243,7,Headache,Headaches NEC,Headaches,Nerv,N
8243,8,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8243,9,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8243,10,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8243,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8243,12,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8243,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8244,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8245,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8246,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8246,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
8246,3,Headache,Headaches NEC,Headaches,Nerv,N
8246,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8247,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8248,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8249,1,Tongue abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8250,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8250,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8250,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
8251,1,Stoma creation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8252,1,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8253,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8253,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8253,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8254,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8254,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
8255,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8255,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8256,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8257,1,Paracoccidioides infection,Paracoccidioides infections,Fungal infectious disorders,Infec,N
8258,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
8259,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8260,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8261,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8261,2,Headache,Headaches NEC,Headaches,Nerv,N
8261,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8261,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8262,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8263,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8263,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8264,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8265,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8265,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8265,3,Coronary arterial stent insertion,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
8265,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8265,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8265,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8265,7,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
8265,8,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8265,9,Peripheral artery stent insertion,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
8265,10,Post procedural swelling,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8266,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8266,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8267,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8268,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8268,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
8269,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8269,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8270,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8271,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8272,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8272,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8272,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8273,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8273,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
8273,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8273,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8274,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8274,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8275,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8275,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8275,3,Headache,Headaches NEC,Headaches,Nerv,N
8276,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8276,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8277,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8277,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8277,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8278,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8278,2,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
8278,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
8278,4,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
8279,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8280,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
8281,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8281,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8281,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8282,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8283,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8284,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
8285,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8285,2,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8286,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8286,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8287,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8287,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8287,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8287,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8288,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
8288,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8289,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
8290,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8291,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
8292,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8292,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8292,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
8292,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8292,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8293,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8293,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8294,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8294,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
8294,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8294,4,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
8294,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
8295,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
8296,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
8296,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8296,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8297,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8297,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8297,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8297,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8298,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8299,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
8300,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
8301,1,Basilar artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8301,2,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8301,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8301,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8302,1,Tension headache,Headaches NEC,Headaches,Nerv,N
8303,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8303,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8303,3,Headache,Headaches NEC,Headaches,Nerv,N
8303,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8303,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8303,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8303,7,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8303,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8304,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8305,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8306,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8306,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8307,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8308,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8308,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8308,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
8308,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8308,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8308,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8309,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8309,2,Migraine,Migraine headaches,Headaches,Nerv,N
8309,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
8309,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8309,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8309,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8309,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8310,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8311,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8312,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8312,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8313,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8314,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8315,1,Device issue,Device issues NEC,Device issues,Prod,N
8315,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8315,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8315,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8316,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8316,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8316,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8316,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8317,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8317,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
8317,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8317,4,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8317,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8317,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8317,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8317,8,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
8317,9,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8317,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8317,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8317,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8318,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8319,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8319,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
8319,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8320,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8321,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8322,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
8323,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8323,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8324,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8325,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8325,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8326,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8326,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8326,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
8326,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8327,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
8328,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8329,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8329,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8330,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8331,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
8331,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8331,3,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8331,4,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
8331,5,Herpes simplex encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
8331,6,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
8331,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8331,8,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
8331,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8331,10,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
8332,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8332,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8333,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8334,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8335,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
8336,1,Detachment of macular retinal pigment epithelium,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
8336,2,Myopic chorioretinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
8336,3,Presbyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
8337,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8338,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8339,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8339,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8340,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8340,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8341,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
8342,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8343,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
8343,2,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8343,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8343,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
8343,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
8343,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8344,1,Lymphangioma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
8345,1,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
8345,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
8346,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8347,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8348,1,Headache,Headaches NEC,Headaches,Nerv,N
8349,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8350,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8351,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8352,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8353,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8353,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8353,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8354,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8355,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8355,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8356,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8356,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8357,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8357,2,Headache,Headaches NEC,Headaches,Nerv,N
8357,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8358,1,Headache,Headaches NEC,Headaches,Nerv,N
8358,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8358,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8358,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
8358,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8359,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8359,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8360,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8360,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
8360,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8361,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8362,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8362,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
8362,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8362,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8362,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8362,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8363,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8364,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8365,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
8365,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8366,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
8366,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8367,1,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
8367,2,Pachydermodactyly,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
8368,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
8368,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8369,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
8369,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8370,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8370,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8370,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8370,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8370,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8370,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8370,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8370,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8371,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8372,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
8373,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8374,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8374,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
8374,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8374,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8374,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8375,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8376,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8377,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8378,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8379,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8380,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8381,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8381,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8381,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8381,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8382,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8382,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8383,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8383,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8384,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8385,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8386,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8387,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8387,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8388,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8389,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8390,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8390,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
8391,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8392,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8393,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8394,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8395,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8396,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8397,1,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
8397,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8397,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8398,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
8398,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
8399,1,Anal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8400,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8401,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8402,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8403,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8403,2,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
8404,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8404,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8404,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8404,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
8404,5,Headache,Headaches NEC,Headaches,Nerv,N
8404,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8405,1,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8406,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8407,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
8408,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8409,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8410,1,Benign prostatic hyperplasia,Prostatic neoplasms and hypertrophy,Prostatic disorders (excl infections and inflammations),Repro,N
8411,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
8412,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8413,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8414,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8415,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8416,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8416,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8417,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8418,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8419,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8420,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8420,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8421,1,Gastrointestinal viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8422,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8423,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
8424,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8424,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8425,1,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
8426,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8427,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
8427,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8428,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8429,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8430,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8431,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
8432,1,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
8433,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8433,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8433,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8433,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8434,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
8435,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8436,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8437,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8438,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8439,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8440,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8441,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
8442,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8443,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8444,1,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
8445,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8446,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8447,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8447,2,Headache,Headaches NEC,Headaches,Nerv,N
8447,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8448,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
8449,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8449,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8450,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8451,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8452,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8453,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8454,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8455,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8456,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8456,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8457,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8458,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8459,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8460,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8460,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8461,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8462,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8463,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8463,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8464,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8465,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8466,1,Headache,Headaches NEC,Headaches,Nerv,N
8467,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
8468,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
8469,1,Ligament injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
8470,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8471,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8471,2,Headache,Headaches NEC,Headaches,Nerv,N
8472,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8473,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8473,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8474,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8474,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8475,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8476,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8477,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8477,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8477,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8478,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8479,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8480,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8481,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8481,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8482,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
8482,2,Meibomian gland dysfunction,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8483,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8484,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8484,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8484,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8485,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8485,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8485,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8485,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8486,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8487,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8487,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8488,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8489,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8490,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8490,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8491,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8492,1,Body tinea,Tinea infections,Fungal infectious disorders,Infec,N
8493,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8494,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8495,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8496,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8497,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8498,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8498,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8499,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8499,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8499,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8499,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8500,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8501,1,Resting tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8502,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8503,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8504,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8505,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8506,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8507,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8507,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8508,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8508,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8509,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8510,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8510,2,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8511,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8511,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
8512,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8513,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8514,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8514,2,Headache,Headaches NEC,Headaches,Nerv,N
8514,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8514,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8514,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8515,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8515,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
8516,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8517,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
8517,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8518,1,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
8518,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8518,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8518,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
8519,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8519,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8520,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
8520,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
8520,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
8520,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8520,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8521,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8522,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
8522,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8523,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8523,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
8523,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8523,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8524,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8525,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8525,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8525,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8525,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8526,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8527,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8528,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8528,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
8528,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8529,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8530,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8531,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
8532,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8533,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8533,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8534,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8535,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8535,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8535,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8535,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8536,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8537,1,Headache,Headaches NEC,Headaches,Nerv,N
8537,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8537,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8537,4,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
8538,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8538,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8539,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8539,3,Faecal calprotectin abnormal,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
8540,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8541,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8541,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8542,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
8542,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8543,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,Y
8544,1,Circumcision,Penile therapeutic procedures,Male genital tract therapeutic procedures,Surg,N
8545,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8546,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8546,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8547,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8548,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8549,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8550,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8550,2,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8550,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
8551,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8552,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8553,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8554,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8554,2,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8555,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8556,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8557,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8557,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8557,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
8557,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8557,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
8558,1,Headache,Headaches NEC,Headaches,Nerv,N
8559,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8560,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8561,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8561,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8561,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8561,4,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8562,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
8562,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8562,3,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
8563,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8563,2,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
8563,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8563,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
8564,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
8565,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8565,2,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
8566,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8566,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8567,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8568,1,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8569,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8569,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8569,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8569,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8569,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8569,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8569,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
8569,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8569,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8569,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
8569,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8569,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8570,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
8571,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8572,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8572,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8572,3,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8572,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8573,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
8574,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
8575,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8575,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8575,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
8576,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8577,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8577,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8578,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8578,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8578,3,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8579,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
8579,2,Headache,Headaches NEC,Headaches,Nerv,N
8579,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8580,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8581,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
8581,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8581,3,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
8582,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8583,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8583,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8584,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8584,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8585,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8586,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8586,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8587,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8587,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8587,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
8587,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8587,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8587,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8587,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8587,8,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
8587,9,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8587,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8587,11,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8588,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8588,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8589,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8589,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8589,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8590,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8591,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8591,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8591,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8592,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8593,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8593,2,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
8594,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8595,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8596,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
8597,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8597,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8597,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8598,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8599,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8600,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8600,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8600,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8601,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8602,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8602,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
8602,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8603,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
8603,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8604,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8605,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8606,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
8607,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8607,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8608,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8609,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8610,1,Headache,Headaches NEC,Headaches,Nerv,N
8611,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8611,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8611,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8611,4,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
8611,5,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8611,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8611,7,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8611,8,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8611,9,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8611,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
8611,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8611,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
8611,13,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
8611,14,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
8611,15,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
8611,16,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
8611,17,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8611,18,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8611,19,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
8611,20,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8611,21,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8611,22,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8611,23,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
8611,24,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8611,25,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8611,26,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8611,27,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8611,28,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8611,29,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8611,30,Headache,Headaches NEC,Headaches,Nerv,N
8611,31,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
8611,32,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8611,33,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
8611,34,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
8611,35,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8611,36,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8611,37,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8611,38,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8611,39,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8611,40,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
8611,41,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8611,42,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8611,43,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
8611,44,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8611,45,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8611,46,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8611,47,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8611,48,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8611,49,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8611,50,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
8611,51,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8611,52,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
8611,53,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8611,54,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8611,55,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8611,56,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8611,57,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8611,58,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8611,59,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8612,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
8612,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8613,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8613,2,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
8614,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8615,1,Haematospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
8616,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8617,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8617,2,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8617,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8617,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8618,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8619,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8620,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8621,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8622,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8623,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8624,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8624,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8624,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
8624,4,Headache,Headaches NEC,Headaches,Nerv,N
8624,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8624,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8625,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8625,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
8626,1,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
8627,1,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
8627,2,Eyelid skin dryness,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
8627,3,Headache,Headaches NEC,Headaches,Nerv,N
8627,4,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
8628,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8629,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8630,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8631,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8632,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8632,2,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
8632,3,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
8633,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8634,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
8635,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
8636,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
8637,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
8637,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8638,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8639,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8639,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
8639,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8639,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8639,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8639,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8639,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8639,8,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8640,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8641,1,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
8642,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
8642,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
8642,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8643,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
8643,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8644,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
8644,2,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
8644,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
8644,4,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
8644,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
8644,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8644,7,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8644,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8644,9,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
8644,10,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8645,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8646,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
8646,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8646,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8646,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8646,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8647,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8647,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8647,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
8647,4,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8647,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
8648,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8649,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8649,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8650,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8651,1,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
8651,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
8651,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8651,4,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
8652,1,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
8652,2,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
8652,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8652,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
8653,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
8653,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8653,3,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
8653,4,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
8654,1,Cutaneous T-cell lymphoma stage II,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
8655,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8655,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8656,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8657,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8658,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8658,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8658,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8659,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
8659,2,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8659,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8660,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
8661,1,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
8662,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
8662,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8662,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8663,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8664,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8665,1,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
8666,1,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
8667,1,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
8668,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8668,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8669,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8669,2,Headache,Headaches NEC,Headaches,Nerv,N
8669,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8670,1,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8671,1,Diffuse vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
8672,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8672,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
8672,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
8672,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8673,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8674,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8674,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8675,1,Migraine,Migraine headaches,Headaches,Nerv,N
8676,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
8677,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8677,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8678,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8679,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8680,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
8680,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8680,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8681,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
8682,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8682,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8683,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8683,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8684,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8684,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8685,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8686,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
8687,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8687,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8687,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8687,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8687,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8687,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8687,7,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8688,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8688,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8689,1,Headache,Headaches NEC,Headaches,Nerv,N
8690,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8691,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8692,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
8693,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8694,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8695,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
8695,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8695,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8696,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8696,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8696,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8697,1,Cystocele,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
8697,2,Sleep disorder due to a general medical condition,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8697,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8698,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8699,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
8699,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8700,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8700,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8701,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8702,1,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
8703,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8703,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8704,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8704,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8704,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8704,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8705,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8706,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8707,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8708,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
8709,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
8709,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8709,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8710,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8711,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
8712,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8713,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8714,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8714,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8714,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8714,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
8715,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
8715,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8715,3,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
8715,4,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
8716,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8717,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8718,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
8719,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8719,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8720,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8720,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8720,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8721,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8722,1,Therapeutic procedure,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8723,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8724,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8724,2,Device issue,Device issues NEC,Device issues,Prod,N
8724,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
8724,4,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
8724,5,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8724,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8724,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8724,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8725,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8726,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8727,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8728,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
8728,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8729,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8730,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8731,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8731,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
8731,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8731,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8732,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8733,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8733,2,Steroid therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
8734,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
8734,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8734,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8734,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8734,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8734,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8735,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8735,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8735,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8736,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
8737,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8737,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8738,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
8738,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
8738,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
8738,4,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
8739,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8740,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8740,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
8741,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8742,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8743,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
8744,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
8744,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8744,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8744,4,Prostatic abscess,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
8745,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8745,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8745,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8745,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
8746,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8746,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8747,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8747,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8748,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8749,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8750,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8750,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8751,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8752,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
8752,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8753,1,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
8754,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8754,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8755,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8755,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8756,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8756,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8756,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
8756,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8757,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8757,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8758,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8758,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8759,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8759,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8759,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8759,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8759,5,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
8759,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8759,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8759,8,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8759,9,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8759,10,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
8759,11,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8760,1,Lip and/or oral cavity cancer stage 0,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
8761,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8762,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
8762,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8762,3,Headache,Headaches NEC,Headaches,Nerv,N
8762,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8763,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8764,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8764,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8764,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8765,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
8766,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8767,1,Anaemia postoperative,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8767,2,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
8767,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8767,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
8767,5,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8768,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8769,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8770,1,Dental care,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8771,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8772,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
8773,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8774,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8775,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8776,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8776,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8777,1,Headache,Headaches NEC,Headaches,Nerv,N
8778,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8779,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8780,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8781,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8782,1,Device issue,Device issues NEC,Device issues,Prod,N
8782,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
8782,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8782,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8782,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8782,6,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8782,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8783,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8784,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8785,1,Cholelithotomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
8786,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
8787,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
8787,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
8788,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8789,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
8790,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
8791,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8792,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8792,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8792,3,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
8792,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
8793,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8794,1,Ear operation,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
8795,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8795,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
8795,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8796,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8797,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8798,1,Endodontic procedure,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
8799,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8800,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8801,1,Joint arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
8802,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8803,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8804,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8804,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8805,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8806,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
8807,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
8807,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8807,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8807,4,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
8807,5,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8808,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8808,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8809,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
8810,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8810,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
8811,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8811,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8811,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8812,1,Alopecia scarring,Alopecias,Skin appendage conditions,Skin,N
8812,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8812,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8813,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8814,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8815,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
8816,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8816,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8816,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8816,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8816,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8816,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8816,7,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
8817,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
8818,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8819,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
8819,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
8819,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8820,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8820,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
8821,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
8822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8822,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8823,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
8823,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8824,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8824,2,Headache,Headaches NEC,Headaches,Nerv,N
8824,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
8824,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8824,5,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8825,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8826,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8826,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8827,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8828,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8829,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
8830,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8831,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8832,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8833,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8833,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
8833,3,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
8834,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8834,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8835,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8835,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8836,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8836,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8836,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8837,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
8838,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8839,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8840,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8841,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8842,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
8842,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8843,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8844,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8844,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8844,3,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
8845,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8846,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8846,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
8846,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
8846,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
8846,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8846,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8846,7,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8846,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8846,9,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8847,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8847,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
8848,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8849,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8850,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
8850,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
8851,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8851,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
8852,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
8852,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8853,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8853,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8854,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8854,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8855,1,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
8856,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
8857,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8858,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8858,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
8858,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8858,4,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
8859,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8859,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
8860,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8861,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8861,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8862,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8863,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8864,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8865,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8866,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8867,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8868,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8868,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8868,3,Headache,Headaches NEC,Headaches,Nerv,N
8869,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8869,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8870,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8871,1,Triple negative breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
8872,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8873,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8873,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
8874,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
8875,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
8876,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8877,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
8878,1,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
8879,1,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
8879,2,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8879,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8880,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8880,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8881,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
8882,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8882,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8883,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8884,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8885,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8885,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8885,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8886,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8886,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8887,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8888,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
8889,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8890,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8890,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
8891,1,Headache,Headaches NEC,Headaches,Nerv,N
8892,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8893,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
8893,2,Intestinal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
8893,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
8893,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8894,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
8895,1,Cutaneous leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
8896,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8897,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8897,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
8898,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8899,1,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
8900,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8901,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8902,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8903,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8904,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
8904,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8905,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8905,2,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
8905,3,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8905,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8906,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
8907,1,Paradoxical psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8908,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8909,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
8909,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8909,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8910,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8911,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8911,2,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
8912,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8912,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8912,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
8913,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8913,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
8913,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8914,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8914,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8915,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
8916,1,Headache,Headaches NEC,Headaches,Nerv,N
8917,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
8918,1,Headache,Headaches NEC,Headaches,Nerv,N
8919,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8919,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8919,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8920,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8921,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8922,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
8922,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8923,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8924,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8924,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8925,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
8925,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
8925,3,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
8926,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
8926,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8927,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8928,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8929,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8930,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8931,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8932,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8932,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
8933,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8934,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
8934,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
8935,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8935,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8936,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
8936,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
8936,3,Ischaemic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
8936,4,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
8936,5,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
8936,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8936,7,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
8936,8,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
8937,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
8938,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8938,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8939,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
8940,1,Incision site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
8940,2,Vulval cancer stage 0,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
8940,3,Vulvar dysplasia,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
8941,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8941,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8941,3,Paradoxical psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8941,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8941,5,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
8942,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8943,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8943,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8944,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8945,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8946,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
8946,2,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
8947,1,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
8947,2,Laryngeal stenosis,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
8947,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8947,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
8947,5,Polychondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
8948,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
8948,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
8949,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8950,1,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8951,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8952,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8952,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8953,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8954,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
8955,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8956,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8956,2,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
8957,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8957,2,Headache,Headaches NEC,Headaches,Nerv,N
8957,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8958,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
8959,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8959,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
8959,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8960,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8961,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8961,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
8961,3,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
8961,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8962,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
8962,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8963,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
8963,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
8963,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
8963,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8963,5,Unmasking of previously unidentified disease,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8964,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8965,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
8966,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
8967,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
8967,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
8967,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
8968,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8968,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8968,3,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
8968,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
8968,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8969,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8969,2,Hepatitis alcoholic,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
8969,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
8969,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
8969,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8970,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8971,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
8972,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8972,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8972,3,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
8973,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8974,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
8975,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
8976,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8976,2,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
8977,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
8978,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
8979,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8979,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8980,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8981,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8981,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
8981,3,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
8982,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8982,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8983,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8983,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8984,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8985,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8985,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8985,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8985,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8985,5,Headache,Headaches NEC,Headaches,Nerv,N
8985,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8985,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8985,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
8985,9,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
8986,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8986,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8987,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
8987,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8988,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
8988,2,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8989,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8990,1,Device issue,Device issues NEC,Device issues,Prod,N
8990,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8990,3,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
8991,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8991,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
8992,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8993,1,Device deployment issue,Device malfunction events NEC,Device issues,Prod,N
8994,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8995,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
8996,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8997,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8998,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
8999,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9000,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9001,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
9002,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9003,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9004,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9004,2,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
9005,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
9006,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9007,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9008,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9008,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
9008,3,Headache,Headaches NEC,Headaches,Nerv,N
9008,4,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
9009,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9009,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9009,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9010,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9011,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9011,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9012,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9012,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
9012,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9013,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
9013,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9014,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9015,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9016,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
9017,1,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9017,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9017,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9018,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9019,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9020,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
9021,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9022,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9022,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9023,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
9023,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9023,3,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
9023,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
9023,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
9024,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9024,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9025,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9025,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
9025,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9026,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9027,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9027,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9028,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
9028,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9029,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9030,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9031,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9032,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9032,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9032,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
9033,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9033,2,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
9034,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9035,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9035,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9036,1,Alcohol problem,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
9037,1,Device failure,Device issues NEC,Device issues,Prod,N
9037,2,Disability,Disability issues,Lifestyle issues,SocCi,N
9037,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
9038,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9039,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9040,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
9041,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9042,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9043,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9043,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9043,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9043,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9043,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9043,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9043,7,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
9044,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
9044,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9044,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9045,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9045,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9046,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9047,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
9048,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9049,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9050,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9051,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9052,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9052,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9053,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9054,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
9054,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
9054,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
9055,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9055,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9056,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9057,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9058,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9058,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9058,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9059,1,Deafness,Hearing losses,Hearing disorders,Ear,N
9059,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9060,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9061,1,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
9062,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
9062,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9062,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9063,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
9063,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
9063,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9064,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
9065,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9065,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9065,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9065,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9066,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9067,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
9067,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9068,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9069,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9070,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
9070,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9071,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
9071,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9072,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9072,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
9073,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9074,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9074,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9075,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9076,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9077,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9077,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9077,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9078,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9078,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
9078,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
9079,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9079,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9079,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9079,4,Headache,Headaches NEC,Headaches,Nerv,N
9079,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9079,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9079,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9080,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
9081,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9082,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
9082,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
9082,3,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
9083,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9084,1,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
9085,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9085,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9086,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9086,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9087,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9087,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9087,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9087,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9088,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
9089,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9090,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9091,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9091,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9092,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9093,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9094,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9095,1,Device issue,Device issues NEC,Device issues,Prod,N
9095,2,Medical device pain,Complications associated with device NEC,Complications associated with device,Genrl,N
9096,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9097,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9097,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9098,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9099,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
9100,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9101,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
9101,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9103,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9104,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9104,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9105,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9106,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9106,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9107,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9107,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9108,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9109,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9110,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9111,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9112,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9113,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9113,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
9113,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9113,4,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
9113,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9113,6,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
9114,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9115,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9116,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9116,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9117,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
9118,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
9119,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
9120,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
9120,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9121,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9121,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9122,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
9123,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9123,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9124,1,Acute disseminated encephalomyelitis,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
9125,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9126,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
9127,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9127,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9128,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9129,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
9130,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9131,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9131,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9132,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9133,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9133,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9134,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
9135,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9136,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9137,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
9138,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9138,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9138,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9138,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9138,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9138,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9138,7,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
9138,8,Gastrointestinal mucosa hyperaemia,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
9138,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9138,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
9138,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9138,12,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
9138,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9139,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9139,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9140,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
9140,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9141,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
9141,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9142,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9143,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9143,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9145,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9145,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9145,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9145,4,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9145,5,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9145,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9145,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9145,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9145,9,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9145,10,Inflammation,Inflammations,General system disorders NEC,Genrl,N
9145,11,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9145,12,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9145,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9145,14,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9145,15,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9145,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9145,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9145,18,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9145,19,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9145,20,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9146,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9146,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9147,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9148,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9148,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
9148,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
9149,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9149,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9150,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9151,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9151,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9151,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9151,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9151,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9152,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9153,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
9153,2,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
9153,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
9154,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9154,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
9155,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
9155,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9155,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9155,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9156,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9157,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9158,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9158,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9159,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9160,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9161,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
9162,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9163,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9164,1,Papillary cystadenoma lymphomatosum,Lip and oral cavity neoplasms benign,Gastrointestinal neoplasms benign,Neopl,N
9165,1,Capillaritis,Skin vasculitides,Skin vascular abnormalities,Skin,N
9165,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
9166,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9166,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9166,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9167,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9168,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9168,2,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9169,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9170,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9171,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9172,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9173,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9174,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9174,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
9174,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9175,1,Animal attack,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9175,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9175,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9175,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9175,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9175,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9175,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
9176,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9177,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9177,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9178,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9179,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9180,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9181,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9181,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9182,1,Carcinoid heart disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,Y
9182,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
9182,3,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
9182,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9182,5,Post procedural sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9182,6,Pulmonary valve incompetence,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
9183,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9183,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9183,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9184,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
9185,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
9185,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
9185,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9185,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
9185,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9185,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
9186,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9187,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9188,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9189,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9190,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9191,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9191,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9192,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
9193,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9193,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9194,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9194,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9194,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9195,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
9195,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9196,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
9197,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9198,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9199,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9200,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9200,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9201,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
9201,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9201,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9202,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9202,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
9202,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9203,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9204,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
9204,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9205,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
9205,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9206,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9206,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9207,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9208,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
9208,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9208,3,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
9208,4,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9209,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
9210,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
9210,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
9211,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
9212,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
9213,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
9213,2,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
9214,1,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
9215,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9215,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9215,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9216,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9216,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9217,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9217,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9217,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9217,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9218,1,Acute stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
9218,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
9218,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9218,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9218,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9218,6,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
9218,7,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
9218,8,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9218,9,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9218,10,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
9218,11,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9218,12,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
9218,13,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
9218,14,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9218,15,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
9219,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9220,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9220,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9220,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9221,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9222,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9223,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9224,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9224,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9225,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9225,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9225,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9226,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
9227,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9228,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9229,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
9230,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9231,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9232,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9233,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9234,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
9235,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9236,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9236,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
9237,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9237,2,Reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
9237,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9238,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9239,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9240,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9240,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9240,3,Headache,Headaches NEC,Headaches,Nerv,N
9240,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9240,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9240,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9241,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9241,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9241,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9241,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9242,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
9243,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9244,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9245,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9245,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9246,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9247,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9248,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9249,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9250,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
9251,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9252,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9252,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9253,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9254,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9255,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9255,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9255,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9256,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9257,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9257,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
9258,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9259,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9260,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9261,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
9261,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9261,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
9262,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9263,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
9263,2,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9263,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9263,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9264,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9264,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9264,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9264,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9265,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9265,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9266,1,Neutrophilic panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
9266,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9267,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9267,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9267,3,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
9267,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9267,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9268,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
9268,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9269,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9270,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9271,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9271,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9271,3,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
9271,4,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9272,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9273,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9274,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9275,1,Colon operation,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
9275,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
9275,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
9276,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9276,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9277,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9277,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9277,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
9278,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
9278,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9278,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9279,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
9280,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
9280,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
9281,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9282,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9283,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9283,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
9284,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9285,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9286,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9286,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9287,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9288,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9289,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9289,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
9289,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9289,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
9290,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9290,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9291,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9291,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9291,3,Radiculopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
9292,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9292,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9293,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9293,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9293,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
9293,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9293,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9293,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9294,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
9294,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9295,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9295,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9296,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
9296,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9296,3,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9297,1,Headache,Headaches NEC,Headaches,Nerv,N
9297,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9297,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9297,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9298,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9298,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9298,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9298,4,Tension headache,Headaches NEC,Headaches,Nerv,N
9299,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9300,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9300,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9301,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9301,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9301,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9302,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9302,2,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
9303,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
9303,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9303,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9304,1,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
9305,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9306,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9307,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
9307,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9308,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9309,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
9310,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9311,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9311,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9312,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9313,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9314,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9315,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
9316,1,Anal spasm,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
9317,1,Anal spasm,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
9318,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9319,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9320,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9321,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9322,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9322,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9323,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9324,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9324,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9324,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9325,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
9325,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9325,3,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9325,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
9325,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9325,6,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9325,7,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
9325,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9325,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9325,10,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
9325,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9325,12,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
9325,13,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
9325,14,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
9325,15,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
9325,16,Viral rash,Viral infections NEC,Viral infectious disorders,Infec,N
9325,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9325,18,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
9326,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
9327,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9328,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
9328,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9328,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9329,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9329,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9330,1,Gestational hypertension,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
9330,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9331,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9332,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
9332,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9333,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9333,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9333,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9334,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9335,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9336,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
9337,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9338,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9339,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
9339,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
9339,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9340,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9341,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9342,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9343,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9343,2,Radiculitis brachial,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
9344,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
9345,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9346,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
9347,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9348,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9349,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9350,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9351,1,Deafness,Hearing losses,Hearing disorders,Ear,N
9351,2,Headache,Headaches NEC,Headaches,Nerv,N
9351,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9351,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9352,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9352,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9353,1,Spinal fusion surgery,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
9353,2,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9354,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9354,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
9354,3,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
9355,1,Deafness,Hearing losses,Hearing disorders,Ear,N
9356,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
9356,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9356,3,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
9356,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9356,5,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
9356,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9356,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9357,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9357,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9358,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9359,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9360,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9361,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
9362,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9362,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9362,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9363,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9363,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9363,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9364,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9364,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9365,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9366,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
9367,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
9368,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9369,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9369,2,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9370,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9371,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
9372,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9373,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9374,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9375,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9376,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9377,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
9378,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
9379,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9380,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9381,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
9382,1,Headache,Headaches NEC,Headaches,Nerv,N
9383,1,Infected bite,Infections NEC,Infections - pathogen unspecified,Infec,N
9384,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9385,1,Sight disability,Disability issues,Lifestyle issues,SocCi,N
9386,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9387,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9388,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9389,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9390,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9391,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9391,2,Perineal disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
9392,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9393,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9394,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9394,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9395,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9396,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9397,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9398,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
9398,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9398,3,Device information output issue,Device information output issues,Device issues,Prod,N
9398,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9398,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9398,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9399,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9400,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
9400,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
9400,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9400,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9400,5,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9400,6,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
9401,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9402,1,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
9402,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9403,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9404,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
9405,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9406,1,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9406,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9406,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9407,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9407,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9408,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9408,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9408,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9409,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9410,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
9410,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9411,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
9411,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
9411,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9412,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
9412,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9412,3,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
9412,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9413,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
9414,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9415,1,Langerhans' cell histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
9416,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9417,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9418,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9419,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9420,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
9421,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9421,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9421,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9422,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9422,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9422,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9422,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9422,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9422,6,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
9422,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9422,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9422,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9423,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9424,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9425,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9425,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9426,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
9427,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9427,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
9428,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9428,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9429,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9430,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
9431,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9431,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9432,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9433,1,Colorectal adenoma,Lower gastrointestinal neoplasms benign,Gastrointestinal neoplasms benign,Neopl,N
9433,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
9433,3,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
9433,4,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9434,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9435,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
9435,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
9435,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9435,4,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
9435,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9435,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9435,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
9435,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9435,9,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9435,10,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
9435,11,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
9435,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9435,13,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
9435,14,Headache,Headaches NEC,Headaches,Nerv,N
9435,15,Heart valve operation,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
9435,16,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
9435,17,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9435,18,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9435,19,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9435,20,Obstruction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9435,21,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9435,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9435,23,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9435,24,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
9435,25,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
9435,26,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9435,27,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9436,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9437,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9438,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
9439,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9439,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9439,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9439,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9439,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9439,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9440,1,Headache,Headaches NEC,Headaches,Nerv,N
9441,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
9441,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
9442,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9443,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9443,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9443,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9444,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9444,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9444,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
9445,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9445,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9446,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9446,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9446,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9447,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9448,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
9448,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9448,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9448,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9449,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9449,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9450,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9450,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9450,3,Headache,Headaches NEC,Headaches,Nerv,N
9451,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
9451,2,Cerebellar atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
9452,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9452,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9453,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9454,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9454,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9455,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9455,2,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
9455,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9456,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9457,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9457,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9457,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9457,4,Headache,Headaches NEC,Headaches,Nerv,N
9457,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9457,6,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9458,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9459,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9460,1,Duodenogastric reflux,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
9460,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9460,3,Temporal lobe epilepsy,Partial complex seizures,Seizures (incl subtypes),Nerv,N
9461,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9462,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9463,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9463,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9464,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
9464,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9464,3,Migraine with aura,Migraine headaches,Headaches,Nerv,N
9464,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9465,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9465,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9465,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9465,4,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9465,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9465,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9465,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9465,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9465,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9466,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
9467,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9468,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9468,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9468,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9468,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
9469,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9470,1,Basal ganglia infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9470,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9471,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9471,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
9472,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9472,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9472,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9473,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
9474,1,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9474,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9475,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9475,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
9475,3,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
9475,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9475,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9476,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9477,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9478,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9479,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
9480,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9481,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9481,2,Headache,Headaches NEC,Headaches,Nerv,N
9481,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
9481,4,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9482,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9483,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9483,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
9484,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9485,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9485,2,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
9486,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9486,2,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
9487,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9488,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9489,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9490,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9490,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9491,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9492,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9493,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9494,1,Nasal mucosal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
9495,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
9495,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9495,3,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9496,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9497,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9497,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
9497,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9497,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9498,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9499,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9499,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9500,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9501,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9502,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9503,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9503,2,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9503,3,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9504,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9504,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9505,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9505,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9506,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
9506,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9506,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
9507,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9507,2,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
9508,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9509,1,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
9510,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9511,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9511,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9512,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
9513,1,Myopic chorioretinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
9513,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9514,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
9515,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9516,1,Disability,Disability issues,Lifestyle issues,SocCi,N
9516,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9517,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9518,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9519,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
9519,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9520,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9520,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9521,1,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
9521,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9521,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9522,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9522,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9522,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9522,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9523,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9523,2,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9523,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9523,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9523,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9524,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9525,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9526,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9527,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9527,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
9527,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9527,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9527,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9527,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9527,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
9527,8,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
9527,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9528,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9528,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9529,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9529,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9530,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9530,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9530,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
9531,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9531,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9532,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
9533,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9533,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9534,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9534,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9535,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9536,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9537,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9537,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9538,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9539,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9540,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
9540,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
9541,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9542,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9543,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9544,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9545,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9546,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9547,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9547,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9548,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9548,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9548,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9549,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9549,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9549,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9549,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9549,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9550,1,Headache,Headaches NEC,Headaches,Nerv,N
9551,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9552,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
9553,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9554,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9554,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
9554,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
9554,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9555,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9556,1,Epicondylitis,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
9556,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9556,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9556,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9556,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9556,6,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
9556,7,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9557,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9557,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9557,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9558,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9558,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
9558,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9559,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
9559,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9560,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9560,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9561,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
9562,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
9562,2,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
9562,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9563,1,Interstitial granulomatous dermatitis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
9563,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9563,3,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
9564,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9565,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9566,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
9567,1,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9568,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
9568,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9568,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9568,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
9569,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9570,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9571,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9572,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
9573,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9574,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9574,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9574,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9574,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9574,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9574,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9575,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9575,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9576,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9577,1,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
9578,1,Ovarian cancer stage IV,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
9579,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9580,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
9580,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9581,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9582,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9582,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9583,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9583,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9583,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9583,4,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
9583,5,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
9584,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9585,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
9585,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9586,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
9587,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9587,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9588,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9588,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9589,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9589,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9589,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9590,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9591,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9592,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9593,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
9593,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9593,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9593,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9593,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9594,1,Device issue,Device issues NEC,Device issues,Prod,N
9594,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9594,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9595,1,Device issue,Device issues NEC,Device issues,Prod,N
9595,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9596,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9597,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9598,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9598,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9598,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9598,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9598,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
9598,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9599,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9600,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
9600,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9601,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9602,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9603,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9604,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
9604,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9604,3,Illiteracy,Educational issues,Lifestyle issues,SocCi,N
9605,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9605,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9606,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9607,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9607,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9608,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
9609,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9610,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9611,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9611,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9611,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
9611,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9611,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9612,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9612,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9613,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9614,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9615,1,Device issue,Device issues NEC,Device issues,Prod,N
9615,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9615,3,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
9616,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
9617,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
9618,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
9619,1,Mineral supplementation,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
9620,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
9621,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
9622,1,Computerised tomogram,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9622,2,Dental care,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9622,3,X-ray,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9623,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9623,2,Renal stone removal,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
9624,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9625,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9626,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9627,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9627,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9627,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9628,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
9629,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9629,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9630,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9632,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
9633,1,Device defective,Device physical property and chemical issues,Device issues,Prod,N
9633,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
9633,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9634,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9635,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9635,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9635,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9635,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9636,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9637,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9637,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9638,1,Eye colour change,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
9639,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
9640,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9641,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9642,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9642,2,Paradoxical psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9642,3,Peripheral spondyloarthritis,Spondyloarthropathies,Joint disorders,Musc,N
9642,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9642,5,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
9642,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9643,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9644,1,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9645,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
9645,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9645,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
9645,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9646,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
9646,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
9646,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9646,4,Double stranded DNA antibody,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
9646,5,Headache,Headaches NEC,Headaches,Nerv,N
9646,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9646,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9646,8,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
9646,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9646,10,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9646,11,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9646,12,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9646,13,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9646,14,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
9646,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9647,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
9648,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9648,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9649,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9649,2,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
9650,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9650,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9650,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9651,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9651,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9652,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
9653,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9654,1,Device issue,Device issues NEC,Device issues,Prod,N
9654,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9655,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
9655,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
9655,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9656,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9657,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
9657,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9658,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9658,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9658,3,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9658,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9659,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9660,1,Device issue,Device issues NEC,Device issues,Prod,N
9660,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9661,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9662,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9662,2,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9663,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
9663,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
9663,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9664,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9665,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
9666,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9666,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9666,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9667,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
9668,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9669,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9670,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9671,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9672,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9672,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
9672,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9673,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
9674,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9675,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9676,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9677,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
9677,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9678,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9678,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9679,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9679,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9680,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9681,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9682,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9682,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9683,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9684,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9685,1,Sperm concentration increased,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
9686,1,Deafness,Hearing losses,Hearing disorders,Ear,N
9687,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9688,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9689,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9689,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9690,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
9691,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9692,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9692,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9693,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9694,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9695,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
9696,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9696,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9697,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9697,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9698,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9699,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9700,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9701,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
9702,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9703,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9703,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9704,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9705,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9706,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9706,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9707,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9707,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9708,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9708,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9709,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9709,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9710,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9710,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9711,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9711,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9712,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9713,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9713,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9714,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
9715,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9715,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9716,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9716,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9717,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9717,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9718,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
9719,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
9720,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
9720,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9721,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9721,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9721,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9721,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9722,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
9722,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9723,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9723,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9723,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9724,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9724,2,Aspiration joint,Musculoskeletal and soft tissue histopathology procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
9724,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9725,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9726,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9726,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9727,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9727,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9727,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9727,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9728,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9729,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9730,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9730,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
9731,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9732,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9732,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9733,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9734,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9734,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9734,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
9735,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9736,1,Fear of disease,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9736,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9737,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9737,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9738,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9739,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9740,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
9741,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9742,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9743,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9744,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9745,1,Vascular graft,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
9746,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9746,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9746,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
9746,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
9747,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9748,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9748,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
9749,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9750,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9751,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9752,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9752,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
9753,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9753,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9754,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9754,2,Incorrect disposal of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9754,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9754,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9755,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9756,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9756,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9756,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9756,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9757,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
9757,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9758,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9759,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9759,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9760,1,Cogan's syndrome,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
9760,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9760,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9761,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9761,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9762,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9762,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
9763,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
9763,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9763,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
9764,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9764,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9764,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9765,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9766,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9767,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
9768,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9769,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9770,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9771,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9772,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9773,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9774,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
9774,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9775,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9776,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9776,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9777,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9777,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9778,1,Headache,Headaches NEC,Headaches,Nerv,N
9778,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
9778,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9778,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9778,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9779,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9779,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
9780,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9781,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9781,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9781,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9782,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9782,2,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9783,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9784,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9785,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
9785,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9786,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9787,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9787,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9788,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
9789,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9789,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9790,1,Headache,Headaches NEC,Headaches,Nerv,N
9790,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
9791,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9792,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9792,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9792,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
9792,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
9792,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
9792,6,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
9792,7,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
9792,8,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9792,9,Injection site coldness,Injection site reactions,Administration site reactions,Genrl,N
9792,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9792,11,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9792,12,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9792,13,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9793,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9794,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9794,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9795,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9796,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9796,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9797,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9798,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9798,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9799,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9800,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9801,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9801,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9802,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9802,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9803,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9804,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9804,2,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9804,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9805,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9806,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9806,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9806,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9807,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9808,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9809,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9810,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9811,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9811,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9812,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
9812,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
9813,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
9814,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9815,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
9816,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
9816,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
9816,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9817,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
9817,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
9818,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9818,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
9818,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
9818,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
9818,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
9818,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9819,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
9819,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9819,3,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9819,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9819,5,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9820,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
9821,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9821,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9822,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9822,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9822,4,Intervertebral disc degeneration,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
9822,5,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
9823,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9823,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9823,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
9823,4,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
9823,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9823,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9823,7,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9823,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9823,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9823,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9823,11,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
9824,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9824,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9825,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9826,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9826,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
9827,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9827,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9828,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9828,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
9828,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9828,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9828,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
9828,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9828,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9828,8,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
9828,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9828,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9828,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9828,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9829,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9829,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9830,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9831,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9831,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9832,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9833,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
9833,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9834,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
9834,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9835,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9835,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9836,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9837,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9838,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9839,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
9839,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
9839,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9840,1,Allergy to arthropod sting,Allergic conditions NEC,Allergic conditions,Immun,N
9841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9841,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9842,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9843,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
9844,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9844,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9845,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9845,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9846,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9847,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
9848,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9849,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9850,1,Migraine,Migraine headaches,Headaches,Nerv,N
9851,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9851,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9851,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9851,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9852,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9852,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9853,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
9853,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9854,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9855,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9855,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9856,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
9857,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
9857,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9858,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9859,1,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
9860,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9861,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9862,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9863,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
9864,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9864,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9864,3,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9864,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9865,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
9866,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9866,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9867,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
9867,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9867,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9867,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9868,1,Deafness,Hearing losses,Hearing disorders,Ear,N
9869,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9870,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9870,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9871,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9872,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
9872,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9872,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9872,4,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
9873,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9873,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
9873,3,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
9873,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
9873,5,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
9874,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9874,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9875,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
9876,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
9877,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
9878,1,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
9879,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9880,1,Gastritis alcoholic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9880,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
9881,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
9882,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
9882,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9883,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9884,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
9885,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9886,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
9886,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9886,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9887,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9887,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9888,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
9889,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9890,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9891,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
9892,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9893,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9894,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9894,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9894,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
9895,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
9896,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9896,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9896,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9897,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9898,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9899,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
9900,1,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
9901,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9902,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
9903,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9903,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9903,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9904,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9905,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
9906,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
9907,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9907,2,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
9907,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9907,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9908,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
9908,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9909,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9909,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9910,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9911,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9912,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9913,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9914,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
9915,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
9916,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
9917,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9918,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
9919,1,Testicular seminoma (pure),Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
9920,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9920,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9920,3,Traumatic delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
9921,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9922,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9922,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9923,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9924,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9925,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9926,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9926,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9927,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9928,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9929,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9929,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9930,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9931,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9932,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
9933,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9933,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9934,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
9934,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9935,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9936,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9936,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9937,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9937,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9938,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9938,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9938,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9938,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9939,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9939,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9940,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9941,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
9942,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9942,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9943,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9943,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9944,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
9945,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9945,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9946,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9946,2,Nail operation,Nail therapeutic procedures,Skin and subcutaneous tissue therapeutic procedures,Surg,N
9946,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9947,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9947,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9948,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
9949,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9950,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9950,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9951,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9951,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9951,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9952,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9952,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9952,3,School refusal,"Infancy, childhood and adolescence psychiatric disorders NEC",Psychiatric disorders NEC,Psych,N
9952,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9952,5,Somatic symptom disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
9952,6,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
9953,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9954,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9954,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9954,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
9955,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9956,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
9957,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9958,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9959,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9959,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9960,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9960,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9960,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9961,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9962,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9962,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
9963,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
9963,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9963,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9963,4,Psoriasis area severity index increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9963,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
9964,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
9965,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9965,2,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
9966,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9967,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9967,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9967,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9968,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9968,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9968,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9969,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9969,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9969,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9970,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9970,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9971,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9971,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9971,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
9972,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9973,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9974,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9975,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9976,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9977,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9977,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9978,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9979,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9980,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9981,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9981,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
9982,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9982,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9983,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9983,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9984,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9984,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9985,1,Device intolerance,Complications associated with device NEC,Complications associated with device,Genrl,N
9985,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9986,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9987,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
9987,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
9987,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
9987,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9988,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
9988,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
9989,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9989,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
9989,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
9990,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
9990,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9991,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9992,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9992,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
9992,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9993,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
9993,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
9994,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9995,1,Refusal of examination,Social issues NEC,Lifestyle issues,SocCi,N
9996,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
9997,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9997,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9998,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9998,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
9998,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9998,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9998,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9999,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10000,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10000,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10000,3,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10001,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10002,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10003,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
10003,2,Infectious thyroiditis,Infections NEC,Infections - pathogen unspecified,Infec,N
10003,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10004,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10004,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10005,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10005,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10006,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10006,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10007,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10007,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10007,3,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,N
10008,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10008,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10009,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10009,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10010,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10010,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10011,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10012,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
10012,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10013,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10013,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10014,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10015,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
10016,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10017,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
10017,2,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10017,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10017,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10017,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
10018,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10019,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
10020,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10021,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10021,2,Hernia repair,Hernia repairs,Gastrointestinal therapeutic procedures,Surg,N
10022,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10022,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10022,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
10022,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10022,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10022,6,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
10022,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10022,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10022,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10022,10,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
10022,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10022,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10022,13,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10022,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10022,15,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10023,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10023,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
10023,3,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10023,4,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
10023,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
10024,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
10025,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
10025,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10026,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10026,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10026,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10027,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10028,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10029,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10029,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10030,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10030,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10030,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10030,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10031,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10032,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10032,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10032,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10033,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10033,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10034,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10035,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
10036,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10037,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
10038,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10039,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10040,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10040,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10040,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10041,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10041,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10042,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10042,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10042,3,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
10042,4,Perineal disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
10042,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10042,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10042,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10042,8,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
10043,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
10043,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10043,3,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10044,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
10045,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10046,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10046,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10047,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10048,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10048,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10049,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
10050,1,Arthropod sting,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10051,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10052,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
10053,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10054,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10054,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10055,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10055,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
10056,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10056,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10057,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10058,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10058,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10058,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10059,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10060,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
10060,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10061,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10062,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10062,2,Pityriasis rubra pilaris,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
10063,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10064,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10065,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10066,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10066,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10067,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10068,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10069,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
10069,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
10070,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10071,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10072,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10073,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10074,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10075,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10076,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10077,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10078,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10079,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10080,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10081,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10082,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10083,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10084,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10085,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10086,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10087,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10088,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10089,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10090,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10090,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10091,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
10091,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10092,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10092,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10093,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10094,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10095,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
10096,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10097,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10098,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10099,1,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10100,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10100,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10101,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10101,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10102,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
10103,1,Gastrointestinal viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10103,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10103,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10104,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10105,1,Deafness,Hearing losses,Hearing disorders,Ear,N
10106,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
10107,1,Migraine,Migraine headaches,Headaches,Nerv,N
10107,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10108,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10108,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10109,1,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10110,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
10111,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
10111,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10111,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
10112,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
10113,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10114,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10114,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10114,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10115,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10115,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10115,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10116,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10117,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10117,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10117,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10117,4,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10118,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10119,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10120,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10120,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
10121,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10122,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10123,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10123,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10124,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
10125,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10125,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
10126,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10126,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10126,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10127,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10127,2,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10127,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10128,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10130,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10131,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10132,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10132,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
10132,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10132,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
10132,5,Thyroid cyst,Thyroid neoplasms,Thyroid gland disorders,Endo,N
10132,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10133,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10134,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10135,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
10135,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10136,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
10137,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
10138,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10139,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10139,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10139,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10139,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10139,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10139,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10139,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10140,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10141,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10142,1,Mineral supplementation,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
10143,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10145,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10145,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
10146,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10147,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10147,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10147,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
10147,4,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
10148,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10148,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10149,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10150,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
10151,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10152,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10153,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
10153,2,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
10153,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10154,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10155,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
10155,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10156,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10156,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10156,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
10157,1,Headache,Headaches NEC,Headaches,Nerv,N
10157,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10157,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10158,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10159,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10160,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10161,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
10162,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10163,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10164,1,Migraine,Migraine headaches,Headaches,Nerv,N
10165,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10166,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10166,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10166,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10167,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10168,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10168,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10169,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10170,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10170,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10171,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10172,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10173,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10173,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10174,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10174,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10175,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
10175,2,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10176,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
10176,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10177,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10177,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10177,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10177,4,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
10177,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10177,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
10177,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10177,8,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
10178,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10179,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10180,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10180,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10181,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10182,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10183,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10184,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10184,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10185,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10185,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10186,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
10187,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10187,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
10187,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10188,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10188,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10189,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10189,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10189,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
10189,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10189,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10189,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10189,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
10190,1,Vulval cancer stage 0,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
10191,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10191,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
10191,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10192,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
10192,2,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
10193,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10193,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10193,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10194,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10195,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10195,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10196,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
10197,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10197,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10197,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10198,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10198,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10199,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
10200,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10200,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10200,3,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10201,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
10201,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10201,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10202,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10202,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10203,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10203,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10204,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10205,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10205,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10205,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
10205,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10206,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10207,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10207,2,Nasal pruritus,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
10207,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10207,4,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
10208,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10208,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10209,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10210,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10210,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10210,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10210,4,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10211,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10211,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10211,3,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10212,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10213,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10213,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10214,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10214,2,Spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10214,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10215,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10216,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10217,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10218,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10219,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10220,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10221,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10221,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10222,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10223,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10224,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
10224,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
10225,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10225,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10226,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10227,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10228,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10228,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10229,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10230,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10230,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10230,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10230,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
10230,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10231,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10231,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10232,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10232,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
10232,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10233,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10234,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10235,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10236,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10237,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10238,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10239,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10240,1,Hip surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10241,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
10241,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
10241,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
10241,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10242,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10242,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10242,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10243,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10243,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10244,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10244,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10245,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10245,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
10246,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10246,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10247,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10248,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10249,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
10250,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10251,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10251,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10251,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10251,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10252,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10253,1,Foot operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10253,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10253,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10253,4,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10254,1,Limbal swelling,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10255,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10255,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
10255,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10256,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10256,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10257,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10258,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10259,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10259,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10260,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10261,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10262,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10263,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10264,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10264,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10264,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10264,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10264,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10265,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10266,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10267,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10267,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
10268,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10269,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10270,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10271,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10271,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10272,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10272,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
10272,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10272,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10272,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10272,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
10272,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10272,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10272,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10272,10,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
10272,11,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
10272,12,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10272,13,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
10272,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
10272,15,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
10272,16,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10272,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10272,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10272,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10272,20,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10272,21,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10272,22,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10272,23,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10273,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10273,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10273,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
10274,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10274,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10275,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10275,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10275,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10275,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10275,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10275,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10276,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
10277,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
10278,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10278,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10279,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
10279,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10280,1,Brain stem glioma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
10280,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10281,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10282,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
10283,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10283,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10283,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10284,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10284,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10285,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10285,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10286,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10287,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10287,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10288,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10289,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10290,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10291,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10291,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
10291,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
10291,4,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
10291,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
10292,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10293,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10294,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10295,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10295,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10296,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10297,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10297,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10298,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
10298,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
10298,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10298,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10298,5,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10298,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10299,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10299,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10300,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
10301,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10301,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10301,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10302,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10303,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10304,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10305,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10305,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10305,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10306,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
10307,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10308,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10308,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10309,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10309,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10309,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10309,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10309,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10309,6,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10310,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10310,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
10311,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10311,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10312,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10313,1,Mole excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
10314,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10315,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10316,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10317,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10318,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10319,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10320,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
10321,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10322,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10322,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10322,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
10322,4,Headache,Headaches NEC,Headaches,Nerv,N
10322,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10322,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
10322,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10322,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10323,1,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
10324,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10324,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10325,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
10326,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10327,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10328,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10328,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10329,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10329,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
10329,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10329,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10329,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10330,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10331,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10332,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10333,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10333,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10333,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10334,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10334,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10334,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10334,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10334,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10334,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10335,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
10335,2,Non-alcoholic fatty liver,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10336,1,Deafness,Hearing losses,Hearing disorders,Ear,N
10337,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
10338,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10339,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
10340,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10340,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10340,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10341,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
10341,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
10342,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10343,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10343,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10344,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10344,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
10344,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10345,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
10346,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10346,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10347,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10348,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10349,1,Deafness,Hearing losses,Hearing disorders,Ear,N
10349,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10350,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10350,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10350,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10350,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10350,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10350,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10351,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10351,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10352,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
10352,2,Herpes ophthalmic,Herpes viral infections,Viral infectious disorders,Infec,N
10353,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
10354,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10354,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10354,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10355,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10355,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10356,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10356,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10356,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10357,1,Deafness,Hearing losses,Hearing disorders,Ear,N
10358,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
10359,1,Nasal operation,Nasal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10360,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10361,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10361,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10362,1,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
10363,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10364,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10364,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10365,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10366,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
10367,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10368,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10369,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10370,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10371,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10372,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10372,2,Muscle abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
10373,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10373,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10373,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10373,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10374,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10374,2,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
10375,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
10376,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10377,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
10377,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10377,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10377,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10378,1,Juvenile idiopathic arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10379,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10380,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10380,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10381,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10382,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10383,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10383,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10384,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10385,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
10386,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10387,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
10388,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
10389,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10389,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10390,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10391,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10392,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10393,1,Anal erythema,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
10393,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
10393,3,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
10393,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10393,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10393,6,Large intestinal stenosis,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
10393,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10394,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10394,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10394,3,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10394,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10395,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10396,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10397,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10398,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10398,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10399,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
10400,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10400,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10400,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
10400,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10400,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10400,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10400,7,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10401,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10401,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10401,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10402,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10403,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10404,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10404,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10405,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10405,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10406,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10406,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10407,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
10408,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10408,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10409,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
10409,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10409,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
10410,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10411,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10411,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10411,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10411,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
10411,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
10412,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10413,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10413,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10414,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10415,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10415,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10416,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10417,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10418,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10419,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10420,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10420,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10421,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10422,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10423,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10423,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10424,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10424,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10424,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10425,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10426,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10426,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10427,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10428,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10429,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10430,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10431,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
10431,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10432,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10433,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10433,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10434,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10435,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10436,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10436,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
10436,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10437,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10437,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10438,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10438,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10439,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10440,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10440,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10441,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10442,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10443,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10443,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10444,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10444,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10445,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10445,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10446,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10447,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10447,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10447,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10449,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10450,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
10451,1,Device issue,Device issues NEC,Device issues,Prod,N
10451,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10451,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10452,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10452,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10452,3,Headache,Headaches NEC,Headaches,Nerv,N
10452,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10452,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10453,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10454,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10454,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10455,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
10455,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10455,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10455,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10455,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10456,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10456,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10457,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10457,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10458,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10459,1,Trigger finger,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
10460,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
10461,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10462,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10463,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10463,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10464,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10465,1,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10465,2,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10465,3,Fistula of small intestine,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
10465,4,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10465,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10466,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10466,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10467,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10468,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10468,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10468,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10468,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10469,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10470,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10471,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10471,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10472,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10473,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10473,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10474,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10474,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10475,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10476,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
10477,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10478,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10478,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10478,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10479,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10479,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10480,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
10481,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
10481,2,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10482,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10482,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
10482,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
10482,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10482,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10482,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10483,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
10484,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10484,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10485,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10486,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10486,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10486,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10486,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10486,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10487,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10487,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10487,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10487,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10487,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10488,1,Nasal operation,Nasal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10489,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10490,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
10491,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10491,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10492,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10493,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10494,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10494,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10495,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10495,2,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
10495,3,Histoplasmosis disseminated,Histoplasma infections,Fungal infectious disorders,Infec,N
10496,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10496,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10497,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10497,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10498,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
10498,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10499,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10499,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10499,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10499,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
10500,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
10500,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10501,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
10502,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10502,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
10502,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10502,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10502,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10502,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10503,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10504,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10505,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10506,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10506,2,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10506,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10507,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10507,2,Headache,Headaches NEC,Headaches,Nerv,N
10507,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10508,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10509,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10510,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
10511,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
10511,2,Migraine,Migraine headaches,Headaches,Nerv,N
10512,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10512,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
10512,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10512,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10513,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10514,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10514,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10515,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10515,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
10516,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10516,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10516,3,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
10516,4,Bedridden,Disability issues,Lifestyle issues,SocCi,N
10516,5,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10516,6,Blood zinc decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10516,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10516,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10516,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
10516,10,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
10516,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10516,12,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
10516,13,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
10516,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10516,15,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10516,16,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
10516,17,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10517,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10517,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
10518,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10518,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10518,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10519,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10519,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10521,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10522,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10522,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10523,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10523,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10524,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
10525,1,Arthritis enteropathic,Arthropathies NEC,Joint disorders,Musc,N
10525,2,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
10525,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10525,4,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
10526,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10526,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10527,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
10527,2,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10528,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10528,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10528,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10529,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
10530,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10530,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10531,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10532,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10533,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10534,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
10534,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
10534,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10534,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10534,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10534,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10534,7,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10534,8,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
10534,9,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10534,10,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
10534,11,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
10534,12,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10534,13,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10534,14,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10534,15,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10534,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10534,17,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
10534,18,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
10534,19,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10535,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10535,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10535,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10535,4,Enterocutaneous fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
10535,5,Faecal calprotectin abnormal,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10535,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10535,7,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
10535,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10536,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10536,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10536,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10536,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10536,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
10537,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10538,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10538,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10538,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10539,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10539,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10540,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
10541,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10542,1,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10543,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10544,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10545,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10545,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10546,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10547,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
10548,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10548,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10548,3,Vascular graft,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
10549,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10549,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10550,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10550,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10550,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10550,4,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10550,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10551,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10552,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10552,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10553,1,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10554,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10555,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
10555,2,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10556,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10556,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10556,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10556,4,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10557,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10558,1,Eosinophilic cellulitis,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
10558,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10558,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
10558,4,Tuberculin test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
10558,5,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
10559,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10559,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10559,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10560,1,Axial spondyloarthritis,Spondyloarthropathies,Joint disorders,Musc,N
10560,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10560,3,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10560,4,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10560,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10561,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10561,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10561,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10561,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10561,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10562,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
10562,2,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
10562,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
10562,4,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
10562,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10562,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10563,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
10563,2,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
10563,3,Blau syndrome,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
10563,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
10563,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
10563,6,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10563,7,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10563,8,Headache,Headaches NEC,Headaches,Nerv,N
10563,9,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10563,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10563,11,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10563,12,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10564,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10564,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
10564,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10564,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10564,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10564,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
10564,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10565,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
10565,2,Bronchial wall thickening,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
10565,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
10565,4,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
10565,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10565,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10565,7,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10566,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10566,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
10566,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
10567,1,Bronchial disorder,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
10568,1,Arthritis enteropathic,Arthropathies NEC,Joint disorders,Musc,N
10568,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10568,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10568,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10568,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10569,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10569,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10570,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10571,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10571,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10572,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10572,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10572,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10572,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
10572,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10572,6,Sacral pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10572,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10573,1,Headache,Headaches NEC,Headaches,Nerv,N
10573,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10573,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10573,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10573,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10574,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10575,1,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10575,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10576,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10576,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10576,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10577,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
10577,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10577,3,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
10577,4,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
10577,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10577,6,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
10577,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10577,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10578,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10578,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10578,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10578,4,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10578,5,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10578,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
10578,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10579,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10580,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10581,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10582,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10583,1,Colonoscopy,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
10584,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10584,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10584,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10585,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10585,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10585,3,Enthesopathy,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
10585,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10585,5,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
10585,6,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10585,7,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
10585,8,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10585,9,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
10585,10,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10585,11,Vertebral lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
10586,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10587,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10588,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10589,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
10589,2,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10590,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10591,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10591,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10591,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10591,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10592,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
10592,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10593,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10594,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
10595,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
10595,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10595,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10596,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10597,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10597,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10597,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10597,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10598,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10599,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10599,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10600,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10600,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10601,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10601,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
10601,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10602,1,Gallbladder operation,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
10603,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10604,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10604,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10605,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
10605,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10606,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10606,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10607,1,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
10607,2,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
10608,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10608,2,Gastrointestinal bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10608,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10608,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10608,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10608,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10609,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10609,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10609,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10610,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
10611,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10611,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10612,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10612,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10612,3,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10613,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10613,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
10614,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10614,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10615,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10615,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10616,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
10617,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10617,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10617,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10618,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10618,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10618,3,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10618,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
10618,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
10618,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10619,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10620,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10620,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10620,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10620,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10620,5,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10620,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10621,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
10621,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10621,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10621,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10621,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10621,6,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10621,7,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10622,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10623,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
10624,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10625,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10625,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10625,3,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10626,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10626,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10626,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
10626,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
10627,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10627,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10628,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10628,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10629,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10630,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10632,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10632,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10632,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10633,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
10633,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10633,3,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
10633,4,Myopathy,Myopathies,Muscle disorders,Musc,N
10633,5,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
10633,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10633,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10633,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10634,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10634,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10635,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10636,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10637,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10638,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10638,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10638,3,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
10638,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10639,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10640,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10640,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10641,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10642,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10643,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10643,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10643,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10643,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10643,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10644,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10645,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10645,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10645,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10646,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10646,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10647,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10648,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10648,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10649,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10650,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10651,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10652,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10652,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
10652,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10652,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10653,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10654,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10654,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10655,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10655,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10656,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10656,2,Headache,Headaches NEC,Headaches,Nerv,N
10656,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
10656,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10656,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10657,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10658,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10658,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10659,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10659,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10660,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10661,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10661,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10662,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10662,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10662,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10663,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10664,1,Headache,Headaches NEC,Headaches,Nerv,N
10664,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
10664,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10664,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
10665,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10666,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
10666,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10666,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10667,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10668,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10668,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
10668,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
10669,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10669,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
10669,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10669,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10669,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10669,6,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10670,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10670,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10670,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10670,4,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
10670,5,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10670,6,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10670,7,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10670,8,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
10670,9,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
10670,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
10670,11,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
10670,12,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10670,13,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
10670,14,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
10670,15,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10670,16,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
10670,17,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10670,18,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10670,19,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10670,20,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10670,21,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
10670,22,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10670,23,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10670,24,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10670,25,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10670,26,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10670,27,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10670,28,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10670,29,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10670,30,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10670,31,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10670,32,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
10670,33,Headache,Headaches NEC,Headaches,Nerv,N
10670,34,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
10670,35,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10670,36,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10670,37,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
10670,38,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
10670,39,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10670,40,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10670,41,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10670,42,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10670,43,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
10670,44,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10670,45,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
10670,46,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10670,47,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,48,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,49,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10670,50,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10670,51,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10670,52,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10670,53,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10670,54,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
10670,55,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10670,56,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10670,57,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
10670,58,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
10670,59,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10670,60,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
10670,61,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10670,62,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,63,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,64,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,65,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10670,66,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10671,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10671,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
10671,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10672,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10673,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10674,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10674,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
10675,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10675,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10675,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10676,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
10677,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10677,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10677,3,Ileal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
10677,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10678,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10679,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10680,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
10681,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
10682,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10682,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
10682,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10682,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10682,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10682,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10682,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10682,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10683,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10683,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10683,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10683,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10683,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10683,6,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
10683,7,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
10683,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10683,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
10683,10,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
10684,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10684,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10684,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10685,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
10686,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
10686,2,Migraine,Migraine headaches,Headaches,Nerv,N
10687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10688,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10688,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10689,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10690,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10691,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10691,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10692,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10693,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10694,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10694,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10695,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10696,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10697,1,Wrist surgery,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10698,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
10698,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10698,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
10698,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10698,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10699,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10699,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
10699,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10699,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10699,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10699,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
10699,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10699,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10699,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10699,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10699,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
10699,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10699,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10699,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10699,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10699,16,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10699,17,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10699,18,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10699,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10700,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10700,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10701,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10701,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10702,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
10703,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
10704,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10704,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10704,3,Incorrect disposal of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10704,4,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10704,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10704,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10705,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10706,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10707,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10708,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
10709,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10710,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10710,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10711,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10712,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10712,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10712,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
10713,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10714,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10715,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10715,2,Ear congestion,Ear disorders NEC,Aural disorders NEC,Ear,N
10715,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10715,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
10715,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10716,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10717,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10718,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10719,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10720,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10721,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10722,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10723,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10724,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10724,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10724,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10724,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10724,5,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
10725,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10725,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10726,1,Extramammary Paget's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10726,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10727,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10727,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
10727,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10728,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10728,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10729,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
10730,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10730,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10730,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10730,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10730,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10730,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
10730,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
10730,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
10730,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10730,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10730,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
10731,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10732,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10732,2,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
10732,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10733,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10734,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10734,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10734,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10735,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10735,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10735,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10735,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10735,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10735,6,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
10735,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
10735,8,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
10735,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
10735,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10735,11,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
10735,12,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
10736,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
10737,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10738,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10738,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10739,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10740,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10741,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10741,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
10741,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
10741,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10741,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10741,6,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
10742,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10742,2,Extramammary Paget's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10742,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
10743,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10743,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
10744,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10745,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10746,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10747,1,Extramammary Paget's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10747,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10748,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10749,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10749,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10750,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10750,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
10750,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10750,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10750,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10751,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10751,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10752,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10752,2,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10752,3,Photodermatosis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
10752,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10752,5,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
10752,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10753,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
10754,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10754,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10755,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
10755,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10756,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10756,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10756,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10757,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10758,1,Colonoscopy,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
10758,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10759,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
10759,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
10759,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10759,4,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
10760,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10760,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10761,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10762,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
10762,2,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
10763,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10764,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10764,2,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10764,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10765,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10765,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10765,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10765,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10765,5,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10765,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10766,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10767,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10768,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10769,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10770,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10770,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10771,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10771,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10771,3,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
10771,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10772,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
10773,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10774,1,Bleeding time,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10774,2,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10774,3,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
10774,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10774,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10774,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
10775,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10776,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10776,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10776,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10776,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10777,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
10777,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
10777,3,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10777,4,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10777,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10777,6,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10777,7,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
10777,8,Palmoplantar pustulosis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10777,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10777,10,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10777,11,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10777,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10777,13,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10777,14,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10777,15,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10777,16,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10778,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10779,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10780,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10781,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10782,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10783,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10783,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10783,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
10784,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10785,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
10786,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10786,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10787,1,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
10787,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10788,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10789,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10790,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10791,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10791,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10792,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10792,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
10792,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10792,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
10793,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
10793,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10794,1,Migraine,Migraine headaches,Headaches,Nerv,N
10795,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10795,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10796,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10796,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10796,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10796,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10797,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
10797,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10797,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10797,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10797,5,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
10797,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10797,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
10797,8,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
10797,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10797,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
10797,11,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
10797,12,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
10798,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
10798,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10798,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10798,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10798,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10798,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
10798,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
10798,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10798,9,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10798,10,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10798,11,Headache,Headaches NEC,Headaches,Nerv,N
10798,12,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10798,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10798,14,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10799,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10799,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10799,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10800,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10801,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10802,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10803,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10804,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10804,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10805,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
10806,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10807,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10807,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10808,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10809,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10810,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
10810,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10810,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10810,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10811,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10811,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10811,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10811,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10812,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10812,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10813,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10814,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10814,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10814,3,Headache,Headaches NEC,Headaches,Nerv,N
10814,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10814,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10815,1,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
10816,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10817,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10818,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10819,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10820,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10820,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
10821,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10822,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10822,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10823,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
10824,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
10825,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10826,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10826,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10827,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
10827,2,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10827,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10827,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10828,1,Miscarriage of partner,Family and partner issues,Family issues,SocCi,N
10829,1,Bovine tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10829,2,Headache,Headaches NEC,Headaches,Nerv,N
10829,3,Junctional ectopic tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10829,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
10829,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
10829,6,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10829,7,Spleen tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10829,8,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10829,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10830,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10830,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10831,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10831,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10832,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10832,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10833,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10834,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
10835,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10836,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
10836,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
10836,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10836,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10837,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
10837,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10838,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
10838,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10838,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
10838,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
10838,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10838,6,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10838,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10839,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10839,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10839,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10839,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10840,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10840,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10842,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
10842,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
10843,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
10843,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10843,3,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
10843,4,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
10844,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10844,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10844,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
10844,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10845,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10846,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10847,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
10847,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10847,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10847,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
10848,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10848,2,Pneumonitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
10849,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10849,2,Adenosine deaminase 2 deficiency,Autoinflammatory diseases,Immune disorders NEC,Immun,N
10849,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10849,4,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10849,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10849,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10850,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10850,2,Adenosine deaminase 2 deficiency,Autoinflammatory diseases,Immune disorders NEC,Immun,N
10850,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10850,4,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10850,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10850,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10851,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10852,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10853,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10854,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10855,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10856,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10857,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10858,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10859,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10859,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
10860,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
10861,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10862,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10863,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
10864,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10865,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10865,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10865,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10865,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10865,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10866,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10866,2,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
10866,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10866,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10866,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10866,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10867,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10867,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10867,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10868,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10868,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10869,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10869,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10870,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10870,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10870,3,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
10870,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10870,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10870,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10871,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10871,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
10871,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10872,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10873,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10873,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10873,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10874,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10875,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
10876,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
10877,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10878,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10878,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10879,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10879,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10879,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10879,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10880,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10880,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10881,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10881,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10881,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10882,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10882,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10882,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10883,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10884,1,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10884,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10884,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10885,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10885,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10886,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10887,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10888,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10888,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
10888,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10888,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10888,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10889,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
10889,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
10889,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10890,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10890,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10890,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10890,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10890,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10890,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10891,1,Antibody test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
10891,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10892,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10892,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10892,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10892,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10893,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10893,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10893,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10894,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10895,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10896,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10896,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10896,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10896,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10897,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10897,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10897,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10897,4,Pilonidal disease,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
10898,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10898,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10898,3,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10898,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
10898,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10898,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10898,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10899,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10899,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10899,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10899,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10899,5,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
10899,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10899,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10900,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10900,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
10900,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
10900,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10900,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10900,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
10901,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10902,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10902,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10902,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
10902,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
10903,1,Headache,Headaches NEC,Headaches,Nerv,N
10903,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10904,1,Intercepted product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10904,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
10904,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
10904,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10905,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10906,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
10907,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10907,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10908,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10908,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10909,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10909,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
10910,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10910,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10911,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
10912,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10912,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10913,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10914,1,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
10915,1,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
10916,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10917,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10917,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10918,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
10919,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10920,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10921,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
10921,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10922,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10922,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10922,3,Headache,Headaches NEC,Headaches,Nerv,N
10922,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
10922,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10923,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
10923,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10924,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
10924,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
10924,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10924,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10925,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10925,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10926,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10927,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10927,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10928,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
10928,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10928,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10928,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10929,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10930,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10930,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10930,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10931,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10931,2,Ligament injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
10931,3,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
10931,4,Tendon injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
10932,1,Headache,Headaches NEC,Headaches,Nerv,N
10933,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10934,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
10934,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10934,3,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
10934,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10935,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10936,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10937,1,Premature ageing,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10937,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10937,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10938,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
10938,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10938,3,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10938,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10938,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10939,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
10939,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10939,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
10939,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10940,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10941,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10942,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
10943,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
10944,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10945,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10946,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10947,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10947,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10947,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10947,4,Headache,Headaches NEC,Headaches,Nerv,N
10947,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
10947,6,Myofascial pain syndrome,Muscle pains,Muscle disorders,Musc,N
10947,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10947,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10947,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
10948,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10948,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10948,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
10948,4,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
10949,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10950,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10951,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
10951,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10952,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10953,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10953,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10954,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10955,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10955,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10956,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10957,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10958,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10959,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
10960,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10961,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10962,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10962,2,Headache,Headaches NEC,Headaches,Nerv,N
10962,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
10962,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10963,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10964,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10965,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
10965,2,Teeth brittle,Dental disorders NEC,Dental and gingival conditions,Gastr,N
10966,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10967,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10967,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10968,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
10969,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10969,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
10969,3,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10970,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10970,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10970,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10971,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10971,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10972,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
10973,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10973,2,Paradoxical psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10974,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
10974,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10974,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10975,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
10976,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
10977,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
10977,2,Headache,Headaches NEC,Headaches,Nerv,N
10978,1,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
10978,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
10978,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10978,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10979,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10980,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10980,2,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
10981,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10982,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10982,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10982,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10982,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
10982,5,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
10982,6,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
10983,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
10984,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10984,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
10984,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
10985,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
10986,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10986,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10987,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10988,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10989,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10989,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10989,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
10989,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10990,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
10990,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10991,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
10991,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
10991,3,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
10991,4,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
10991,5,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
10992,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
10992,2,Neurosarcoidosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
10992,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
10993,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
10993,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
10994,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10994,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10995,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
10995,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
10996,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10997,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
10997,2,Headache,Headaches NEC,Headaches,Nerv,N
10998,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10999,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10999,2,Angiotensin converting enzyme increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
10999,3,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
10999,4,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
10999,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10999,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
10999,7,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
10999,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10999,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10999,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10999,11,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
11000,1,Headache,Headaches NEC,Headaches,Nerv,N
11001,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11001,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11001,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11001,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11002,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11002,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11003,1,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11003,2,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11003,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11004,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11004,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11005,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
11005,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11006,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11006,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11006,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11006,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11007,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11008,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11008,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11008,3,Headache,Headaches NEC,Headaches,Nerv,N
11008,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11008,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11009,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11010,1,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11010,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11011,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11012,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11013,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11013,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11013,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
11013,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11014,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11015,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11015,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11016,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11016,2,Foetal malformation,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,Y
11016,3,Intestinal malrotation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
11016,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11017,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11018,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11019,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11020,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11020,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11020,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11021,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
11022,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11022,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11022,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11023,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11023,2,Headache,Headaches NEC,Headaches,Nerv,N
11023,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11024,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11024,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11025,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11026,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
11027,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11027,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11027,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11027,4,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
11027,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11028,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,Y
11029,1,Biopsy bladder,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
11029,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11030,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
11031,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
11032,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11033,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
11034,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11035,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11035,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
11036,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
11037,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11037,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11037,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11037,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11038,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
11038,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11039,1,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
11040,1,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
11041,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11041,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11042,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11043,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
11043,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
11044,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11045,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11045,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11046,1,Headache,Headaches NEC,Headaches,Nerv,N
11046,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
11046,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11047,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11047,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11047,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11047,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11048,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11048,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
11048,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11049,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
11050,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11051,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11051,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11052,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11052,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11052,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11053,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11053,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11053,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11053,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11054,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
11054,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11055,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11056,1,Headache,Headaches NEC,Headaches,Nerv,N
11057,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11057,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11057,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11057,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11057,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11057,6,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11057,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11057,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11057,9,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11057,10,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
11057,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11057,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11057,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11058,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11058,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11059,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11059,2,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
11059,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11060,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11060,2,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
11061,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11061,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11061,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11062,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11063,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11063,2,Deafness,Hearing losses,Hearing disorders,Ear,N
11063,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11064,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11064,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11065,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11066,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11066,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11067,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11068,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11068,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11068,3,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11069,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11070,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11070,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11070,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11071,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
11072,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11072,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11072,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11072,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11072,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11073,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
11074,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11074,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11074,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11075,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
11075,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
11075,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11076,1,Antiviral treatment,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11077,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11078,1,Colonoscopy,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
11079,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11080,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11080,2,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
11081,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11082,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11082,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11083,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11084,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11085,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11086,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
11086,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11086,3,Headache,Headaches NEC,Headaches,Nerv,N
11086,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11087,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11087,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11088,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11089,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11089,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11089,3,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
11089,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11089,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11089,6,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
11089,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11090,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11091,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11092,1,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11093,1,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
11094,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11095,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11096,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11096,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11097,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11097,2,Viral diarrhoea,Viral infections NEC,Viral infectious disorders,Infec,N
11098,1,Migraine,Migraine headaches,Headaches,Nerv,N
11099,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11100,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11100,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11100,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
11101,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11102,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11102,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11103,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11104,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11105,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11106,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11107,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11108,1,Bile duct stone,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
11109,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11109,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11110,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11110,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11111,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11111,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11112,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11112,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11112,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11112,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
11113,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11114,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
11114,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11115,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11115,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11116,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
11117,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11118,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11119,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11119,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11119,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11120,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11121,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11121,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11122,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
11123,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11124,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
11125,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11125,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11126,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11126,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11126,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11126,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11127,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11127,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11128,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11128,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11129,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11129,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11130,1,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11130,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11131,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11132,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11133,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11133,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11133,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11134,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11134,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11134,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11135,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11135,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11136,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11137,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11138,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
11139,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11139,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
11139,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11139,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11139,5,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11140,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
11140,2,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11140,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
11141,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11141,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11141,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11141,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11142,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11142,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11143,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11143,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11144,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
11145,1,Headache,Headaches NEC,Headaches,Nerv,N
11146,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
11146,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
11147,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11148,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11149,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11150,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11151,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11151,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11151,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11152,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
11153,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11153,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
11154,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11154,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11155,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11156,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11157,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11158,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11159,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11160,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11160,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11161,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
11162,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11163,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11163,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11164,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11164,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11165,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11166,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11167,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11167,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11168,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11169,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11170,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11171,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
11171,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11172,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11172,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11173,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11174,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11174,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11174,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11174,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11174,5,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
11174,6,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11175,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11176,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11176,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11177,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11177,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
11177,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11177,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11177,5,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
11177,6,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
11178,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11178,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11179,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11179,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11180,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11180,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11180,3,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11181,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
11182,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11182,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
11183,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11184,1,Bartholin's cyst,Vulvovaginal cysts and neoplasms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
11184,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11184,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11184,4,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11184,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11184,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11184,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11185,2,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11185,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
11185,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
11186,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
11187,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
11188,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11189,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11189,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11190,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11190,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
11190,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11191,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11191,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11191,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11191,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11191,5,Toe operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11192,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
11193,1,Ankylosing spondylitis,Spondyloarthropathies,Joint disorders,Musc,N
11193,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11194,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
11195,1,Headache,Headaches NEC,Headaches,Nerv,N
11195,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11196,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11196,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11197,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11197,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11198,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11198,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11198,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11198,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11199,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
11199,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11200,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11201,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11202,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11202,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11203,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11203,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11203,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11203,4,Headache,Headaches NEC,Headaches,Nerv,N
11203,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11204,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11204,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11205,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11205,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11206,1,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11207,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11208,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
11208,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
11208,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11209,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11210,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11210,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11210,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11210,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11211,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11211,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
11211,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11211,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
11211,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11212,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11213,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11213,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11214,1,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11214,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11215,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11216,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11217,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11217,2,Medical procedure,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11217,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11218,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11218,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11219,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
11220,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11221,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11222,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
11222,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
11222,3,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
11222,4,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
11222,5,Gestational hypertension,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
11222,6,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
11222,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11222,8,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
11222,9,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
11223,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11223,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11224,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11225,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11226,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11227,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11228,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11228,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11229,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11229,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11230,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11231,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11231,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11233,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11234,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11235,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11235,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11236,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11237,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11238,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11238,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11238,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11239,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11239,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11239,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11240,1,Dental care,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11241,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11241,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11241,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11242,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
11243,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11244,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11244,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11245,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
11245,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11246,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11247,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11247,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11247,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11248,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11249,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11249,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11250,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11251,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11251,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11252,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11253,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11253,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
11253,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
11253,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11254,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11254,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11254,3,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
11254,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11255,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11255,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11255,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11255,4,Headache,Headaches NEC,Headaches,Nerv,N
11255,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11256,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11256,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11256,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11257,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11258,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11258,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11259,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11259,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11259,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11260,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11260,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11261,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11261,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11262,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11263,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11264,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11264,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11265,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11266,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11266,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11266,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
11266,4,White blood cell analysis abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11267,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11268,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11269,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11270,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11271,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11272,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11272,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11272,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11272,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11272,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
11273,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11274,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11274,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11274,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11275,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
11275,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11275,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11275,4,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
11276,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11276,2,Shoulder arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11277,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11277,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11277,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11277,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
11277,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11278,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11278,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11278,3,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
11279,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11279,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11279,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11280,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11280,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11281,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11281,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11281,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11282,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11282,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11282,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
11282,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11282,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11282,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
11282,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11283,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11284,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11284,2,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11284,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11284,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11285,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11285,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11286,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11287,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11287,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11288,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11288,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11289,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11289,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11290,1,Deafness,Hearing losses,Hearing disorders,Ear,N
11291,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11291,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11291,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11292,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11292,2,Genital candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11292,3,Headache,Headaches NEC,Headaches,Nerv,N
11292,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11292,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11292,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11292,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11293,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11293,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11294,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11295,1,Device issue,Device issues NEC,Device issues,Prod,N
11295,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
11295,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11296,1,Blood pressure systolic inspiratory decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
11296,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11297,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11298,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11298,2,Scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11299,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11299,2,Viral diarrhoea,Viral infections NEC,Viral infectious disorders,Infec,N
11300,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
11301,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11302,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11302,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11303,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11303,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11303,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11304,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11305,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11305,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11306,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11307,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11308,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
11309,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11310,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11310,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11310,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11310,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11311,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
11312,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11313,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11313,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11313,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11314,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11315,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11315,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11315,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11315,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11316,1,Headache,Headaches NEC,Headaches,Nerv,N
11316,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11316,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11316,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11317,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11317,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11318,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11318,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11319,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11320,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11320,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11321,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11322,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11322,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11323,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11323,2,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11324,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11324,2,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
11325,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
11325,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11326,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11327,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11327,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
11328,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
11328,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11328,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11329,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11330,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11330,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11331,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11332,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11333,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11333,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11334,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11335,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11336,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11336,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11337,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11338,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11339,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11339,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11339,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11339,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11340,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11341,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
11341,2,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
11342,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
11342,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11342,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11343,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
11343,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11343,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11343,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
11343,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11343,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
11344,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11344,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
11345,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11346,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11347,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11348,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11348,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11348,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11349,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11349,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11350,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11350,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11351,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11351,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11352,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
11353,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11354,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11354,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11355,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11355,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11355,3,Tension headache,Headaches NEC,Headaches,Nerv,N
11356,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11356,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11356,3,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
11356,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11356,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11356,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11357,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11358,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11359,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11359,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11359,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11359,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11359,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11360,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11361,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
11361,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11362,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11362,2,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
11362,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11362,4,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
11363,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11364,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11364,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
11364,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11365,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11365,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11366,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11366,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11367,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11368,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11368,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11369,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
11369,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11369,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11369,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11370,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11370,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11371,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11372,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11372,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11373,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11374,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11374,2,Headache,Headaches NEC,Headaches,Nerv,N
11375,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11376,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11377,1,Hypertrophic scar,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
11377,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11378,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11379,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11379,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11380,1,Incorrect disposal of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11380,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11381,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11382,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11382,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11383,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11384,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11384,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
11384,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11385,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11386,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11386,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
11387,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11387,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11387,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11388,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11389,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11389,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11390,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
11390,2,Subacute inflammatory demyelinating polyneuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
11391,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
11392,1,Subacute inflammatory demyelinating polyneuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
11393,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11394,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
11394,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11395,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11395,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11395,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11396,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11397,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
11398,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
11398,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11399,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
11400,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11401,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11402,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11402,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11402,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11403,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11403,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11403,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
11404,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11404,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11405,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11405,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11406,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11407,1,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
11408,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11408,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11409,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11410,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11411,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11412,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11413,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11414,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11414,2,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11414,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11415,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11416,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11417,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11418,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
11418,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11418,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11419,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11419,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11420,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11421,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11421,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11421,3,Endodontic procedure,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11421,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
11421,5,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11421,6,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
11422,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11422,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11422,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11423,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11424,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11425,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11425,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11425,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11426,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11427,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11428,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11428,2,Lyme disease,Borrelial infections,Bacterial infectious disorders,Infec,N
11429,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11430,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
11430,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11431,1,Axial spondyloarthritis,Spondyloarthropathies,Joint disorders,Musc,N
11431,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11431,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11432,1,Fracture delayed union,Fracture complications,Fractures,Musc,N
11432,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
11433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11433,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11433,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11434,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11434,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
11434,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11435,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11436,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11437,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11437,2,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
11438,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
11439,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
11440,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11441,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
11441,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
11442,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11442,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11442,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11443,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11443,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11444,1,Headache,Headaches NEC,Headaches,Nerv,N
11445,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11445,2,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
11446,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
11446,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11446,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
11447,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
11448,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11449,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11449,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11450,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11450,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11451,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11451,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11451,3,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
11452,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11453,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11454,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11455,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11455,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11456,1,Headache,Headaches NEC,Headaches,Nerv,N
11456,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11457,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
11458,1,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
11459,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
11459,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11460,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11461,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
11462,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
11462,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11462,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11462,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11462,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11462,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11462,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11462,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11462,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11463,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11463,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11464,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
11465,1,Benign neoplasm,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
11466,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11466,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11467,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11468,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11469,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11470,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11471,1,Alcohol problem,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
11472,1,Genital disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
11472,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11472,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11473,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11473,2,Headache,Headaches NEC,Headaches,Nerv,N
11474,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11475,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11476,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11477,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11477,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
11477,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11477,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11478,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11478,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
11478,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11478,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11478,5,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
11478,6,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
11479,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11479,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11480,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11481,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
11481,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
11481,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
11482,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11482,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11482,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11482,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11482,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11483,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11484,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11485,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11486,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11487,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11487,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11488,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11488,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11489,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11489,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11490,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11491,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11491,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11492,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
11493,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
11494,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11495,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11496,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11496,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11496,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11497,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11498,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11499,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11500,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11501,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11501,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11501,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11502,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11503,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11504,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11504,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11504,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11504,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11505,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
11505,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11505,3,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11505,4,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11506,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
11506,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11507,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11507,2,Headache,Headaches NEC,Headaches,Nerv,N
11507,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11507,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11508,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11509,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11509,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11510,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11510,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
11511,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
11511,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11512,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
11513,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11513,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11513,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11513,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11514,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
11515,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11516,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11517,1,Wisdom teeth removal,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11518,1,Thunderclap headache,Headaches NEC,Headaches,Nerv,N
11519,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11520,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
11521,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11522,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11523,1,Demyelinating polyneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
11524,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11524,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
11525,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11525,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11526,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11527,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11528,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
11528,2,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11529,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
11529,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
11529,3,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
11529,4,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11530,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11530,2,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11530,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11530,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11531,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11532,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
11532,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11532,3,Fear of falling,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
11532,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11533,1,Infection parasitic,Infections NEC,Infections - pathogen unspecified,Infec,N
11534,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11534,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11535,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11535,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11535,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11535,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11536,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11537,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11537,2,Pharyngitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
11537,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11538,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11539,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
11539,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11539,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11540,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
11541,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
11541,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11542,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
11543,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11543,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11543,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11544,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11544,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11545,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
11545,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11545,3,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
11545,4,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11546,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11546,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11547,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11547,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11547,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
11548,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
11549,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11549,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11549,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11549,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11549,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11549,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11549,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
11549,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11549,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11550,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11551,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11552,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11553,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11554,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11555,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11556,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
11557,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11558,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11558,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11559,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11559,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11560,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11560,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11561,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11561,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11562,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11562,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11563,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11564,1,Migraine,Migraine headaches,Headaches,Nerv,N
11565,1,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
11566,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11566,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11566,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11566,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11566,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11566,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11567,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11567,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
11568,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11568,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11569,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11569,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11570,1,Headache,Headaches NEC,Headaches,Nerv,N
11571,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11571,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11571,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
11572,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11572,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11572,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11573,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
11573,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11574,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11574,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11574,3,Headache,Headaches NEC,Headaches,Nerv,N
11574,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11574,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11574,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11575,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11575,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11576,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11577,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
11577,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11578,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11579,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
11580,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11581,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11581,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11582,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11583,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11583,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11584,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11584,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
11584,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
11584,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
11584,5,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11584,6,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11584,7,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11585,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11586,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11586,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11586,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11586,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11587,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11588,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
11589,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11590,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
11590,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11590,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
11590,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11590,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11591,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
11592,1,Intercepted product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11592,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11592,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
11593,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11594,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11595,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11596,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11597,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11597,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11598,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11598,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11599,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11599,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11600,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11600,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11600,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11600,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11601,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11601,2,Headache,Headaches NEC,Headaches,Nerv,N
11602,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11603,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11603,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11603,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
11603,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11603,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11604,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11604,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11605,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11605,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11605,3,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11606,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11607,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
11607,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11607,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11608,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11608,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11608,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
11608,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11608,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11609,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11609,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11610,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
11610,2,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
11611,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11611,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11611,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11611,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11611,5,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
11611,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11611,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
11611,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11611,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11612,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11612,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11612,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
11612,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11612,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11613,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
11614,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11615,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11615,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
11615,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
11616,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
11616,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11617,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11617,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
11617,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11617,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
11618,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
11618,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11618,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
11619,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
11620,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11620,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11620,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11621,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11621,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11621,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11622,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11622,2,Headache,Headaches NEC,Headaches,Nerv,N
11622,3,Migraine,Migraine headaches,Headaches,Nerv,N
11622,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11623,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11623,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11623,3,Thoracic operation,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
11624,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11625,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
11626,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
11626,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11627,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11627,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11627,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11629,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
11629,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11630,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11630,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11630,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
11631,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
11632,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11632,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11632,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11633,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11634,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11634,2,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11634,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11634,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11635,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11636,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11637,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11638,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11638,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11638,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11639,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11639,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11640,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11640,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11640,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11640,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11640,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
11640,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11640,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11640,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11640,9,Headache,Headaches NEC,Headaches,Nerv,N
11640,10,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11640,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11640,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11641,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11641,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11642,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11643,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
11644,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11645,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11645,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11646,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11647,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11647,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11648,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11649,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
11650,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11650,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11650,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11651,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11651,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11651,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
11651,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11651,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11652,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
11652,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
11652,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11653,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11653,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11654,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11654,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11654,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11654,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11654,5,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
11654,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11654,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11655,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11655,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
11656,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11656,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11657,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11658,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11659,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11660,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11661,1,Device issue,Device issues NEC,Device issues,Prod,N
11661,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11662,1,Nail psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11662,2,Onychomalacia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
11663,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11664,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11665,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
11666,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11667,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11668,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11668,2,Headache,Headaches NEC,Headaches,Nerv,N
11668,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11668,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11669,1,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11669,2,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11669,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11670,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11671,1,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11671,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11672,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
11672,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11673,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
11674,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11674,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11675,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11676,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11676,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
11677,1,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
11677,2,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11677,3,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11677,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11678,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11679,1,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
11680,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11680,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11680,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11681,1,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11681,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11682,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
11683,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
11683,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11684,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
11684,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11684,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11684,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11684,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11684,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11684,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11684,8,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11684,9,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
11684,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
11684,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11684,12,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11685,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11685,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11686,1,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11687,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11687,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11687,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
11688,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11688,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11689,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11690,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11691,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11691,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11692,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11693,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11694,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11695,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11695,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11695,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11695,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11695,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11696,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11697,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11697,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11697,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11698,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11698,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11698,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11698,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11699,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11700,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11701,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11701,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
11702,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11703,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11704,1,Headache,Headaches NEC,Headaches,Nerv,N
11704,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11705,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11706,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11707,1,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11707,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11708,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11708,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
11709,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
11709,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11709,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11710,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
11711,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11711,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
11712,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11712,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11713,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11713,2,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11713,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11713,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11714,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11715,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11715,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11716,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11716,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11716,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11716,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
11716,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11717,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11717,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11717,3,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11718,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11719,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11719,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11719,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
11719,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11720,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
11720,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11721,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11722,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
11722,2,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11723,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11723,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11724,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11725,1,Acne,Acnes,Skin appendage conditions,Skin,N
11726,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
11726,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11726,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11726,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11727,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11727,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11728,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11728,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11728,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
11728,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11729,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
11729,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11729,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11729,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11730,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
11731,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
11732,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11732,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11733,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
11733,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11734,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11735,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11735,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11735,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
11736,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11737,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
11738,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
11738,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
11739,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11739,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
11739,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11740,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11740,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
11741,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11741,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11741,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11741,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11741,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11742,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
11742,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11742,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11743,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11743,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11744,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
11745,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11746,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11746,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11747,1,Abortion of ectopic pregnancy,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
11747,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11747,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11748,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11749,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11750,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11750,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11750,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
11751,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11752,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11752,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11752,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
11752,4,Intestinal transit time decreased,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
11752,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11752,6,Spondyloarthropathy,Spondyloarthropathies,Joint disorders,Musc,N
11752,7,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11753,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11754,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
11754,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11755,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11755,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
11755,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11755,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11756,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11757,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11757,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11758,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
11759,1,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11760,1,Delayed delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
11760,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
11760,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11760,4,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11761,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11762,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11763,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11763,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11763,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11763,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11764,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11764,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
11765,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11766,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11767,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11768,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11768,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11768,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
11769,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
11770,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11770,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
11770,3,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
11770,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11771,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11771,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11771,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11772,1,Headache,Headaches NEC,Headaches,Nerv,N
11773,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11773,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11773,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11773,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11774,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11775,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11775,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11775,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11776,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11777,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
11778,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11778,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11779,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11779,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11779,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11780,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11781,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11781,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11782,1,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
11783,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
11784,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11785,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
11786,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11786,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11786,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11787,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
11788,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
11789,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11790,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11790,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11791,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
11791,2,Headache,Headaches NEC,Headaches,Nerv,N
11792,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11793,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11794,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11794,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
11794,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11794,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11794,5,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11795,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
11795,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
11795,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11795,4,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
11796,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
11796,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
11796,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
11797,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11797,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
11798,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11798,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11799,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11799,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11799,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11800,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11801,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11801,2,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
11801,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11801,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11801,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11801,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11801,7,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
11801,8,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
11801,9,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11801,10,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
11802,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11803,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11804,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11804,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
11804,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11805,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11805,2,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
11806,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11807,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11807,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11807,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11808,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11808,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11809,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11810,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11811,1,Liver function test,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11812,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11812,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11812,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11813,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11814,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11814,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11815,1,Extradural abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
11816,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11817,1,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11818,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11818,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11818,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11819,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
11819,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11820,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11820,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11820,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11821,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11821,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11821,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11821,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11822,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
11822,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11822,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11823,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11823,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11823,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
11823,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11823,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11824,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11824,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11824,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11824,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11824,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11824,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
11824,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11825,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11825,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11825,3,Headache,Headaches NEC,Headaches,Nerv,N
11825,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11825,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11826,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11826,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11826,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11826,4,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11827,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
11827,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
11827,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11828,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11829,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11829,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11829,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11829,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11829,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11829,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11829,7,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11830,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11830,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11831,1,Headache,Headaches NEC,Headaches,Nerv,N
11831,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11831,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11831,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11832,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
11833,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11833,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11833,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
11833,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
11833,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11834,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11835,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11835,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
11836,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11836,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11836,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11837,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11837,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11837,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11837,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11837,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11837,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11838,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11839,1,Headache,Headaches NEC,Headaches,Nerv,N
11839,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11839,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11840,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11841,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11841,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11842,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
11842,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11843,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
11844,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11845,1,Headache,Headaches NEC,Headaches,Nerv,N
11845,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11846,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
11847,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11847,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11848,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11848,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11849,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11849,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11849,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
11849,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11850,1,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11851,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11851,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11852,1,Headache,Headaches NEC,Headaches,Nerv,N
11853,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11853,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
11853,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11854,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11854,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
11854,3,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11854,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11855,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11855,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11855,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
11855,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11856,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11856,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11856,3,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11856,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11857,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11858,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
11858,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11859,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11859,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11859,3,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
11859,4,Peripheral artery stenosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
11859,5,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11860,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11860,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11860,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
11860,4,Headache,Headaches NEC,Headaches,Nerv,N
11860,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11860,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11861,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11861,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11861,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11861,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11861,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11861,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11862,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11862,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11862,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11862,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
11863,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11863,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
11863,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
11863,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
11863,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11863,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11863,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11864,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11864,2,Headache,Headaches NEC,Headaches,Nerv,N
11864,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11864,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11864,5,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
11864,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11865,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
11865,2,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11865,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
11866,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11866,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11866,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11867,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11867,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
11867,3,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
11867,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11868,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11868,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
11869,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11870,1,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11871,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11871,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11871,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11871,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11871,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11871,6,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11871,7,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11872,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11872,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11872,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11873,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11874,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11874,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11874,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11875,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11875,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11876,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11876,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
11877,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11878,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11878,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11879,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11880,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
11880,2,Headache,Headaches NEC,Headaches,Nerv,N
11880,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
11880,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11880,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
11881,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11882,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
11883,1,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11884,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11884,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11884,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11884,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11885,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
11885,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11885,3,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
11885,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11886,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11886,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11886,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11886,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11887,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11888,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
11888,2,Exposure via skin contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
11888,3,Headache,Headaches NEC,Headaches,Nerv,N
11889,1,Headache,Headaches NEC,Headaches,Nerv,N
11889,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11890,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
11891,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
11892,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11892,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11893,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
11894,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11895,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11895,2,Deafness,Hearing losses,Hearing disorders,Ear,N
11895,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11895,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11895,5,Headache,Headaches NEC,Headaches,Nerv,N
11895,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11895,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
11895,8,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11895,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11895,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11896,1,Exposure to communicable disease,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
11897,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11897,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11898,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
11899,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11900,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11901,1,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
11901,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11902,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11902,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
11902,3,Rapid eye movement sleep behaviour disorder,Parasomnias,Sleep disorders and disturbances,Psych,N
11902,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
11903,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11903,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11903,3,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11903,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11903,5,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11903,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11903,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
11903,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
11903,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11903,10,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11903,11,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
11904,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
11904,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11904,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11905,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
11906,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
11907,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11908,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11909,1,Headache,Headaches NEC,Headaches,Nerv,N
11909,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11910,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
11910,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
11911,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11912,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
11913,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11913,2,Headache,Headaches NEC,Headaches,Nerv,N
11913,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
11914,1,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
11914,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
11914,3,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
11915,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11916,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11916,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11916,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11917,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11917,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11918,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11918,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11919,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11919,2,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
11919,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11919,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11920,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11921,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
11922,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11922,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11923,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
11923,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
11923,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11923,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11924,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11924,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11924,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11924,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
11924,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11924,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11924,7,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
11924,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11924,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11925,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11926,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
11927,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11928,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11928,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11929,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11930,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11931,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11932,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11932,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11933,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11933,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11934,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
11935,1,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
11935,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
11936,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11936,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11937,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11937,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
11938,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11938,2,Steroid therapy,Hormonal therapeutic procedures NEC,Endocrine gland therapeutic procedures,Surg,N
11939,1,Headache,Headaches NEC,Headaches,Nerv,N
11939,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11939,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11940,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11941,1,Headache,Headaches NEC,Headaches,Nerv,N
11941,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11942,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11943,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11943,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11943,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
11943,4,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
11944,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11944,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
11945,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11946,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11946,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11947,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11948,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11948,2,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
11949,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11950,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11951,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11951,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11952,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11953,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11954,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11955,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11955,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11956,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11956,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11956,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11956,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
11956,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
11956,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11957,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
11957,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
11957,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11957,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
11958,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
11958,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
11958,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11959,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11960,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11960,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11960,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11960,4,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11960,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
11960,6,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
11960,7,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
11960,8,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11960,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
11960,10,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
11960,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11960,12,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11960,13,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
11960,14,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
11960,15,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
11961,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
11961,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
11962,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11962,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11963,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11963,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
11964,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11965,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11966,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11966,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11967,1,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11968,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11968,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11969,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11970,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11970,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11970,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
11970,4,Headache,Headaches NEC,Headaches,Nerv,N
11970,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11970,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11970,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11971,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
11971,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
11971,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11971,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
11972,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11972,2,Genital candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11972,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11972,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11973,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
11974,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11975,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
11975,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11975,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11975,4,Drug specific antibody absent,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
11975,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11976,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11977,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11977,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11978,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11978,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
11978,3,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
11978,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11978,5,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
11978,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11978,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11978,8,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
11978,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
11978,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
11978,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
11979,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11980,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
11981,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11982,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11982,2,Headache,Headaches NEC,Headaches,Nerv,N
11982,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
11983,1,Device issue,Device issues NEC,Device issues,Prod,N
11983,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11983,3,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
11984,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11985,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
11985,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11985,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11985,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11985,5,Headache,Headaches NEC,Headaches,Nerv,N
11985,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11985,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11985,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11985,9,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
11985,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11986,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11987,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
11988,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11988,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
11989,1,Intercepted product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11989,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
11989,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
11990,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
11991,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
11991,2,Injection site papule,Injection site reactions,Administration site reactions,Genrl,N
11991,3,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
11992,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
11992,2,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
11992,3,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
11992,4,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
11993,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11993,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11994,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11994,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11994,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11994,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11995,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
11995,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
11995,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11996,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11996,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11997,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
11997,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11998,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
11998,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11999,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12000,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12001,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
12002,1,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12002,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12002,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12002,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12003,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12004,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12004,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12005,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
12006,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12006,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
12007,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12008,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12009,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
12010,1,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
12011,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12012,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12012,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
12012,3,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
12012,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
12012,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12013,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12014,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12015,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12016,1,Folliculitis barbae,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
12017,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12017,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12017,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12017,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12018,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12019,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12020,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
12021,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12022,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12023,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
12023,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12024,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12024,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12024,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12024,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
12024,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
12024,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
12024,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12025,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12026,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
12026,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12027,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12027,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12027,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12028,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
12028,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
12029,1,Headache,Headaches NEC,Headaches,Nerv,N
12030,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12030,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12031,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12031,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12031,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12031,4,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12032,1,Extrapulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
12032,2,Ileal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
12033,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12034,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12035,1,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12036,1,Headache,Headaches NEC,Headaches,Nerv,N
12037,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
12037,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12037,3,Headache,Headaches NEC,Headaches,Nerv,N
12037,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12037,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12037,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12038,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
12039,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
12039,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
12039,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
12040,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
12040,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12040,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12040,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12041,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12041,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12042,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12042,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12042,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
12043,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
12044,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12044,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12045,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
12045,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12046,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12046,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
12047,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12047,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
12048,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12048,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12048,3,Headache,Headaches NEC,Headaches,Nerv,N
12048,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12048,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
12049,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12050,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12051,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12051,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12052,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
12053,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12054,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12055,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12056,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
12056,2,Migraine,Migraine headaches,Headaches,Nerv,N
12057,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12057,2,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12058,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12059,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
12059,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12060,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12061,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
12062,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12063,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12064,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
12064,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
12064,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
12064,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
12064,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12064,6,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
12064,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12064,8,Migraine,Migraine headaches,Headaches,Nerv,N
12064,9,Mitral valve prolapse,Mitral valvular disorders,Cardiac valve disorders,Card,N
12065,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
12066,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
12066,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
12067,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
12068,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12069,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
12070,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12070,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12070,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12070,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12071,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12071,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12071,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12072,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12073,1,Headache,Headaches NEC,Headaches,Nerv,N
12073,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
12073,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12074,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12075,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
12076,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
12077,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12077,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12077,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12077,4,Headache,Headaches NEC,Headaches,Nerv,N
12077,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12077,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12078,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12079,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12080,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12080,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12081,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
12082,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12083,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
12083,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12083,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
12083,4,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
12083,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12084,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
12085,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12085,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12085,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
12085,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12086,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12086,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12087,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
12088,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
12089,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12089,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12090,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12091,1,Antibiotic therapy,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
12091,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12091,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12092,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12093,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
12093,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
12093,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
12094,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12095,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12095,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12095,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12095,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12095,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
12095,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12096,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12097,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12097,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
12098,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
12098,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12099,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12101,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12105,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
12105,2,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
12106,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12107,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
12108,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12109,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
12109,2,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12109,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12110,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
12110,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12110,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12110,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12111,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12112,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12112,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
12113,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12113,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12113,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
12114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12115,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12115,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
12116,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12117,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12118,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12119,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
12120,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12121,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
12122,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
12123,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12123,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
12124,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
12125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12126,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12126,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12127,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
12128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12128,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12128,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12128,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
12129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12130,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12131,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12131,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12132,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12132,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12133,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
12133,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
12133,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12133,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12133,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12134,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12134,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12135,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
12135,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
12136,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
12137,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12137,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12137,3,Product expiration date issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
12138,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
12138,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
12139,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
12139,2,Migraine,Migraine headaches,Headaches,Nerv,N
12139,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
12139,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
12140,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12140,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
12140,3,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12141,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12141,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12142,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
12142,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
12142,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12142,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
12142,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
12142,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12142,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12143,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
12143,2,Coronary artery dilatation,Coronary artery disorders NEC,Coronary artery disorders,Card,N
12143,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12143,4,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
12143,5,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
12143,6,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
12144,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12145,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12145,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12145,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12145,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12146,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12147,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12148,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12149,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
12149,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12150,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12150,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12151,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12152,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12153,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
12154,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
12154,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
12154,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12154,4,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
12154,5,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
12155,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
12156,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
12157,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12157,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12158,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12158,2,Headache,Headaches NEC,Headaches,Nerv,N
12159,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
12160,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12160,2,Headache,Headaches NEC,Headaches,Nerv,N
12160,3,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
12160,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
12161,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12161,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
12161,3,Headache,Headaches NEC,Headaches,Nerv,N
12161,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12162,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12163,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12164,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12165,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12165,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12166,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
12166,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12167,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12167,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12167,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12168,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12169,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12170,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12171,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12171,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12172,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12172,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
12173,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12174,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12174,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12174,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12175,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12176,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
12177,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
12177,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12177,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12178,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12178,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
12178,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
12178,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12178,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
12178,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
12178,7,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
12179,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12180,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
12180,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12181,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12181,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
12181,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12182,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
12182,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
12183,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12183,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12184,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12184,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
12184,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12185,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
12185,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12185,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12185,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12186,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
12187,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12187,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12187,3,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
12188,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
12188,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12188,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12188,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12188,5,Mass excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12189,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
12190,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12190,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
12190,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
12190,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
12190,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12191,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12191,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
12192,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
12192,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
12193,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
12194,1,Device use confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12194,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12194,3,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12195,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12196,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12196,2,Knee operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
12197,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
12197,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
12198,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12198,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12199,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12201,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12201,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
12202,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12202,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12203,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
12204,1,Inner ear disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
12204,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12204,3,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
12204,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
12205,1,Ostomy bag placement,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
12206,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12206,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12206,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
12207,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12207,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12208,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12208,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12208,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
12208,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12208,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12208,6,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
12208,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12208,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12209,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
12209,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12210,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12211,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12212,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
12212,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12212,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
12213,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12213,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12213,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
12213,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12214,1,Headache,Headaches NEC,Headaches,Nerv,N
12214,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12214,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12214,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12215,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
12215,2,Treatment delayed,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12216,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12216,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
12217,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12218,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12219,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12219,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12219,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
12219,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12220,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12221,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
12221,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12222,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
12223,1,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
12224,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
12224,2,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
12225,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12225,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
12226,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12226,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
12226,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12226,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12226,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12226,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12227,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12227,2,Headache,Headaches NEC,Headaches,Nerv,N
12227,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
12227,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12227,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
12227,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12227,7,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
12227,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
12228,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
12229,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12229,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12230,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12230,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12231,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12232,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
12232,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12232,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12233,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12233,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12233,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12233,4,Headache,Headaches NEC,Headaches,Nerv,N
12233,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12233,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12233,7,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
12234,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
12235,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12235,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12235,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12236,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12237,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12237,2,Headache,Headaches NEC,Headaches,Nerv,N
12237,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12237,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
12237,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12237,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12237,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
12238,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12238,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12238,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12238,4,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12238,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12238,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
12239,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12239,2,Headache,Headaches NEC,Headaches,Nerv,N
12239,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
12239,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12239,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12239,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
12239,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12240,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
12240,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12240,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12242,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12242,2,Colonoscopy,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
12242,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
12242,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12243,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12244,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12244,2,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
12244,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
12245,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
12245,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
12246,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12247,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12247,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
12247,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
12247,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
12247,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12247,6,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12248,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12249,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
12249,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
12250,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
12251,1,Acne,Acnes,Skin appendage conditions,Skin,N
12251,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
